Study ID,Study_Publication_Year,Study Class,Treatment Focus (Study level),N Randomized,N Randomized Detail,PTSD Criteria Met at Baseline Percent,PTSD Criteria Met at Baseline Percent Detail,PTSD Severity at Baseline Definition,PTSD Severity at Baseline Mean,PTSD Severity at Baseline Standard Deviation,PTSD Severity at Baseline Detail,Additional PTSD Severity Data,Duration of Symptoms/Diagnosis Mean,Duration of Symptoms/Diagnosis Standard Deviation,Duration of Symptoms/Diagnosis Detail,Active Duty Military Percent,Service-Connected Veteran Percent,Service-Connected Veteran Percent Detail,Veteran Percent,Community Percent,Military Status,Military Status Detail,Age Mean,Age Standard Deviation,Age Detail,Female Percent,Female Detail,Male Percent,Race/Ethnicity Reported,"Race, White","Race, Black","Race, AIAN","Race, Asian","Race, NHPI","Race, Other","Race, Detail","Ethnicity, Hispanic","Ethnicity, Hispanic Detail",Percent Treatment-naive,Percent Treatment-naive Detail,Percent with Depression,Percent with Depression Detail,Percent with TBI History,Percent with TBI History Detail,Trauma Type,Trauma Detail,Trauma Types Mean,Trauma Types Standard Deviation,Trauma Types Detail,Trauma Events Mean,Trauma Events Standard Deviation,Trauma Events Detail,SUD Substance Class,SUD Specific Substance Target,Current SUD Inclusion/Exclusion Criteria,Percent With Any SUD Detail,Patients with Suicidality Excluded,Suicide or Self-Directed Violence Exclusion/Inclusion Criteria,Suicide or Self-Directed Violence Definition,Suicide or Self-Directed Violence Percent,Suicide or Self-Directed Violence Detail,Psychotic Disorder or Symptom Inclusion/Exclusion Criteria,Psychotic Disorder or Symptom Related Definition,Psychotic Disorder or Symptom Related Percent,Psychotic Disorder or Symptom Related Detail,Personality Disorder Definition,Personality Disorder Percent,Personality Disorder Detail,Anxiety Disorder Definition,Anxiety Disorder Percent,Anxiety Disorder Detail,Prior Inpatient Hospitalization Percent,Prior Inpatient Hospitalization Percent Detail,Geometric Point,Risk of Bias Rating,Citation,PTSDPubs ID,Year Added to PTSD-Repository
abdallah2022,2022,Pharmacotherapy,PTSD,158,"n=163 randomized, n=5 excluded ""never began"" treatment",1,,CAPS-5,39.2,8.5,,Additional definitions of PTSD severity at baseline reported in the study,,,,0.3228,,,0.6772,0,Mixed,Veteran and active duty military,43.5,11.6,,0.2342,,0.7658,Race and Ethnicity data reported,0.5949,0.1266,,,,0.2785,"""White Non-Hispanic"" entered as White; ""Hispanic"" and ""Other"" entered as Other (Hispanic also entered separately under ethnicity)",0.1962,,,Inclusion limited to participants with prior nonresponse to at least 1 antidepressant for treatment of PTSD or depression,0.99,Current major depressive episode,0%,"Severe: 0% (excluded)
Mild/moderate: NR",,,,,,,,,,,Included,"Current moderate or severe SUD: 0% (excluded)
Mild to moderate AUD: NR (allowed but % not provided)",,,,,Suicidal risk meriting crisis intervention excluded,,Psychotic disorder or features,0,Exclusion criterion,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Abdallah CG, Roache JD, Gueorguieva R, et al. Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial. Neuropsychopharmacology. 2022 Jul;47(8):1574-81. doi: 10.1038/s41386-022-01266-9. PMID: 35046508.",1586306,2023
abraham2022,2022,Other study class,PTSD,29,,1,,PCL-C,60.9,12.9,,Additional definitions of PTSD severity at baseline reported in the study,,,Time since last PTSD diagnosis: ≤2 months: 38%; 2-3 months: 31%; > 3 months: 31%,,,,,0,Mixed,"""included active duty, reserve, and National Guard service members""",32,7,,0.28,,0.72,Race and Ethnicity data reported,0.55,0.14,,,,0.31,"""Other"" includes ""other or biracial"" and ""Hispanic/Latino"" as reported in paper",0.1,,0%,All patients receiving concurrent individual psychotherapy; 93% were on psychotropic medication,,,0%,"Severe TBI: 0% (excluded)
Sustained head injury: 59%",,,,,,,,,,,Excluded,Active substance abuse disorder: 0% (excluded),,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Abraham PA, Kazman JB, Bonner JA, et al. Effects of training service dogs on service members with PTSD: A pilot-feasibility randomized study with mixed methods. Military Psychology. 2022;34(2):187-96. doi: 10.1080/08995605.2021.1984126.",1620165,2023
acarturk2016,2016,Psychotherapy,PTSD,98,,1,,IES-R,61.12,13.07,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,33.68,10.56,,0.7449,,0.2551,,,,,,,,,,,,,,,,,Terrorism/political violence/forced displacement,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (35.16896 39.0616),Some Concerns,"Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.",45262,2019
acierno2017,2017,Psychotherapy,PTSD,150,,1,,PCL-M,59.2,11.2,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,1,,Veteran,,41.8,14.5,,0.0379,,0.9621,Race and Ethnicity data reported,0.6061,0.3333,,,,0.0606,,0.053,,,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.",45948,2019
acierno2021,2021,Psychotherapy,PTSD,136,,1,,PCL-5,52.6,12.63,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,43.4,11.51,,1,,0,Race and Ethnicity data reported,0.2941,0.6397,,0.0147,0.0074,0.0441,,0.0662,,,,,,,,MST,,,,,,,,,,Excluded,Current severe substance use disorder on MINI for DSM-5: 0% (excluded),,,,,Current suicidal ideation with clear intent: 0% (excluded),,,,Active psychosis: 0% (excluded),,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Acierno R, Jaffe AE, Gilmore AK, et al. A randomized clinical trial of in-person vs. home-based telemedicine delivery of prolonged exposure for PTSD in military sexual trauma survivors. J Anxiety Disord. 2021 Oct;83:102461. doi: 10.1016/j.janxdis.2021.102461. PMID: 34391978.",1575093,2023
adenauer2011,2011,Psychotherapy,PTSD,34,,1,,CAPS,84.5,15.7,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,33.5,9.6,,0.4412,,0.5588,,,,,,,,,,,,,0.8235,,,,Terrorism/political violence/forced displacement,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (10.38578 51.10698),High,"Adenauer H, Catani C, Gola H, et al. Narrative exposure therapy for PTSD increases top-down processing of aversive stimuli -- evidence from a randomized controlled treatment trial. BMC Neurosci. 2011 Dec 19;12:127. doi: 10.1186/1471-2202-12-127. PMID: 22182346.",37889,2019
ahmadi2015,2015,Other mixed,PTSD,48,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,1,,,0,0,Active Duty Military,,29.9,7.8,,0,,1,,,,,,,,,,,0%,,,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,1,,POINT (54.27407 32.57503),High,"Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.",46896,2019
ahmadizadeh2018,2018,Nonpharmacologic biological,PTSD,65,,1,,PCL-M,70.8,8.58,,Additional definitions of PTSD severity at baseline reported in the study,25.77,4.93,,0,,,1,0,Veteran,,50.45,7.31,,0,,1,,,,,,,,,,,,68.97% psychotherapy-naïve; 22.41% pharmacotherapy-naive,,,0%,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (54.27407 32.57503),Some Concerns,"Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.",50480,2019
ahmadizadeh2019,2019,Nonpharmacologic biological,PTSD,40,,1,,PCL-5,54.29,2.86,,Additional definitions of PTSD severity at baseline reported in the study,,,mean 2.22 (SD 0.86) years since index trauma,,,,,1,Community,,43.75,10.56,,0.65,,0.35,,,,,,,,,,,,,,,0%,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,POINT (54.27407 32.57503),High,"Ahmadizadeh MJ, Rezaei M, Fitzgerald PB. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial. Brain research bulletin. 2019;153:273-8. PMID: 31560945.",1545324,2020
ahmadpanah2014,2014,Pharmacotherapy,PTSD,100,,1,,MINI,7,0.37,,Additional definitions of PTSD severity at baseline reported in the study,7.85,1.38,,,,,,1,Community,,35.51,6.41,,0.28,,0.72,,,,,,,,,,,,,0,,,,Mixed,"combat-related, accidents, natural or manmade disasters, other (not specified)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (54.27407 32.57503),Low,"Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 Jul;69(4):235-42. doi: 10.1159/000362243. PMID: 24993832.",43996,2019
akbarian2015,2015,Psychotherapy & pharmacotherapy,PTSD,40,,1,,IES-R,65.18,4.96,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,31.64,5.93,,0.7857,,0.2143,,,,,,,,,,,,,0,,,,Mixed,"intimate partner violence, accidents, illness/medical procedure",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (54.27407 32.57503),High,"Akbarian F, Bajoghli H, Haghighi M, et al. The effectiveness of cognitive behavioral therapy with respect to psychological symptoms and recovering autobiographical memory in patients suffering from post-traumatic stress disorder. Neuropsychiatr Dis Treat. 2015;11:395-404. doi: 10.2147/NDT.S79581. PMID: 25737635.",43629,2019
akuchekian2004,2004,Pharmacotherapy,PTSD,67,,1,,CAPS,49.81,8.43,,Additional definitions of PTSD severity at baseline reported in the study,17.9,2.2,,,,,1,0,Veteran,,39.8,4.19,,0,,1,,,,,,,,,,,0%,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (54.27407 32.57503),High,"Akuchekian S, Amanat S. The Comparison of Topiramate and Placebo in the Treatment of Posttraumatic Stress Disorder: A Randomized, Double- Blind Study. J Res Med Sci. 2004;9(5):240-4.",50403,2019
aldahadha2012,2012,Psychotherapy,PTSD,51,,1,,TSI,58.9,6.78,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,26.41,,range 19 to 37,0.5294,,0.4706,,,,,,,,,,,,,,,,,Accidents,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (56.09166 20.60515),High,"Aldahadha B, Al-Harthy H, Sulaiman S. The Efficacy of Eye Movement Desensitization Reprocessing in Resolving the Trauma Caused by the Road Accidents in the Sultanate of Oman. Journal of Instructional Psychology. 2012;39(3/4):146-58.",1548482,2019
alghamdi2015,2015,Psychotherapy,PTSD,34,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0,,0,1,Community,,30.4,5.1,,0,,1,,,,,,,,,,,,,,,,,,,,,,,,"8.82% reported 1 event, 17.64% reported 2-3 events, 73.53% reported >3 events",,,,,,,,,,,,,,,,,,,,,,POINT (44.53687 24.12245),High,"Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.",46524,2020
alon2022,2022,Nonpharmacologic cognitive,PTSD,60,,1,,CAPS-5,30.6,7.215,,Additional definitions of PTSD severity at baseline reported in the study,10.8,10.98,Time since traumatic event (unit of time NR),,,,,1,Community,,39.68,12.19,,0.333,Discrepancy in publication; text states 40 (66.7%) female participants but Table 1 states 20 (33.3%) female participants. Data entered from Table 1,0.667,Not reported,,,,,,,,,,,,0.567,Depressive episode (baseline comorbidity),0%,"Excluded: ""brain injury""",Mixed,Combat-related; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Terrorism/political violence/forced displacement,,,"""Thirty participants (50%) reported that they had experienced additional traumas to the main trauma encoded in the CAPS-5 interview.""",,,,,,Excluded,"""Drugs/alcohol abuse"": 0% (excluded)",,,,,Excluded: suicidal ideation,,,,Excluded: current or past psychosis,,,,GAD,0.3,"Additional anxiety disorders:
Social phobia: 23.33%
Panic disorder: 35.00%
Agoraphobia: 13.33%
Obsessive-compulsive disorder: 1.67%",,,POINT (35.00445 31.4611),Low,"Alon Y, Azriel O, Pine DS, et al. A randomized controlled trial of supervised remotely-delivered attention bias modification for posttraumatic stress disorder. Psychol Med. 2022 Feb 8:1-10. doi: 10.1017/S003329172200023X. PMID: 35132952.",1587317,2023
alsheikhali2020,2020,Psychotherapy,PTSD,40,,,,PCL-C,58.55,9.73,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,,,,1,,0,,,,,,,,,,,,,,,,,Terrorism/political violence/forced displacement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (36.77137 31.24579),High,Alsheikh Ali ASS. Efficiency of Intervention Counseling Program on the Enhanced Psychological Well-being and Reduced Post-traumatic Stress Disorder Symptoms Among Syrian Women Refugee Survivors. Clin Pract Epidemiol Ment Health. 2020 Jul 30;16(Suppl-1):134-141. doi: 10.2174/1745017902016010134. PMID: 33029190; PMCID: PMC7536727.,1558371,2022
angelakis2020,2020,Psychotherapy,PTSD,52,"53 randomized, 1 withdrawn ""due to medication status""",1,,CAPS,79.41,19.42,,Additional definitions of PTSD severity at baseline reported in the study,4.7,6.98,Years since index trauma,,,,,1,Community,,33.11,12.86,,0.92,,0.08,Race data reported,0.9,,,,,0.1,Only reports Caucasian race,,,,38.5% currently on psychotropic medication,1,Inclusion criterion,0%,Severe TBI excluded,Mixed,Accidents; Child physical abuse; Child sexual abuse; Rape/sexual assault; Community/school violence; Natural or manmade disasters; Terrorism/political violence/forced displacement; Other (traumatic loss),3.46,2.57,Number of other trauma types experienced,,,,,,Included,Current substance abuse or dependence: 26.9%,,,,,Active suicidal intent excluded,,,,,,,,"MINI, additional anxiety disorder",0.6,,,,POINT (134.491 -25.73289),Low,"Angelakis S, Weber N, Nixon RDV. Comorbid posttraumatic stress disorder and major depressive disorder: The usefulness of a sequential treatment approach within a randomised design. J Anxiety Disord. 2020 Dec;76:102324. doi: 10.1016/j.janxdis.2020.102324. Epub 2020 Oct 20. PMID: 33137600.",1560706,2022
ardani2017,2017,Pharmacotherapy,PTSD,36,,1,,PCL-M,50.5,4.92,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,50.22,5.66,,0,,1,,,,,,,,,,,0%,,0,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,1,,POINT (54.27407 32.57503),Some Concerns,"Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.",47465,2019
arntz2007,2007,Psychotherapy,PTSD,67,,1,,PSS-SR (Dutch version),26.85,10.59,,Additional definitions of PTSD severity at baseline reported in the study,3.92,7.42,,,,,,1,Community,,35.36,12.15,,0.6567,,0.3433,,,,,,,,,,,71.64%,,,,,,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)",,,,,,38.81% with multiple index traumas,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (5.281473 52.10081),High,"Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. J Behav Ther Exp Psychiatry. 2007 Dec;38(4):345-70. doi: 10.1016/j.jbtep.2007.10.006. PMID: 18005935.",30284,2019
asukai2010,2010,Psychotherapy,PTSD,24,,1,,CAPS,84.46,,SE 7.78,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,29.3,7.3,,0.875,,0.125,,,,,,,,,,,8.33%,,0.875,,,,Mixed,"rape/sexual assault, accidents, community/school violence",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,"Panic disorder: MINI 37.50%;


Generaized anxiety disorder: MINI 12.50%;


Social anxiety disorder: MINI 4.17%",,,POINT (138.0309 37.5923),Some Concerns,"Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.",84311,2019
back2019,2019,Psychotherapy,PTSD+SUD,81,,1,,CAPS-IV,79.8,18,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,40.4,10.7,,0.091,,0.909,Race and Ethnicity data reported,0.605,0.37,,,,0.025,,0.037,,,,0.296,,,,Mixed,"Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)",8.4,2.7,,,,,Mixed Alcohol/Drug,Mixed Alcohol/Drug,Included,"Alcohol use disorder only: 63.0%


Alcohol and drug use disorder: 27.2%


Drug use disorder only: 9.9%


Cigarette smoker: 56.8%",,,,,"Lifetime suicidal ideation: 42.0%


Lifetime suicide attempt: 27.2%",,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.",51384,2020
badurabrack2015a,2015,Nonpharmacologic cognitive,PTSD,52,,1,,PCL,59.38,1.8,,Additional definitions of PTSD severity at baseline reported in the study,14.14,11.46,,0,,,1,0,Veteran,,36.05,12.1,,0,,1,,,,,,,,,,,,,0.55,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,Cluster B personality disorder: DSM-IV,0.1538,,Generalized anxiety disorder: DSM-IV,0.3846,,,,POINT (35.00445 31.4611),High,"Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.",44617,2019
badurabrack2015b,2015,Nonpharmacologic cognitive,PTSD,46,,1,,CAPS,72.26,3.26,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,32.43,7.93,,0,,1,,,,,,,,,,,,,0.59,,0%,,Combat-related,,,,,,,,,,Excluded,"""Substance use dependence"": 0%


Substance abuse: NR


AUD: NR",,,,,,,,,,Cluster B personality disorder: DSM-IV,0.0435,,,,"Generalized anxiety disorder: DSM-IV 8.70%;


Panic disorder: DSM-IV 15.22%;


Social phobia: DSM-IV 4.35%",,,POINT (-95.71289 37.09024),High,"Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.",44617,2019
baekkelund2021,2021,Psychotherapy,PTSD,89,,1,,PSS-I,33.37,8.21,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,39.15,9.9,,0.843,,0.157,,,,,,,,,,,,"59.1% with ""previous PTSD diagnosis or treatment""",0.91,MINI any depressive disorder (present or lifetime),,,Mixed,Child physical abuse; Child sexual abuse; Child other abuse,3.58,1.12,Number of Childhood Trauma Questionaire abuse types,,,,,,Excluded,"Excluded ""serious substance abuse interfering with treatment""",,,MINI severe suicidality (score >2),0.079,Acute suicidality excluded,,MINI any psychotic disorder (present or lifetime),0.112,"""Serious psychotic symptoms"" excluded",,,,MINI any anxiety disorder (present or lifetime),0.82,,0.422,,POINT (15.34833 68.75014),Low,"Baekkelund H, Karlsrud I, Hoffart A, et al. Stabilizing group treatment for childhood-abuse related PTSD: a randomized controlled trial. Eur J Psychotraumatol. 2021 Jan 22;12(1):1859079. doi: 10.1080/20008198.2020.1859079. PMID: 33537118.",1564973,2022
baig2022,2022,Psychotherapy & pharmacotherapy,PTSD,20,,1,,CAPS-5,49.4,6.77,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,53.5,13.36,,0.05,,0.95,Race and Ethnicity data reported,0.9,0.1,,,,,,0.6,,,,,,100%,All had a history of mild TBI,Combat-related,,,,,,,,,,Excluded,SUD severe enough to require medical detoxification or inpatient hospitalization in the past month: 0% (excluded),,,,,Excluded ongoing serious suicidal risk,,Schizophrenia or schizoaffective disorder,0,Exclusion criterion,,,,,,,,,POINT (-95.71289 37.09024),High,"Baig MR, Wilson JL, Beck RD, et al. Quetiapine as an adjunct to enhance engagement in prolonged exposure therapy for PTSD in veterans: A randomized, pilot trial. Journal of Behavioral and Cognitive Therapy. 2022 doi: 10.1016/j.jbct.2022.04.001.",1620166,2023
baker1995,1995,Pharmacotherapy,PTSD,118,,1,,CAPS,83.4,18,,Additional definitions of PTSD severity at baseline reported in the study,12.81,11.22,,0,,,0.602,0.398,Mixed,,44,7.2,,0.193,,0.807,,,,,,,,,,,,,0,,,,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.",6773,2019
baniasadi2014,2014,Pharmacotherapy,PTSD,37,,1,,PCL-M,55.94,7.71,,Additional definitions of PTSD severity at baseline reported in the study,17.5,11.1,,0,,,1,0,Veteran,,48.2,3.6,,0,,1,,,,,,,,,,,0%,,,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (54.27407 32.57503),High,"Baniasadi M, Hosseini G, Fayyazi Bordbar MR, et al. Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Psychiatr Pract. 2014 Nov;20(6):419-27. doi: 10.1097/01.pra.0000456590.12998.41. PMID: 25406046.",44618,2019
basoglu2005,2005,Psychotherapy,PTSD,59,,1,,CAPS,64.3,15.4,,Additional definitions of PTSD severity at baseline reported in the study,3,0.3,,,,,,1,Community,,36.3,11.5,,0.8475,,0.1525,,,,,,,,,,,,,,,,,Natural or manmade disasters,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (35.16896 39.0616),Low,"Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.",18886,2019
basoglu2007,2007,Psychotherapy,PTSD,31,,1,,CAPS,62.71,12.43,,Additional definitions of PTSD severity at baseline reported in the study,,,mean 4.5 (SD 0.2) years since index trauma,0,0,,0,1,Community,,34,11,,0.871,,0.129,,,,,,,,,,,,,0.3548,,,,Natural or manmade disasters,,,,,,,,,,,,,,,,,,,,,,,,,,"Panic disorder: 9.68%


Panic disorder with agoraphobia: 19.35%",,,POINT (35.16896 39.0616),High,"Basoglu M, Salcioglu E, Livanou M. A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator. Psychological Medicine. 2007;37(2):203-13. doi: 10.1017/S0033291706009123. PMID: 17254365.",29446,2020
batki2014,2014,Pharmacotherapy,PTSD+SUD,30,,1,,CAPS,78.3,16,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,50,13.3,,0.0667,,0.9333,Race and Ethnicity data reported,0.5333,0.2333,0.0333,0.0667,0.0333,0.1,,0.0667,,,,,,,,Mixed,"combat-related, other (""civilian related trauma"")",,,,,,,Alcohol,Alcohol,Included,"Current SUD: 33.33%


Current alcohol dependence: 100%",,,Suicide attempt or ideation in 6 momths prior to enrollment,0,,,Met criteria for a psychotic disorder,0,,,,,,,,,,POINT (-95.71289 37.09024),High,"Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014 Aug;38(8):2169-77. doi: 10.1111/acer.12496. PMID: 25092377.",42646,2020
battaglia2016,2016,Other study class,PTSD+SUD,175,,1,,PCL,58.8,11.5,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,55.6,11,,0.1371,,0.8629,Race data reported,0.7029,,,,,0.2971,,,,,,0.6286,Depressive Disorder,5.14%,,,,,,,,,,Drug,Nicotine,Included,Nicotine: 100%; Substance abuse: 32.00%,,,,,,,,,,,,,"Anxiety disorder, chart diagnosis",0.1314,,,,POINT (-95.71289 37.09024),High,"Battaglia C, Peterson J, Whitfield E, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: a randomized controlled trial. J Clin Psychol. 2016 Mar;72(3):194-206. doi: 10.1002/jclp.22252. PMID: 26783736.",49060,2020
battersby2013,2013,Collaborative care,PTSD,82,,0.9481,,PCL-M,53.08,11.8,N analyzed = 72,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,60.4,2.99,,,,,,,,,,,,,,,,,0.7922,,,,,,,,,,,,,,Included,Alcohol dependence: 53.25%,,,,,,,,,,,,,,,"Generalized anxiety disorder by DSM-IV-TR criteria: 10.39%


Panic disorder by DSM-IV-TR criteria: 7.79%",,,POINT (134.491 -25.73289),High,"Battersby MW, Beattie J, Pols RG, et al. A randomised controlled trial of the Flinders Program™ of chronic condition management in Vietnam veterans with co-morbid alcohol misuse, and psychiatric and medical conditions. Aust N Z J Psychiatry. 2013 May;47(5):451-62. doi: 10.1177/0004867412471977. PMID: 23307806.",1587974,2020
beck2009,2009,Psychotherapy,PTSD,44,,1,,CAPS,57.5,15.2,completers only,Additional definitions of PTSD severity at baseline reported in the study,4.4,8.34,,,,,,1,Community,,43.3,12.8,,0.8182,,0.1818,Race and Ethnicity data reported,0.8864,0.0909,,,,0.0227,,0.0227,,,,,,,,Accidents,,,,,,,45% of participants reported additional traumatic events,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.",32054,2019
beck2021,2021,Psychotherapy & CIH,PTSD,74,,1,,HTQ,3.16,0.47,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,42,,,0.4189,,0.5811,,,,,,,,,,,,,,,,,Mixed,"Terrorism/political violence/forced displacement; Other (child abuse, unspecified); Other (adult abuse, unspecified)",,,,,,,,,Excluded,Substance abuse: 0% (excluded),,,,,,,,,,,,,,,,,,POINT (10.02799 55.98126),High,"Beck BD, Meyer SL, Simonsen E, et al. Music therapy was noninferior to verbal standard treatment of traumatized refugees in mental health care: results from a randomized clinical trial. Eur J Psychotraumatol. 2021 Jul 6;12(1):1930960. doi: 10.1080/20008198.2021.1930960. PMID: 34285768.",1574199,2022
becker2007,2007,Pharmacotherapy,PTSD,30,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,0.7857,0.2143,Mixed,,50.39,7.46,,0.2143,,0.7857,Race data reported,0.2857,0.6429,,,,0.0714,,,,,,,,,,Mixed,"combat-related, child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, illness/medical procedure, other (homicide, death/suicide of a loved one)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Becker ME, Hertzberg MA, Moore SD, et al. A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Apr;27(2):193-7. doi: 10.1097/JCP.0b013e318032eaed. PMID: 17414245.",31131,2019
beidel2011,2011,Psychotherapy,PTSD,35,,1,,CAPS,87.7,14.3,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,,,,0,,1,Race data reported,1,,,,,,,,,,,,,0%,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.",35248,2019
bell2019,2019,Other mixed,PTSD,24,characteristics reported for N analyzed = 23,,,PCL-5,47.92,12.45,,Additional definitions of PTSD severity at baseline reported in the study,,,≥6 months since traumatic event,0,,,,1,Community,,44.17,11.22,,,,,,,,,,,,,,,,,,,0%,Moderate or severe TBI,Mixed,"combat-related, rape/sexual assault, community/school violence, illness/medical procedure, natural or manmade disasters, child other abuse, other (""work-related trauma [e.g. first responders]"")",,,,6,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Bell AN, Moss D, Kallmeyer RJ. Healing the neurophysiological roots of trauma: a controlled study examining loreta z-score neurofeedback and HRV biofeedback for chronic PTSD. NeuroRegulation. 2019;6(2):54-70. doi: 10.15540/nr.6.2.54.",1515967,2020
bellehsen2021,2021,CIH,PTSD,40,,1,,CAPS-5,39.9,9,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,51.6,11.4,,0.15,,0.85,Race and Ethnicity data reported,0.575,0.225,0.1,,,0.1,"""Other or not reported"" abstracted here as Other",0.175,Caucasian (Hispanic); Hispanic ethnicity NR with other race groups,0%,"Participant inclusion required ""a stable treatment regimen of medication and/or psychotherapy for PTSD that had been in place for at least 2 months before study enrollment""",,,,,Mixed,Combat-related; Rape/sexual assault; Illness/medical procedure; Natural or manmade disasters; Other (other traumatic event),,,,,,,,,Excluded,"Excluded patients who ""reported substance dependence that had not been in remission for at least 3 months""",,,,,,,,0,"""Current acute symptoms of psychosis"" excluded",,,,,,,,,POINT (-95.71289 37.09024),Low,"Bellehsen M, Stoycheva V, Cohen BH, et al. A pilot randomized controlled trial of transcendental meditation as treatment for posttraumatic stress disorder in veterans. J Trauma Stress. 2021 Mar 18;18:18. doi: 10.1002/jts.22665. PMID: 33734493.",1554186,2022
belleville2018,2018,Psychotherapy,PTSD,42,,1,,Modified PSS-SR,66.89,22.56,,Additional definitions of PTSD severity at baseline reported in the study,,,"age at time of assault: 42.86% child [0 to 12 years], 19.05% adolescent [13 to 17], 38.10% adult [≥18]",0,0,,0,1,Community,,,,,0.881,,0.119,,,,,,,,,,,,57.14% without current use of psychotropic medications,,26.19% with mood disorder,,,Mixed,"child sexual abuse, rape/sexual assault",,,,,,repeated event for 64.29%,,,Excluded,0% (current),,,Suicidal thoughts requiring immediate intervention,0,,,"Past or


present psychotic episode",0,,,,,Anxiety disorder: SCID-IV,0.1667,,,,POINT (-106.3468 56.13037),Some Concerns,"Belleville G, Dube-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018 Aug;31(4):591-601. doi: 10.1002/jts.22306. PMID: 30070398.",50883,2020
bichescu2007,2007,Psychotherapy,PTSD,18,,1,,CIDI,11.6,2.4,,Additional definitions of PTSD severity at baseline reported in the study,42,6.3,,,,,,1,Community,,69.4,5.3,,0.0556,,0.9444,,,,,,,,,,,,,,,,,Terrorism/political violence/forced displacement,,,,,,,mean 13.7 [SD 3.7] mistreatments during detention,,,,,,,,,,,,,,,,,,,,,,POINT (10.38578 51.10698),High,"Bichescu D, Neuner F, Schauer M, et al. Narrative exposure therapy for political imprisonment-related chronic posttraumatic stress disorder and depression. Behav Res Ther. 2007 Sep;45(9):2212-20. doi: 10.1016/j.brat.2006.12.006. PMID: 17288990.",29906,2019
bisson2020,2020,Psychotherapy,PTSD,42,,1,CAPS-5,CAPS-5,48,7.67,,Additional definitions of PTSD severity at baseline reported in the study,19.28,14.17,Time since trauma,0,,,1,0,Veteran,,42.1,11.12,,0,,1,Race data reported,0.952,0.024,,,,0.024,"Study provides categories as ""White British, African, or Any other Mixed/multiple ethnic background""; categorized in this data as, respectively, White, Black, Other.",,,0%,Previous trauma-focused therapy was an inclusion criterion,0.452,Comorbid depressive disorder,,,Mixed,"Combat-related, Rape/sexual assault, Community/school violence, Other (""severe human suffering"", ""serious injury, harm or death you caused to someone"", ""fire or explosion"", ""exposure to a war zone, sudden violent death, sudden unexpected death of smoeone close to you"", ""captivity"")",,,,,,,,,Excluded,Substance dependence: 0% (excluded),,,,,Excluded current suicidal ideation,,,,Excluded current psychosis,,,,,,,,,POINT (-2.865634 54.12387),Low,"Bisson JI, van Deursen R, Hannigan B, Kitchiner N, Barawi K, Jones K, Pickles T, Skipper J, Young C, Abbott LR, van Gelderen M, Nijdam MJ, Vermetten E. Randomized controlled trial of multi-modular motion-assisted memory desensitization and reconsolidation (3MDR) for male military veterans with treatment-resistant post-traumatic stress disorder. Acta Psychiatr Scand. 2020 Aug;142(2):141-151. doi: 10.1111/acps.13200. Epub 2020 Jun 28. PMID: 32495381.",1554186,2022
bisson2022,2022,Other mixed,PTSD,196,,1,,CAPS-5,35.1,6.7,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,36.5,13.4,,0.638,,0.362,Race data reported,0.9184,0.0255,,0.0357,,0.0051,,,,,,0.571,history of depressive disorder diagnosed by a health professional,,,Mixed,"Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (""Serious incident not transportation; Sudden unexpected death of someone close; Sudden violent death; Life threatening injury; Captivity; Severe human suffering; Serious injury, harm, or death caused to someone; Other unwanted sexual experience; Any other stressful event or experience"")",,,,5.5,,"Excluded patients with ""current 
PTSD symptoms to more than one traumatic event"" but ""individuals who experienced multiple traumatic events were included if their current PTSD symptoms were to one traumatic event.""",,,Excluded,Substance dependence: 0% (excluded),,,,,"Excluded: ""active suicide risk""",,Diagnosis of psychosis,0,Exclusion criterion,,,,History of anxiety disorder diagnosed by a health professional,0.658,,,,POINT (-2.865634 54.12387),Low,"Bisson JI, Ariti C, Cullen K, et al. Guided, internet based, cognitive behavioural therapy for post-traumatic stress disorder: pragmatic, multicentre, randomised controlled non-inferiority trial (RAPID). BMJ. 2022;377:e069405. doi: 10.1136/bmj-2021-069405. PMID: 35710124.",1594681,2023
blanchard2003,2003,Psychotherapy,PTSD,98,,0.8265,,CAPS,66.9,23.4,,Additional definitions of PTSD severity at baseline reported in the study,12.9,8.8,,,,,,1,Community,,39.9,11.9,,0.7347,,0.2653,Race data reported,0.898,,,,,0.102,,,,,,,,,,Accidents,,,,,,,,,,,,,,,,,,,,,,,,Generalized anxiety disorder: SCID (completer only),0.346,,,,POINT (-95.71289 37.09024),High,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
boals2015,2015,Other study class,PTSD,70,,1,,PCL-S,49.34,14.91,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,21.2,4.7,,,,,Race and Ethnicity data reported,0.4429,0.1571,,0.0286,,0.3714,,0.3286,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.",1548485,2019
boggio2010,2010,Nonpharmacologic biological,PTSD,30,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,3.91,4.42,,,,,,1,Community,,44.5,4.4,,0.7,,0.3,,,,,,,,,,,,,,,0%,,Mixed,"rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-53.09783 -10.78778),Some Concerns,"Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.",33726,2019
bohus2013,2013,Psychotherapy,PTSD,82,,1,,CAPS,85.2,16.4,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,35.95,10.22,,1,,0,,,,,,,,,,,0%,,0.7973,,,,Child sexual abuse,,,,,,,,,,,,,,One or more events of NSSI behaviors during the 18 weeks prior to randomization,0.7,,,,,,Meeting ≥ 5 of the 9 DSM-IV BPD criteria,0.4459,,,,,,67% in the year before randomization,POINT (10.38578 51.10698),Some Concerns,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2020,2020,Psychotherapy,PTSD,193,200 randomized but 7 later found ineligible and excluded,1,DSM-5 diagnosis following sexual or physical abuse before age 18 years,CAPS-5,40.44,9.96,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0,,0,1,Community,,36.3,11.1,,1,Inclusion criterion,0,,,,,,,,,,,10.90%,89.1% with prior psychotherapy or pscyhiatric treatment,,,,,Mixed,"Child physical abuse, Child sexual abuse",,,,,,,,,Excluded,Current substance dependence: 0% (excluded),,,"≥1 suicide attempt, lifetime





Nonsuicidal self-injury at least once in last month",,,,,0,Lifetime schizophrenia exclusion criteria,3 or more DSM-5 criteria for borderline personality disorder,1,Inclusion criterion,,,,,,POINT (10.38578 51.10698),Some Concerns,"Bohus M, Kleindienst N, Hahn C, et al. Dialectical behavior therapy for posttraumatic stress disorder (DBT-PTSD) compared with cognitive processing therapy (CPT) in complex presentations of PTSD in women survivors of childhood abuse: a randomized clinical trial. JAMA Psychiatry. 2020 Jul 22;22:22. doi: 10.1001/jamapsychiatry.2020.2148. PMID: 32697288.",1556502,2022
bomyea2015,2015,Nonpharmacologic cognitive,PTSD,42,,1,,CAPS,64.24,13.77,,Additional definitions of PTSD severity at baseline reported in the study,10.27,11.62,,,,,,1,Community,,28,10.65,,1,,0,Race data reported,0.6905,0.0714,,0.2143,,0.0238,,,,,,0.524,,,,Rape/sexual assault,,,,,4.93,2.25,,,,Included,9.50%,,,,,,,,,,,,,Anxiety disorders: SCID-IV,0.476,,,,POINT (-95.71289 37.09024),High,"Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.",44517,2019
bonnmiller2021,2021,Pharmacotherapy,PTSD,80,"80 randomized, 76 completed Stage 1 outcome assessment",1,,CAPS-5,37.2,7.3,,Additional definitions of PTSD severity at baseline reported in the study,,,inclusion required symptom duration at least 6 months,0,,,1,0,Veteran,,44.9,13.8,,0.1,,0.9,Race data reported,0.663,,,,,0.337,Study reports non-Hispanic white and other,,,,,,,,,Mixed,"combat-related, other (not specified)",,,,,,,,,Excluded,Current moderate-severe Cannabis Use Disorder: 0% (excluded),,,,,,,,0,Exclusion criteria,,0,Exclusion criteria,,,,,,POINT (-95.71289 37.09024),High,"Bonn-Miller MO, Sisley S, Riggs P, et al. The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial. PLoS One. 2021;16(3):e0246990. doi: 10.1371/journal.pone.0246990. PMID: 33730032.",1566890,2022
bormann2008,2008,CIH,PTSD,29,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,1,,Veteran,,56,6.57,,0,,1,Race and Ethnicity data reported,0.66,0.14,,,,0.2,,0.1,,,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Bormann JE, Thorp S, Wetherell JL, et al. A spiritually based group intervention for combat veterans with posttraumatic stress disorder: feasibility study. J Holist Nurs. 2008 Jun;26(2):109-16. doi: 10.1177/0898010107311276. PMID: 18356284.",30929,2019
bormann2013,2013,CIH,PTSD,146,,1,,CAPS,82.95,17.86,,Additional definitions of PTSD severity at baseline reported in the study,32,11.95,,,,,1,,Veteran,,57,10.1,,0.0274,,0.9726,Race and Ethnicity data reported,0.5822,0.2466,,,,0.1712,,0.0959,,84.00%,,0.8014,,,,Combat-related,,,,,,,,,,Excluded,"AUD: 0%


SUD: NR",,,,,,,,,,,,,,,"Obsessive–Compulsive Disorder: 33.56%;


Generalized Anxiety Disorder: 56.16%",,,POINT (-95.71289 37.09024),Low,"Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.",38465,2019
bormann2018,2018,CIH,PTSD,173,,1,,CAPS,76.56,16.65,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,48.88,14.57,,0.1503,,0.8497,Race and Ethnicity data reported,0.6416,0.1445,0.0347,0.0347,0.0405,0.104,"""More than one race"" reported here as ""other""",0.1734,,,,,,,,Other,"""related to military service""",,,,,,,,,Excluded,"AUDIT consumption items score ≥3 for women or ≥4 for men: 0% (excluded)


DAST score ≥6: 0% (excluded)",,,,,Excluded severe suicidal ideation,,Schizophrenia spectrum disorders on MINI,0,Excluded,,,,,,,,,POINT (-95.71289 37.09024),Low,"Bormann JE, Thorp SR, Smith E, et al. Individual treatment of posttraumatic stress disorder using mantram repetition: a randomized clinical trial. Am J Psychiatry. 2018 Oct 1;175(10):979-88. doi: 10.1176/appi.ajp.2018.17060611. PMID: 29921143.",50584,2022
boterhovendehaan2020,2020,Psychotherapy,PTSD,155,,1,,CAPS-5,37.78,13.33,"Using pre-treatment values, not values for those waitlisted",Additional definitions of PTSD severity at baseline reported in the study,17.94,14.59,,,,,,1,Community,,38.54,11.17,,0.768,,0.232,Race data reported,,,,0.039,,0.961,"Study reports as ""Ethnic background"" (e.g. Dutch, Moroccan); ""Asian"" entered in race data element, remaining categories do not match our list and are entered as ""other""",,"Study reports as ""Ethnic background"" (e.g. Dutch, Moroccan); ""Asian"" entered in race data element, remaining categories do not match our list and are entered as ""other""",18.70%,,,,,,Mixed,"Child physical abuse; Child sexual abuse; Child other abuse; Intimate partner violence; Other (""serious injury/death""); Other (not described)",,,Index trauma required to be a childhood trauma (prior to age 16),,,14% (22/155) experienced their index trauma once only; the remainder exerienced the index trauma multiples times,,,Excluded,"Excluded: ""alcohol or drug dependence""


Allowed: ""DSM-IV diagnosis of substance abuse""",,,,,,,,0,Exclusion criterion,,,,Anxiety disorders,0.561,comorbid disorder,0.252,,,Low,"Boterhoven de Haan KL, Lee CW, Fassbinder E, et al. Imagery rescripting and eye movement desensitisation and reprocessing as treatment for adults with post-traumatic stress disorder from childhood trauma: randomised clinical trial. Br J Psychiatry. 2020 11;217(5):609-15. doi: 10.1192/bjp.2020.158. PMID: 32892758.",1558454,2022
bottche2021,2021,Other study class,PTSD,224,"227 randomized, 3 excluded for not meeting criteria (no trauma at baseline)",1,,PDS,32.4,9.3,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,25.3,5.9,,0.674,,0.326,,,,,,,,,,,,,,,,,Mixed,Rape/sexual assault; Other (sexual intercourse before age 18 with someone 5 years older; proximity to death); Other (NR),,,,5.14,3.34,According to a trauma list from the PDS part I,,,Excluded,"Substance abuse, assessed by CIDI: 0%",,,,,"Excluded ""risk of suicide"" assessed with the CIDI",,"Psychotic symptoms, assessed with the CIDI",0,Excluded,,,,,,,,,,High,"Bottche M, Wagner B, Vohringer M, et al. Is only one cognitive technique also effective? Results from a randomized controlled trial of two different versions of an internet-based cognitive behavioural intervention for post-traumatic stress disorder in Arabic-speaking countries. Eur J Psychotraumatol. 2021 Jul 15;12(1):1943870. doi: 10.1080/20008198.2021.1943870. PMID: 34345377.",1574907,2022
bradshaw2014,2014,Psychotherapy,PTSD,10,,1,,CAPS,79.4,18.33,,Additional definitions of PTSD severity at baseline reported in the study,7.3,9.3,,,,,,1,Community,,43,10,,0.8,,0.2,Race data reported,0.8,,,,,0.2,,,,,,,,,,Mixed,"rape/sexual assault, intimate partner violence, accidents, community/school violence",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-106.3468 56.13037),High,"Bradshaw RA, McDonald MJ, Grace R, et al. A randomized clinical trial of Observed and Experiential Integration (OEI): a simple, innovative intervention for affect regulation in clients with PTSD. Traumatology (Tallahass Fla). 2014 Sep;20(3):161-71. doi: 10.1037/h0099401.",45231,2019
brady2000,2000,Pharmacotherapy,PTSD,187,,1,,CAPS-2,75.9,17.6,,Additional definitions of PTSD severity at baseline reported in the study,12.2,12.3,,,,,,1,Community,,39.9,10.1,,0.733,,0.267,Race data reported,0.845,0.118,,,,0.037,,,,,,0.3316,,,,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)",,,,,,,,,Excluded,"Current abuse or dependence: 0%





Lifetime


AUD: 26.20%


SUD: 13.90%",,,,,,,,,,,,,Current anxiety disorder,0.1604,,,,POINT (-95.71289 37.09024),High,"Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.",22232,2019
brady2005,2005,Psychotherapy & pharmacotherapy,PTSD+SUD,94,,1,,CAPS,58.9,19.2,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,36.62,8.46,,0.457,,0.543,Race and Ethnicity data reported,0.851,0.117,,,,0.032,,0.011,,,,0.5426,,,,Mixed,"rape/sexual assault, accidents, community/school violence, other (childhood trauma not specified)",,,,,,,Alcohol,Alcohol,Included,"AUD: 100%


SUD: NR",,,,,,,,,,,,,Other anxiety disorder: SCID for DSM-IV,0.383,,,,POINT (-95.71289 37.09024),High,"Brady KT, Sonne SC, Anton RF, et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar;29(3):395-401. doi: 10.1097/01.ALC.0000156129.98265.57. PMID: 15770115.",27416,2020
brady2021,2021,Psychotherapy,PTSD,25,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,29.16,10.03,,0.76,,0.24,Not reported,,,,,,,,,,,Inclusion required not having received prior trauma-focused treatment,,,,,Terrorism/political violence/forced displacement,,,,,,,,,,"Excluded: ""significant and frequent substance misuse""",,,,,,Excluded recent suicide attempt or persistent severe self-harm,,,,,,,,,,,,,POINT (-2.865634 54.12387),High,"Brady F, Chisholm A, Walsh E, et al. Narrative exposure therapy for survivors of human trafficking: feasibility randomised controlled trial. BJPsych Open. 2021 Nov;7(6):e196. doi: 10.1192/bjo.2021.1029.",1585372,2023
braun1990,1990,Pharmacotherapy,PTSD,16,,1,,IES,26.5,6.71,,Additional definitions of PTSD severity at baseline reported in the study,4,,,,,,,1,Community,,38,,,,,,,,,,,,,,,,,,0.2,,0%,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (35.00445 31.4611),High,"Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.",2466,2019
bremner2017,2017,Psychotherapy & CIH,PTSD,26,"(population characteristics reported for completers, n=17)",1,,CAPS,53.6,23.2,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,1,,Veteran,,34.5,8.5,,0,,1,Race data reported,0.5882,0.4118,,,,,,,,,,,,0%,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Bremner JD, Mishra S, Campanella C, et al. A pilot study of the effects of mindfulness-based stress reduction on post-traumatic stress disorder symptoms and brain response to traumatic reminders of combat in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with post-traumatic stress disorder. Front Psychiatry. 2017 Aug 25;8:157. doi: 10.3389/fpsyt.2017.00157. PMID: 28890702.",49077,2019
bremner2021,2021,Nonpharmacologic biological,PTSD,20,,1,,CAPS-5,41,9,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,,,,39,14,,0.65,,0.35,Race data reported,0.5,0.45,,,,0.05,"Race for one participant reported as ""Asian/Pacific Islander"", entered here as Other",,,,,0.2,Current MDD on SCID,0%,Excluded,Mixed,"Combat-related; Child sexual abuse; Rape/sexual assault; Community/school violence; Other (""injury or death of someone close to them; ""husband left for hockey game, never returned""; failed suicide; ""mother attempted suicide multiple times in childhood"")",,,,,,,,,,,,,,,,,"DSM-5 diagnosis of schizophrenia or schizoaffective disorder, on SCID",0,Exclusion criterion,,,,"current GAD, SCID for DSM-5",0.35,"additional current anxiety disorder diagnoses, SCID for DSM-5
Panic disorder wihout agoraphobia: 10.00%
Panic disorder with agoraphobia: 5.00%
Social phobia: 10.00%
Obsessive-compulsive disorder: 5.00%
Body dysmoprhic disorder: 5.00%",,,POINT (-95.71289 37.09024),Low,"Bremner JD, Wittbrodt MT, Gurel NZ, et al. Transcutaneous cervical vagal nerve stimulation in patients with posttraumatic stress disorder (PTSD): a pilot study of effects on PTSD symptoms and interleukin-6 response to stress. J Affect Disord Rep. 2021 Dec;6:100190. doi: 10.1016/j.jadr.2021.100190. PMID: 34778863.",1583895,2023
brom1989,1989,Psychotherapy & CIH,PTSD,112,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,5 years duration required for study entry,,,,,1,Community,,42,14.3,,0.79,,0.21,,,,,,,,,,,,,,,,,Mixed,"accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (5.281473 52.10081),High,"Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.",3090,2019
brom2017,2017,CIH,PTSD,63,,1,,CAPS,68.16,20.23,,Additional definitions of PTSD severity at baseline reported in the study,4,6.2,,,,,,1,Community,,40.51,13.05,,0.507,,0.493,,,,,,,,,,,,,,,,,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (35.00445 31.4611),Some Concerns,"Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.",48274,2019
brunet2018,2018,Other mixed,PTSD,61,,1,,CAPS,73.56,15.87,,Additional definitions of PTSD severity at baseline reported in the study,14.2,13.82,,,,,,1,Community,,39.4,11.21,,0.5833,,0.4167,Race and Ethnicity data reported,0.7,0.05,0.0833,0.0167,,0.15,,0.0833,,,,,,0%,,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,Current comorbid anxiety diagnosis,0.2167,,,,POINT (-106.3468 56.13037),Some Concerns,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
bryant2003,2003,Psychotherapy,PTSD,58,,1,,"CAPS, intensity",32.67,8.09,,Additional definitions of PTSD severity at baseline reported in the study,9.38,8.86,,,,,,1,Community,,35,11,,0.52,,0.48,,,,,,,,,,,,,,,,,Mixed,"accidents, community/school violence",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (134.491 -25.73289),Some Concerns,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2008,2008,Psychotherapy,PTSD,118,,1,,CAPS,74.39,17.83,,Additional definitions of PTSD severity at baseline reported in the study,20.08,25.44,,,,,,1,Community,,37.42,12.3,,,,,Race data reported,0.9153,,,0.0847,,,,,,,,,,,,Mixed,"accidents, community/school violence",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (134.491 -25.73289),High,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2011,2011,Psychotherapy,PTSD,28,,1,,PSS-I,25,11.1,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,43,9.1,,0.9643,,0.0357,,,,,,,,,,,,,,,,,Terrorism/political violence/forced displacement,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (101.0029 15.11816),Some Concerns,"Bryant RA, Ekassawin S, Chakkraband MLS, et al. A randomized controlled effectiveness trial of cognitive behavior therapy for post-traumatic stress disorder in terrorist-affected people in Thailand. World Psychiatry. 2011 Oct;10(3):205-9.  PMID: 21991280.",37395,2019
bryant2013,2013,Psychotherapy,PTSD,70,,1,,CAPS-2,70.81,17.06,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,39.46,12.81,,0.5429,,0.4571,Race data reported,0.8286,,,,,0.1714,,,,,,0.6349,,,,Mixed,"accidents, community/school violence",,,,,,,,,Included,11.11%,,,,,,,,,,,,,Anxiety disorder: SCID,0.3,,,,POINT (134.491 -25.73289),High,"Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.",40045,2019
bryant2019,2019,Psychotherapy,PTSD,100,,1,,CAPS,75.3,16.4,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0,,0,1,Community,,43.63,9.1,,0.23,,0.77,Race data reported,0.88,,,,,0.12,,,,,,0.54,,,,Other,"emergency service personnel including police, firefighters, and paramedics; exposure to fatality",,,,4.39,5.13,,,,Included,AUD: 23.00%,,,Imminent plans of suicide,0,,,Psychotic disorders,0,,,,,,,"GAD: 4.00%


Social phobia: 11.00%


Panic disorder: 9.00%


Agoraphobia: 7.00%",,,POINT (134.491 -25.73289),Low,"Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.",51039,2020
bryant2023,2023,Other mixed,PTSD,130,,1,,CAPS-2,82.3,19.5,,Additional definitions of PTSD severity at baseline reported in the study,4.8,5.8,Time since trauma,,,,,1,Community,,39.1,14.4,,0.61,,0.39,Race data reported,0.76,,,0.11,,0.13,,,,,,0.6231,"MDD, MINI",0%,"Moderate to severe TBI: 0% (excluded)
Mild TBI: NR",Mixed,Accidents; Community/school violence,,,,,,,,,Included,"Substance use disorder, MINI: 8%
Substance dependence, MINI: 0% (excluded",,,,,Excluded: imminent suicidal risk with plan,,,,Excluded: current psychosis,,,,"Anxiety disorder, MINI",0.4077,no further details on specific anxiety disorders,,,POINT (134.491 -25.73289),Low,"Bryant RA, Dawson KS, Azevedo S, et al. Augmenting trauma-focused psychotherapy for post-traumatic stress disorder with brief aerobic exercise in Australia: a randomised clinical trial. Lancet Psychiatry. 2023;10(1):21-9. doi: 10.1016/S2215-0366(22)00368-6. PMID: 36436532.",1609320,2023
buhmann2016,2016,Psychotherapy & pharmacotherapy,PTSD,280,,1,,HTQ,3.3,0.5,,Additional definitions of PTSD severity at baseline reported in the study,14.7,10,,,,,,1,Community,,45,9,,0.4101,,0.5899,,,,,,,,,,,,psychotherapy-naive: 20.28%; antidepressant-naive: 27.65%,0.9401,,25.35%,,Terrorism/political violence/forced displacement,,,,,,,,,,,,,,,,,,Psychotic symptoms,0.09,,,,,,,,,,POINT (10.02799 55.98126),High,"Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.",46863,2019
butler2018,2018,Psychotherapy & CIH,PTSD,20,,1,,PDS,33,10.81,,Additional definitions of PTSD severity at baseline reported in the study,,,,1,0,,0,0,Active Duty Military,,28.4,6.2,,0,,1,,,,,,,,,,,,,0,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (10.38578 51.10698),High,"Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",1508056,2020
butollo2016,2016,Psychotherapy,PTSD,141,,1,,PDS,29.36,10.01,,Additional definitions of PTSD severity at baseline reported in the study,,,mean 18.85 (SD 25.30) months since index trauma,,,,,1,Community,,35.94,11.3,,0.6596,,0.4404,,,,,,,,,,,,,,,,,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",,,,2.9,1.8,,,,,,,,,,,,,,,,,,Anxiety disorder : DIA-X (modified version of CIDI),0.461,,,,POINT (10.38578 51.10698),High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butterfield2001,2001,Pharmacotherapy,PTSD,15,,1,,SI-PTSD,41.8,9.2,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,43.2,14.7,,0.9333,,0.0667,Race data reported,0.5333,0.4667,,,,,,,,,,0.5333,,,,Mixed,"MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])",,,,8.5,7.6,,,,Excluded,0%,,,,,,,,,,,,,,,"GAD: 60.00%;


Panic disorder: 53.33%",,,POINT (-95.71289 37.09024),Some Concerns,"Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.",23547,2019
capone2018,2018,Psychotherapy,PTSD+SUD,44,,1,,CAPS,77.61,15.75,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,34.19,8.75,,0.0455,,0.9545,Race and Ethnicity data reported,0.8409,0.0909,,0.0227,,0.0455,,0.1364,,,,,,,,Mixed,"MST, combat-related, child sexual abuse, rape/sexual assault",,,,,,,Mixed Alcohol/Drug,Mixed Alcohol/Drug,Included,"Current: 100% Lifetime diagnosis


AUD: 84.09%


Cannabis use disorder: 25.00%


Cocaine use disorder: 13.64%


Opioid use disorder: 11.36%


Sedative use disorder: 2.27%


Polysubstance use disorder: 2.27%",,,Suicide attempt within the past month,0,,,Acute psychotic disorder or acute psychosis,0,,,,,,,,,,POINT (-95.71289 37.09024),High,"Capone C, Presseau C, Saunders E, et al. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cognit Ther Res. 2018;42(6):735-46. doi: 10.1007/s10608-018-9931-8.",50582,2020
carey2012,2012,Pharmacotherapy,PTSD,34,,1,,CAPS,81,14,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,40.75,11.61,,0.6071,,0.3929,,,,,,,,,,,,,0,,,,Mixed,"intimate partner violence, community/school violence",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (25.08388 -29.00034),High,"Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.",38996,2019
carlson1998,1998,Psychotherapy & CIH,PTSD,35,,1,,CAPS,41.2,,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,48,5.6,,0,,1,Race data reported,0.5429,,,,,0.4571,,,,,,,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,0.7143,recent psychiatric hospitalization,POINT (-95.71289 37.09024),High,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlsson2018,2018,Psychotherapy,PTSD,140,,1,,HTQ,3.2,0.06,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,43.3,9.5,,0.4365,,0.5635,,,,,,,,,,,,,0.9841,,,,Terrorism/political violence/forced displacement,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (10.02799 55.98126),Some Concerns,"Carlsson J, Sonne C, Vindbjerg E, et al. Stress management versus cognitive restructuring in trauma-affected refugees - A pragmatic randomised study. Psychiatry Res. 2018 Aug;266:116-23. doi: 10.1016/j.psychres.2018.05.015. PMID: 29859498",1519484,2019
carr2012,2012,CIH,PTSD,17,,1,,IES-R,55.74,12.48,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,39,,range 20 to 57,0.5625,,0.4375,Race data reported,0.25,0.3125,,,,0.4375,,,,0%,,,,,,Mixed,"child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement, other (torture)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-2.865634 54.12387),High,"Carr C, D'Ardenne P, Sloboda A, et al. Group music therapy for patients with persistent post-traumatic stress disorder -- an exploratory randomized controlled trial with mixed methods evaluation. Psychol Psychother. 2012 Jun;85(2):179-202. doi: 10.1111/j.2044-8341.2011.02026.x. PMID: 22903909.",39454,2019
carter2013,2013,CIH,PTSD,31,,1,,CAPS,56.4,15.5,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,1,,1,0,Veteran,,58.5,4.3,,0,,1,,,,,,,,,,,0%,,0.28,,,,,,,,,,,,,,Excluded,"SUD: 0%


AUD: NR",,,"Suicidality ""present in any severity""",0.16,,,,,,,,,,,"Panic: MINI-Plus 20.00%;


Agoraphobia: MINI-Plus 60.00%;


Generalized anxiety disorder: MINI-Plus 72.00%;


Anxiety: MINI-Plus 16.00%",,,POINT (134.491 -25.73289),Some Concerns,"Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.",46976,2019
castillo2016,2016,Psychotherapy,PTSD,86,,1,,CAPS,72.77,10.47,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,1,,Veteran,,35.9,11,,1,,0,Race and Ethnicity data reported,0.314,,0.1744,,,0.5116,,0.4302,,,,,,36.05%,,Mixed,"MST, combat-related, other (not specified)",,,70% experienced 8 to 17 trauma types,,,66% experienced ≥ 25 trauma incidents,,,Included,3.49%,,,,,,,,,,,,,Anxiety disorder: SCID I,0.6047,,,,POINT (-95.71289 37.09024),Some Concerns,"Castillo DT, Chee CL, Nason E, et al. Group-delivered cognitive/exposure therapy for PTSD in women veterans: a randomized controlled trial. Psychol Trauma. 2016 May;8(3):404-12. doi: 10.1037/tra0000111. PMID: 26854355.",44771,2019
celik2011,2011,Pharmacotherapy,PTSD,50,,1,,CAPS,47.7,11.5,,Additional definitions of PTSD severity at baseline reported in the study,,,"(26.19% experienced traumatic event 0-6 months ago, 11.90% experienced 6 month to 3 years ago, and 61.90% experienced >3 years ago",,,,,1,Community,,30.9,6.1,,,,,,,,,,,,,,,,,,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (35.16896 39.0616),High,"Celik C, Ozdemir B, Ozmenler KN, et al. Efficacy of paroxetine and amitriptyline in posttraumatic stress disorder: an open-label comparative study. Klinik Psikofarmakol Bülteni. 2011 Sep;21(3):179-85. doi: 10.5455/bcp.20110627111141.",1519639,2019
chard2005,2005,Psychotherapy,PTSD,71,,1,,CAPS-SX,66.85,25.09,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,32.77,8.87,,1,,0,Race and Ethnicity data reported,0.814,0.1395,,,,0.0465,,0.0349,,,,0.4,,,,Child sexual abuse,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.,27944,2019
chung2004,2004,Pharmacotherapy,PTSD,113,,1,,CAPS-2,96.1,24.2,,Additional definitions of PTSD severity at baseline reported in the study,34.5,10.65,,0,,,1,0,Veteran,,59.8,6.35,,0,,1,,,,,,,,,,,,,0.1504,,,,Combat-related,,,,,,,,,,Excluded,0%,,,History of suicide attempt,0.06,,,,,,,,,,,,0.23,,POINT (127.8392 36.38525),High,"Chung MY, Min KH, Jun YJ, et al. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial. Hum Psychopharmacol. 2004 Oct;19(7):489-94. doi: 10.1002/hup.615. PMID: 15378676.",26712,2019
church2013,2013,CIH,PTSD,59,,0.9661,,PCL-M,63.7,9.1,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,51.7,14,,0.1017,,0.8983,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Church D, Hawk C, Brooks AJ, et al. Psychological trauma symptom improvement in veterans using Emotional Freedom Techniques. J Nerv Ment Dis. 2013 Feb;201(2):153-60. doi: 10.1097/NMD.0b013e31827f6351. PMID: 23364126.",40000,2019
classen2001,2001,Psychotherapy,PTSD,58,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,38.4,11.7,,1,"Sexual orientation


Heterosexual: 82.69%


Lesbian: 9.62%


Bisexual: 7.69%",0,Race and Ethnicity data reported,0.6347,0.0769,0.0385,,,0.25,,0.1538,,,,,,,,Child sexual abuse,,,,,,,inclusion criterion of ≥2 sexual abuse events,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Classen CC, Koopman C, Nevill-Manning K, et al. A preliminary report comparing trauma-focused and present-focused group therapy against a wait-listed condition among childhood sexual abuse survivors with PTSD. J Aggress Maltreat Trauma. 2001 Jun;4(2):265-88. doi: 10.1300/J146v04n02_12.",16145,2019
cloitre2002,2002,Psychotherapy,PTSD,58,,1,,CAPS,69,16.5,completers only,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,34,7.22,,1,,0,Race and Ethnicity data reported,0.46,0.2,,,,0.34,,0.15,,,,0.45,,,,Mixed,"child physical abuse, child sexual abuse",,,,,,,,,Excluded,0%,,,"""History of suicide attempts or engaging in self-mutilating behavior (e.g., cutting or burning)""",0.48,,,,,,,,,,,"Generalized anxiety disorder: SCID-I 48%;


Anxiety disorder: SCID-I 79%",,,POINT (-95.71289 37.09024),Some Concerns,"Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.",24762,2019
cloitre2010,2010,Psychotherapy,PTSD,104,,1,,CAPS,63.99,18.69,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,36.4,9.5,,1,,0,Race and Ethnicity data reported,0.3558,0.2788,,,,0.3654,,0.2596,,,,0.7404,,,,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",,,,6.57,1.17,,,,,,,,,,,,,,,,,"Avoidant personality disorder: 32%


Paranoid personality disorder: 25%


Borderline personality disorder: 24%",,,"GAD: 82.69%


Panic disorder ± agoraphobia: 50.00%


Social phobia: 63.46%


Specific phobia: 55.77%",,,POINT (-95.71289 37.09024),High,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
coffey2006,2006,Psychotherapy & CIH,PTSD,43,,1,,CAPS,65.2,18.3,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,37.5,8,,0.6744,,0.3256,Race data reported,0.2791,0.6512,0.0465,,,0.0233,,,,,,,,,,Mixed,"child physical abuse, child sexual abuse",,,,,,,,,Included,"100%


AUD: 100%


Cocaine dependence: 62.79%


Marijuana dependence: 41.86%


Amphetamine dependence: 9.30%


Opioid dependence: 18.60%


Sedative/anxiolytic dependence: 18.60%",,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Coffey SF, Stasiewicz PR, Hughes PM, et al. Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: revealing mechanisms of alcohol craving in a cue reactivity paradigm. Psychol Addict Behav. 2006 Dec;20(4):425-35. doi: 10.1037/0893-164X.20.4.425. PMID: 17176177.",34482,2019
coffey2016,2016,Psychotherapy,PTSD+SUD,126,,1,,CAPS,79,18.1,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,34,8.8,,0.4603,,0.5397,Race data reported,0.7937,0.1905,,,,0.0159,,,,,,0.8016,,0%,,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters",,,,,,Median 8,,,Included,100%,,,,,,,,,,,,,Anxiety disorders except PTSD: MINI for DSM-IV,0.6905,,,,POINT (-95.71289 37.09024),Some Concerns,"Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.",48230,2019
cohen2004,2004,Nonpharmacologic biological,PTSD,29,,1,,CAPS,89.75,17.3,,Additional definitions of PTSD severity at baseline reported in the study,5.4,7,,,,,,1,Community,,41.72,11.4,,0.29,,0.71,,,,,,,,,,,,,,,0%,,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (35.00445 31.4611),High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
connor1999,1999,Pharmacotherapy,PTSD,54,,1,,SI-PTSD,34.25,8.5,,Additional definitions of PTSD severity at baseline reported in the study,,,Median 6 (IQR 3 to 17),0,0,,0,1,Community,,,,,0.91,,0.09,Race data reported,0.93,,,,,0.07,,,,,,,,,,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)",,,,,,"(number of traumatic events reported by patients: 1 event, 3.70%; 2 events, 7.41%; 3 events, 14.81%; 4 to 6 events, 22.22%; 7 to 9 events, 29.63%; >9 events, 20.37%; NR, 1.85%)",,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.",21108,2019
connor2006,2006,Pharmacotherapy,PTSD,18,,1,,SI-PTSD,17.2,13.2,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,41.3,10.1,,0.7308,,0.2692,Race data reported,0.6154,,,,,0.3846,,,,,,0,,,,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Low,"Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.",29324,2019
cook2010,2010,Psychotherapy,PTSD,124,,1,,CAPS,80.4,14.66,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0.677,,1,0,Veteran,,59.42,3.55,,0,,1,Race data reported,0.4194,0.5161,,,,0.0645,,,,,,0.5645,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,Anxiety disorder: SCID for DSM-IV,0.524,,,,POINT (-95.71289 37.09024),High,"Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.",84153,2019
cottraux2008,2008,Psychotherapy,PTSD,60,,1,,PCL,60.52,8.91,,Additional definitions of PTSD severity at baseline reported in the study,8.44,11.73,,,,,,1,Community,,41.04,10.1,,0.7619,,0.2381,,,,,,,,,,,,23.81% pharmacotherapy-naïve; 45.24% psychotherapy-naive,,,,,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)",,,,1.78,0.9,,,,,,,,,,,,,,,Axis II personality disorder: DSM-IV,0.4762,,,,,,,POINT (2.536185 46.18701),High,"Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.",30573,2019
dadabayev2020,2020,Pharmacotherapy,PTSD,21,total for two arms for patients with comorbid PTSD and chronic pain,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,42.8,10.5,,0.381,,0.619,Race data reported,0.9524,,,,,0.0476,,,,,,,,,,Other,"""related to military service""",,,,,,,,,Excluded,"Current (past 3 months) alcohol abuse or dependence: 0% (excluded)


Active substance use disorder: 0% (excluded)",,,,,Active suicidal or homicidal ideation on presentation was exclusion criterion,,Current or lifetime history of psychotic disorder,0,Excluded,,,,,,,,,POINT (-95.71289 37.09024),Low,"Dadabayev AR, Joshi SA, Reda MH, et al. Low dose ketamine infusion for comorbid posttraumatic stress disorder and chronic pain: a randomized double-blind clinical trial. Chronic Stress (Thousand Oaks). 2020 Jan-Dec;4:2470547020981670. doi: 10.1177/2470547020981670. PMID: 33426410",1563929,2022
davidson1990,1990,Pharmacotherapy,PTSD,46,,1,,SI-PTSD,25.14,8.01,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,,,,,,,,,,,,,,,,,,,0.1957,,,,Combat-related,,1.2,0.5,,,,,,,Included,15.22%,,,,,,,,,,,,,,,"GAD: 34.78%;


Panic disorder: 13.04%",,,POINT (-95.71289 37.09024),High,"Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.",912,2019
davidson2001,2001,Pharmacotherapy,PTSD,208,,1,,CAPS-2,73.7,16.1,,Additional definitions of PTSD severity at baseline reported in the study,12.3,11.8,,,,,,1,Community,,37.1,10.6,,0.7788,,0.2212,Race data reported,0.8365,0.1202,,,,0.0433,,,,,,0.4,,,,Mixed,"accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")",,,,,,,,,Included,"AUD: 25.48%


SUD: 15.87%",,,,,,,,,,,,,Current anxiety disorder,0.1971,,,,POINT (-95.71289 37.09024),Some Concerns,"Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.",23358,2019
davidson2003,2003,Pharmacotherapy,PTSD,29,,1,,SI-PTSD,36.9,6.9,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,46.5,13,,,65.00% of 8-week completers,,,,,,,,,,,,,,0.7308,,,,Mixed,"child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,"GAD: 53.85%;


Agoraphobia: 57.69%;


Panic disorder: 30.77%;


Social anxiety: 19.23%",,,POINT (-95.71289 37.09024),High,"Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.",25290,2019
davidson2006a,2006,Pharmacotherapy,PTSD,329,,1,,CAPS-SX17,82,15.08,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,41.3,12.57,,0.541,,0.459,,,,,,,,,,,,,,,,,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,,High,"Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.",28838,2019
davidson2006b,2006,Pharmacotherapy,PTSD,538,,1,,CAPS-SX17,82.5,15.04,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,,,,,,,,,,,,,,,,,,,,,,,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.",28788,2019
davidson2007,2007,Pharmacotherapy,PTSD,232,,1,,CAPS,82.55,15.12,,Additional definitions of PTSD severity at baseline reported in the study,13.1,13.3,,,,,,1,Community,,42.6,,,0.66,,0.34,,,,,,,,,,,,,0.38,,,,Mixed,"rape/sexual assault, community/school violence, accidents, combat-related, natural or manmade disasters, other (non-specified)",,,,7.3,3.1,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Davidson JR, Brady K, Mellman TA, et al. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol. 2007 Feb;27(1):85-8. doi: 10.1097/JCP.0b013e31802e5115. PMID: 17224720.",29658,2019
davis2004,2004,Pharmacotherapy,PTSD,42,,1,,CAPS,81.8,19,,Additional definitions of PTSD severity at baseline reported in the study,29.9,12.9,,0,,,0.9762,0.0238,Mixed,,53.8,8.1,,0.0238,,0.9762,Race data reported,0.5366,0.4634,,,,,,,,,,0.3902,,,,Mixed,"combat-related, rape/sexual assault",,,,,,,,,Excluded,"Current


SUD (except nicotine and caffeine): 0%


AUD (lifetime): 29.27%


SUD (lifetime): 12.20%",,,,,,,,,,,,,Panic ± agoraphobia,0.0732,,,,POINT (-95.71289 37.09024),Some Concerns,"Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.",26401,2019
davis2008a,2008,Pharmacotherapy,PTSD,36,,1,,CAPS,85.14,17.33,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,53.46,7.58,,0.0571,,0.9429,Race data reported,0.9259,0.0741,,,,,,,,,,0.5714,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,Panic disorder,0.129,,,,POINT (-95.71289 37.09024),Some Concerns,"Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.",34102,2019
davis2008b,2008,Pharmacotherapy,PTSD,85,,1,,CAPS,76.3,17.3,,Additional definitions of PTSD severity at baseline reported in the study,24.4,10.9,,0,,,1,0,Veteran,,55.2,6.8,,0.0244,,0.9756,,,,,,,,,,,,,,,,,Mixed,"combat-related, other (non-specified)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347",30463,2019
davis2018b,2018,Psychotherapy & CIH,PTSD,214,,1,,CAPS-IV,82.51,18.16,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0.351,,1,0,Veteran,,51.4,11.2,,0.162,,0.838,Race data reported,0.3194,0.6387,,,,0.0419,,,,,,0.5602,,0%,Severe,Mixed,"Combat-related; Rape/sexual assault; Other (noncombat military, civilian)",,,,,,,,,Included,"Past 12 months:


Alcohol dependence: 13.09%


Alcohol abuse: 4.71%


Substance dependence: 9.42%


Substance abuse:1.57%",,,Actively considering suicide,0,,,Schizophrenia or a schizoaffective disorder,0,,,,,,,"Panic disorder: 31.41%


Agoraphobia: 43.98%


Social phobia: 21.47%


Obsessive compulsive disorder: 6.81%",,,POINT (-95.71289 37.09024),Some Concerns,"Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..",51046,2020
davis2020a,2020,Other mixed,PTSD,212,,1,,CAPS-5,36.6,8.7,,Additional definitions of PTSD severity at baseline reported in the study,,,mean 24.8 (SD 16.2) years since index trauma,,,,,0.086,Mixed,"""91.4% veteran or active duty""",50.6,12.9,,0.34,,0.66,Race data reported,0.617,0.313,,,,0.072,,,,,21.5% had no history or did not remember,,,13.90%,,Mixed,"MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",1552693,2020
davis2020b,2020,Pharmacotherapy,PTSD,78,,1,,CAPS,81,15.2,,Additional definitions of PTSD severity at baseline reported in the study,4.65,4.9,Duration of PTSD illness,0,0.487,,1,0,Veteran,,38,9.9,,0.064,,0.936,Race and Ethnicity data reported,0.385,0.59,,,,0.026,,0.013,"Spanish, Hispanic, or Latino",,,0.59,Current MDD,,,Mixed,"Combat-related, Other (not specified)",,,,,,,,,Excluded,"Substance abuse or dependence in the past month: 0% (excluded)


Past year:


Alcohol dependence: 10.3%


Alcohol abuse: 15.4%


Substance dependence: 3.8%


Substance abuse: 1.3%",,,MADRS question 10 score ≥6,0,"Excluded.


Active suicidal ideation also an exclusion criterion",,Lifetime psychotic disorder or active psychotic ideation,0,Excluded,,,,See detail,,"Current


Panic disorder: 20.5%


Agoraphobia: 25.6%


Social anxiety: 15.4%",,,POINT (-95.71289 37.09024),Low,"Davis LL, Pilkinton P, Lin C, et al. A randomized, placebo-controlled trial of mirtazapine for the treatment of posttraumatic stress disorder in veterans. J Clin Psychiatry. 2020 10 20;81(6):20. doi: 10.4088/JCP.20m13267. PMID: 33084254",1560536,2022
davis2021,2021,Psychotherapy,PTSD,92,46 couples; data for sample characteristics entered for veterans only,1,,CAPS-IV,70.8,13.2,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,40,10.3,,0.1087,,0.8913,Race data reported,0.8696,,,,,0.1304,White is only category reported,,,,,0.217,,34.80%,"Described in text as any experience of TBI, but in Table 1 as having TBI as index trauma",Mixed,Combat-related; Other (TBI),,,,,,,,,Included,"NR; history of substance abuse permitted, with agreement to limit use that would interfere with treatment.",,,,,Imminent suicidality was exclusion criterion,,,,Uncontrolled psychotic disorder was exclusion criterion,,,,Anxiety,0.1739,,,,POINT (-95.71289 37.09024),High,"Davis LW, Luedtke BL, Monson C, et al. Testing adaptations of cognitive-behavioral conjoint therapy for PTSD: a randomized controlled pilot study with veterans. Couple Family Psychol. 2021 Jun;10(2):71-86. doi: 10.1037/cfp0000148.",1571223,2022
decker2018,2018,Psychotherapy & CIH,PTSD,38,"characteristics reported for completers, n=31",1,,PCL-M,68.2,8,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,44.5,,,0.0323,,0.9677,Race data reported,0.5484,0.4516,,,,,,,,,,0.6452,severe depression,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,Agoraphobia:,,,POINT (-95.71289 37.09024),High,"Decker KP, Deaver SP, Abbey V, et al. Quantitatively improved treatment outcomes for combat-associated PTSD with adjunctive art therapy: randomized controlled trial. Art Therapy. 2018;35(4):184-94. doi: 10.1080/07421656.2018.1540822.",1587975,2020
dedert2019,2019,Psychotherapy,PTSD+SUD,40,,1,,CAPS-5,39.1,9.6,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,49.5,10.8,,0.825,,0.175,Race and Ethnicity data reported,0.25,0.575,,,,0.175,,0.05,,,,0.375,,,,,,,,,,,,Drug,Nicotine,Excluded,"Nicotine: 100%; Other Current


SUD (except nicotine): 0% Lifetime AUD: 60.00%


Lifetime drug dependence: 72.50%",,,,,,,,,,,,,,,Social anxiety:,,,POINT (-95.71289 37.09024),High,"Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",1556168,2020
dekleine2012,2012,Psychotherapy & pharmacotherapy,PTSD,75,,1,,CAPS,67.88,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,38.3,11.4,,0.806,,0.194,,,,,,,,,,,,,0.5373,,,,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",,,,,,,,,Excluded,0%,,,,,,,,,,,,,Anxiety disorders,0.418,,,,POINT (5.281473 52.10081),High,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dell2022,2022,Psychotherapy,PTSD,138,,1,,CAPS-5,40.84,9.86,,Additional definitions of PTSD severity at baseline reported in the study,,,,0.3358,,,0.6642,0,Mixed,,45.56,11.85,,0.1194,,0.8806,Not reported,,,,,,,,,,,60% on psychotropic medication(s) at baseline,0.811,HADS depression ≥8,,,Mixed,Combat-related; Other (trauma occurring during military service but not required to be specific to deployment),,,,,,"Traumatic deployment exposures: mean (SD): 7.86 (3.37)
Other traumatic events N",,,Included,"AUD, AUDIT ≥8: 62.20% (reported for 127 of 134 participants)
AUD, MINI: 33.58%
SUD, MINI: 4.48%",,,Low or medium risk of self-harm,0.627,"Excluded: high risk of self-harm, with active current plans and intent",,,,Excluded: current psychosis,,,,HADS anxiety ≥8,0.88,,,,POINT (134.491 -25.73289),High,"Dell L, Sbisa AM, Forbes A, et al. Effect of massed v. standard prolonged exposure therapy on PTSD in military personnel and veterans: a non-inferiority randomised controlled trial. Psychol Med. 2022 Apr 20:1-8. doi: 10.1017/S0033291722000927. PMID: 35440345.",1592061,2023
devilly1998,1998,Psychotherapy,PTSD,51,,0.9608,,M-PTSD,118.59,22.88,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,50.1,6.48,,0,,1,,,,,,,,,,,,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (134.491 -25.73289),High,"Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.",20740,2019
devilly1999,1999,Psychotherapy,PTSD,23,"32 randomized, characteristics and results only reported for completer sample of n=23",1,,PTSD-I,92.31,12.47,,Additional definitions of PTSD severity at baseline reported in the study,9.37,12.29,mean 112.44 (SD 147.49) months,,,,,1,Community,,37.96,12.82,,0.652,,0.348,Not reported,,,,,,,,,,,43.48% currently taking psychotropic medication at baseline; 56.52% had taken psychotropic medication within the past 3 months,,,,,Mixed,"Accidents; Natural or manmade disasters; Rape/sexual assault; Community/school violence; Other (""war zone"")",,,,,,,,,,,,,,,"Excluded ""depressed with suicidal ideation judged severe enough to warrant concern for the participant’s life""",,,,"""current psychosis"" was exclusion criterion",,,,,,,,,POINT (134.491 -25.73289),High,"Devilly GJ, Spence C. The relative efficacy and treatment distress of EMDR and a cognitive-behavior trauma treatment protocol in the amelioration of posttraumatic stress disorder. J Anxiety Disord. 1999 2016-09-15;13(1-2):131-57. doi: 10.1016/S0887-6185(98)00044-9. PMID: 10225505.",14687,2023
difede2014,2014,Psychotherapy & pharmacotherapy,PTSD,25,,1,,CAPS,78.48,22.95,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,45.84,10.51,,0.24,,0.76,Race and Ethnicity data reported,0.84,0.04,,,,0.12,,0.12,,,,0.64,,,,Terrorism/political violence/forced displacement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Difede J, Cukor J, Wyka KE, et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology. 2014 Apr;39(5):1052-108. doi: 10.1038/npp.2013.317. PMID: 24217129.",41641,2019
difede2022,2022,Psychotherapy & pharmacotherapy,PTSD,192,,1,,CAPS for DSM-IV,73.04,19.47,,Additional definitions of PTSD severity at baseline reported in the study,,,,0.24,,,0.76,0,Mixed,,34.62,7.8,,0.104,,0.896,Race and Ethnicity data reported,0.458,0.151,,,,0.391,"""Other"" abstracted includes ""other"" reported + Hispanic/Latino",0.276,Ethnicity not reported separately from race,38.50%,No past PTSD treatment,0.542,MINI for DSM-IV,34.60%,Self-reported lifetime TBI,Combat-related,,,,65.3% also had physical or sexual trauma,,,,,,"Excluded: substance dependence within past 90 days, except nicotine and caffeine","Alcohol abuse: 24.0%
Substance abuse: 6.3%
Participants meeting MINI criteria for abuse (past 12 months) and dependence (past 12 months but not past 3 months)",,,,,,,Lifetime or current diagnosis of schizophrenia or other psychotic disorder,0,Exclusion criterion,,,,,,,,,POINT (-95.71289 37.09024),Low,"Difede J, Rothbaum BO, Rizzo AA, et al. Enhancing exposure therapy for posttraumatic stress disorder (PTSD): a randomized clinical trial of virtual reality and imaginal exposure with a cognitive enhancer. Translational psychiatry. 2022;12(1):299. doi: 10.1038/s41398-022-02066-x. PMID: 35896533.",1597237,2023
doenyasbarak2022,2022,Nonpharmacologic biological,PTSD,35,Sample characteristics reported for completer sample only (N=29),1,,CAPS-5,48.1,11.1,,Additional definitions of PTSD severity at baseline reported in the study,,,treatment resistant PTSD for at least 4 years (inclusion criterion),0,,,1,0,Veteran,,35.7,8.7,,0,,1,Not reported,,,,,,,,,,0%,"Treatment-resistant, exposed to at least one trauma focused therapy and pharmacotherapy (inclusion criteria)",0.7931,current major depression,0%,Excluded,Combat-related,,,,,,,,,,Excluded,Current substance use (except prescribed cannabis): 0% (excluded),,,,,Excluded: serious current suicidal ideation,,,,Excluded: current psychotic episode,,,,,,,,,POINT (35.00445 31.4611),High,"Doenyas-Barak K, Catalogna M, Kutz I, et al. Hyperbaric oxygen therapy improves symptoms, brain's microstructure and functionality in veterans with treatment resistant post-traumatic stress disorder: a prospective, randomized, controlled trial. PLoS One. 2022 Feb 22;17(2):e0264161. doi: 10.1371/journal.pone.0264161. PMID: 35192645.",1587823,2023
dorrepaal2012,2012,Psychotherapy,PTSD,71,,1,,DTS,85.3,21.8,,Additional definitions of PTSD severity at baseline reported in the study,,,51.5% have duration of symptoms >10 years,,,,,1,Community,,38.9,10.5,,1,,0,,,,,,,,,,,,,0.5493,,,,Mixed,"child sexual abuse, child physical abuse",,,,,,,,,Included,19.72%,,,,,,,,,,,,"Borderline personality disorder: Structured Interview for DSM-IV Personality: 52.11%;


Avoidant personality disorder: Structured Interview for DSM-IV Personality: 25.35%",,,"Social phobia: DSM-IV 40.85%;


Panic disorder: DSM-IV 42.25%",,,POINT (5.281473 52.10081),High,"Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.",39141,2019
dowd2020,2020,Pharmacotherapy,PTSD,25,,1,,CAPS,65,17.61,,Additional definitions of PTSD severity at baseline reported in the study,6,8,,,,,0.04,0.96,Mixed,,43,12.2,,0.4,,0.6,Race and Ethnicity data reported,0.24,0.56,,,,0.2,,0.08,,,,0.56,,,,Mixed,Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one),,,,,,,,,Excluded,Current: 0% Lifetime alcohol or substance abuse or dependency: 44.00%,,,,,,,,,,,,,,,"Social anxiety disorder: 12.00%


GAD: 4.00%",,,POINT (-95.71289 37.09024),High,"Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World J Psychiatry. 2020 Mar 19;10(3):21-8. doi: 10.5498/wjp.v10.i3.21. PMID: 32257848.",1552152,2020
duberstein2018,2018,Psychotherapy,PTSD,161,,0.8758,,MPSS,70.6,32.2,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0,,0,1,Community,,37.6,12.02,,1,,0,Race and Ethnicity data reported,0.5404,0.3737,,,,0.087,,0.1056,,,,1,,,,Child sexual abuse,,,,,,,,,,Excluded,Current: 0% Lifetime substance abuse/dependence: 38.51%,,,,,,,,,,Borderline personality disorder on SCID for DSM-IV,0.5342,,"Other anxiety disorder (not including PTSD, specific diagnoses not specified)",0.5776,,,,POINT (-95.71289 37.09024),High,"Duberstein PR, Ward EA, Chaudron LH, et al. Effectiveness of interpersonal psychotherapy-trauma for depressed women with childhood abuse histories. J Consult Clin Psychol. 2018 Oct;86(10):868-78. doi: 10.1037/ccp0000335. PMID: 30265045.",51365,2020
duffy2007,2007,Psychotherapy,PTSD,58,,1,,PDS,35.8,7.3,,Additional definitions of PTSD severity at baseline reported in the study,,,"time since trauma: median 5 [range 0.3 to 25] years for immediate cognitive therapy group, median 5.4 [range 0.2 to 32] for WL group",,,,,1,Community,,43.9,11.8,,0.3966,,0.6034,,,,,,,,,,,46.55%,psychotherapy-naive,0.6379,,,,Mixed,"terrorism/political violence/forced displacement, community/school violence, accidents",,,,,,Median 3 traumatic events for immediate cognitive therapy group; Median 3 (range 1 to 10) for WL group,,,Included,13.79%,,,,,,,,,,,,,,,"Panic disorder: DSM-IV 20.69%;


Specific phobias: DSM-IV 10.34%;


Generalized anxiety disorder: DSM-IV 5.17%;


Social phobia: DSM-IV 3.45%;


Other anxiety disorder: DSM-IV 3.45%",,,POINT (-2.865634 54.12387),Low,"Duffy M, Gillespie K, Clark DM. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. BMJ. 2007 Jun 2;334(7604):1147-50. doi: 10.1136/bmj.39021.846852.BE. PMID: 17495988.",29736,2019
dunlop2017,2017,Pharmacotherapy,PTSD,128,,1,,,,,"CAPS past month: 80.9 (14.2)





CAPS past week: 76.1 (16.1)",Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,,,,40.5,12.1,,1,,0,Race and Ethnicity data reported,0.5625,0.3594,,,,0.0781,,0.1016,,,,0.6563,,,,Mixed,"combat-related, other (unspecified child abuse, unspecified)",,,,3.6,1.9,,,,,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974",49315,2019
dunlop2021,2021,Pharmacotherapy,PTSD,41,,1,,CAPS-5,39.2,6.5,,Additional definitions of PTSD severity at baseline reported in the study,,,58.54% with index trauma >5 years before screening,,,,,1,Community,"Military/Veteran status NR, but combat was index trauma for 4 participants",42.1,11.4,,0.68,,0.32,Race and Ethnicity data reported,0.4634,0.439,,,,0.0976,"""Other/unknown"" abstracted here as Other",0.2195,,31.70%,"31.7% had failed at least one prior evidence-based medication treatment, but none had completed an evidence-based psychotherapy for PTSD (assessed by Emory Treatment Resistance Interview for PTSD). NR if participants had received other treatments.",0.6098,Current MDD on MINI for DSM-5,"Moderate/severe: 0%


Mild: NR","Excluded ""organic brain impairment (including moderate or severe traumatic brain injury)""",Mixed,"Combat-related; Child sexual abuse; Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Other (imprisonment, torture, other not specified)",,,,3.7,1.7,,,,Excluded,"Substance use disorder diagnosis (within 90 days), or positive urine drug screen: 0% (excluded)",,,Lifetime suicide attempt,0.122,"Excluded ""imminent suicidal...risk requiring immediate intervention""",,"Schizophrenia or other psychotic disorder, lifetime or current",0,Excluded,,,,,,,,,POINT (-95.71289 37.09024),Low,"Dunlop BW, Rakofsky JJ, Newport DJ, et al. Efficacy of vortioxetine monotherapy for posttraumatic stress disorder: a randomized, placebo-controlled trial. J Clin Psychopharmacol. 2021 Mar-Apr 01;41(2):172-9. doi: 10.1097/JCP.0000000000001363. PMID: 33587394",1565688,2022
dunne2012,2012,Psychotherapy,PTSD,26,,1,,DTS,22.35,8.36,,Additional definitions of PTSD severity at baseline reported in the study,,,"mean 2.4 years [SD NR, range 3 months to 5 years] of whiplash-associated disorder",,,,,1,Community,,32.54,7.09,,0.5,,0.5,,,,,,,,,,,,,0.5385,,0%,,Accidents,,,,,,,,,,Included,"AUD: 30.77%


SUD: NR",,,,,,,,,,,,,,,,,,POINT (134.491 -25.73289),High,"Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.",39572,2019
duran2020,2020,Psychotherapy,PTSD,95,,1,,DTS,88.54,27.49,,Additional definitions of PTSD severity at baseline reported in the study,7.46,10.89,,,,,,1,Community,,41.75,12.47,,0.8,,0.2,,,,,,,,,,,,,,,,,,,,,,2.37,1.55,,,,Excluded,,,,SCID,0,Excluded,,,0,Excluded,,,,,,,,,POINT (-53.09783 -10.78778),High,"Duran EP, Corchs F, Vianna A, et al. A randomized clinical trial to assess the efficacy of trial-based cognitive therapy compared to prolonged exposure for post-traumatic stress disorder: preliminary findings. CNS Spectr. 2020 May 26:1-8. doi: 10.1017/S1092852920001455. PMID: 32450928.",1553709,2022
echeburua1996,1996,Psychotherapy & CIH,PTSD,20,,1,,Scale of Severity of Posttraumatic Stress Disorder Symptoms,35.5,7.96,,Additional definitions of PTSD severity at baseline reported in the study,,,"mean 5 months [SD NR, range 4 to 13 months] since index trauma",,,,,1,Community,,22,,,1,,0,,,,,,,,,,,,,0,,,,Rape/sexual assault,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-3.647549 40.24449),Some Concerns,"Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.",7521,2019
echiverricohen2021,2021,Nonpharmacologic cognitive,PTSD,49,demographics data missing for 17/49 (34.69%) due to computer error; unclear exactly which data is missing,1,Self-report via PDS for DSM-V,PDS,38.56,3.37,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,37.69,12.8,,0.745,"Entries are reported values for total sample in Table 1. Values do not add up with percents reported by arm in Table 1 or separately in the text. Text reports total 30 female, 2 male, missing data for 17; 30/49=61.2% female; 2/49 = 4.08% male.",0.255,Race data reported,0.667,0.205,,0.051,,0.077,Entered values reported for total sample in Table 1. Do not add up to same as what is reported for each arm in Table 1.,,,,,,,,,,,,,,,,,,,,,,,,,Excluded suicidality assessed by QIDS,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Echiverri-Cohen A, Spierer L, Perez M, et al. Randomized-controlled trial of response inhibition training for individuals with PTSD and impaired response inhibition. Behav Res Ther. 2021 Aug;143:103885. doi: 10.1016/j.brat.2021.103885. PMID: 34089923.",1571015,2023
efendi2020,2020,Psychotherapy,PTSD,90,,1,CAPS-5,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,71.28,8.6,,0.744,,0.256,,,,,,,,,,,,,1,GDS-15 ≥5  (inclusion criterion),,,Natural disaster,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (117.2401 -2.21505),High,"Efendi F, Indarwati R, Aurizki GE. Effect of trauma-focused cognitive behavior therapy on depression and the quality of life of the elderly in Indonesia. Work Older People. 2020;24(3):149-57. doi: 10.1108/WWOP-02-2020-0004.",1587976,2022
ehlers2003,2003,Psychotherapy,PTSD,85,,1,,"CAPS, intensity",26.4,8.5,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,,,,,,,,,,,,,,,,,,,,,,,Accidents,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-2.865634 54.12387),Some Concerns,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2005,2005,Psychotherapy,PTSD,28,,1,,PDS,31.8,6.4,,Additional definitions of PTSD severity at baseline reported in the study,,,median time since traumatic event: 11.5 vs. 10.8 months,,,,,1,Community,,36.6,11.05,,0.536,,0.464,Race data reported,0.964,0.036,0,0,0,0,,,,,,0.4583,"Major depression, current",,,Mixed,"Accidents; Community/school violence; Other (""witness death"")",,,,,,,,,Excluded,Current alcohol or drug dependence: 0% (excluded),,,,,"Excluded ""severe depression needing immediate treatment in its own right (i.e., suicide risk)""",,History of psychosis,0,Exclusion criterion,Borderline personality disorder,0,Excluded,Anxiety disorder,0.2143,not further defined,,,POINT (-2.865634 54.12387),High,"Ehlers A, Clark DM, Hackmann A, McManus F, Fennell M. Cognitive therapy for post-traumatic stress disorder: development and evaluation. Behav Res Ther. 2005 Apr;43(4):413-31. doi: 10.1016/j.brat.2004.03.006. PMID: 15701354.",26999,2023
ehlers2014,2014,Psychotherapy,PTSD,121,,1,,CAPS,73.44,15.88,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,39,11.2,,0.5868,,0.4132,Race data reported,0.7025,,,,,0.2975,,,,63.64%,,0.3636,,,,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",,,"71.9% with ""history of other traumas besides their index traumas""",,,,,,Included,"Substance abuse (current): 16.53%


Substance dependence (current): 0%


Substance dependence (lifetime): 7.44%",,,,,,,,,,Axis II diorder,0.1983,,Anxiety disorder,0.3058,,,,POINT (-2.865634 54.12387),High,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
elbarazi2022,2022,Psychotherapy & pharmacotherapy,PTSD,150,,1,,CAPS-5,66.6,4.2,,Additional definitions of PTSD severity at baseline reported in the study,,,"Duration of PTSD
>6 months: 2.67%
12-24 months: 25.33%
2-5 years: 56.00%
6-10 years: 16.00%",,,,,1,Community,,,,"Age reported in ranges
20-30: 76.67%
31-40: 12.67%
41-50: 8.67%
>50: 2.00%",0.0467,,0.9533,Not reported,,,,,,,,,,,,,,,,Mixed,"Accidents; Community/school violence; Rape/sexual assault; Other (war, threatened physical assault, threatened sexual violence)",,,,,,,Mixed Alcohol/Drug,Mixed Alcohol/Drug,Included,"SUD, DSM-5 diagnostic criteria: 100%
Substance used
Alcohol: 0.67%
Cannabis: 48.00%
Hallucinogen: 22.67%
Inhalant: 9.33%
Opioid: 7.33%
Sedative, hypnotic, or anxiolytic: 0.67%
Amphetamine or another stimulant: 0.67%
Other unknown: 10.67%",,,,,,,Schizophrenia or other psychotic disorder,0,Exclusion criterion,,,,,,,,,POINT (29.8619 26.49593),Some Concerns,"ElBarazi A, Badary OA, Elmazar MM, et al. Cognitive Processing Therapy versus medication for the treatment of comorbid substance use disorder and post-traumatic stress disorder in Egyptian patients (randomized clinical trial). Journal of Evidence-Based Psychotherapies. 2022;22(2):63-90. doi: 10.24193/jebp.2022.2.13.",1620168,2023
elbogen2019,2019,Nonpharmacologic cognitive,PTSD,112,,1,,CAPS,75.63,17.3,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,36.52,8.42,,0.098,,0.902,Race data reported,0.527,,,,,0.473,,,,,,,,,"Any severity TBI: 100%


Mild TBI: 42.9%


Moderate/severe TBI: 57.1%",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Elbogen EB, Dennis PA, Van Voorhees EE, et al. Cognitive rehabilitation with mobile technology and social support for veterans with TBI and PTSD: a randomized clinical trial. J Head Trauma Rehabil. 2019 Jan/Feb;34(1):1-10. doi: 10.1097/HTR.0000000000000435. PMID: 30169439.",51118,2020
engel2014,2014,CIH,PTSD,55,,1,,PCL-C,58.1,11.4,,Additional definitions of PTSD severity at baseline reported in the study,,,,1,0,,0,0,Active Duty Military,,34.8,9.7,,0.309,,0.691,Race data reported,0.491,0.309,,,,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Low,"Engel CC, Cordova EH, Benedek DM, et al. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S57-64. doi: 10.1097/mlr.0000000000000237. PMID: 25397825.",43160,2019
engel2015,2015,Other study class,PTSD,80,,1,,PCL,56.99,10.43,,Additional definitions of PTSD severity at baseline reported in the study,,,,0.6,,,0.4,,Mixed,,36.43,8.73,,0.1875,,0.8125,Race data reported,0.55,,,,,0.45,,,,,,,,,,Mixed,"combat-related, MST",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Engel CC, Litz B, Magruder KM, et al. Delivery of self training and education for stressful situations (DESTRESS-PC): a randomized trial of nurse assisted online self-management for PTSD in primary care. Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):323-8. doi: 10.1016/j.genhosppsych.2015.04.007. PMID: 25929985.",44647,2019
engel2016,2016,Collaborative care,PTSD,666,,0.8498,,PCL-C,58.1,11,,Additional definitions of PTSD severity at baseline reported in the study,,,,1,0,,0,0,Active Duty Military,,31.2,7.7,,0.1907,,0.8093,Race and Ethnicity data reported,0.479,,,,,0.521,,0.1757,,,,0.6486,,,,,,,,,,,,,,Excluded,"Current alcohol dependence: 0%





Current substance dependence: NR",,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Low,"Engel CC, Jaycox LH, Freed MC, et al. Centrally assisted collaborative telecare for posttraumatic stress disorder and depression among military personnel attending primary care: a randomized clinical trial. JAMA Intern Med. 2016 Jul 1;176(7):948-56. doi: 10.1001/jamainternmed.2016.2402. PMID: 27294447.",45003,2019
falsetti2008,2008,Psychotherapy,PTSD,60,,1,,MPSS-SR,68.93,20.38,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,35,9.82,,1,,0,Race and Ethnicity data reported,0.6935,0.2419,0.0161,0.0161,,0.0323,,0.0323,,,,,,,,Mixed,"child sexual abuse, rape/sexual assault, community/school violence, natural or manmade disasters",,,,6,2.03,,,,,,,,,,,,,,,,,,Panic disorder: Anxiety Disorders Interview Schedule-Revised,0.9167,,,,POINT (-95.71289 37.09024),High,"Falsetti SA, Resnick HS, Davis JL. Multiple channel exposure therapy for women with PTSD and comorbid panic attacks. Cogn Behav Ther. 2008;37(2):117-30. doi: 10.1080/16506070801969088. PMID: 18470742.",82073,2019
fani2009,2009,Pharmacotherapy,PTSD,43,(all baseline characteristics reported only for 18 completers),1,,CAPS,70.72,26.08,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,41.44,9.65,,0.556,,0.444,Race data reported,0.556,0.444,,,,,,,,,,0.7222,,0%,,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, other (witnessing trauma)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,"Panic disorder: 44%;


Agoraphobia: 16%;


Obsessive-compulsive disorder: 39%;


Social phobia: 11%;


Specific phobia: 22%",,,POINT (-95.71289 37.09024),High,"Fani N, Kitayama N, Ashraf A, et al. Neuropsychological functioning in patients with posttraumatic stress disorder following short-term paroxetine treatment. Psychopharmacol Bull. 2009 Jan 1;42(1):53-68.  PMID: 19204651.",47120,2019
farahimanesh2021,2021,Psychotherapy,PTSD,60,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,49.4,10.66,,0.68,,0.32,,,,,,,,,,,,,,,,,,,,,,,,,,,Excluded,"Alcohol abuse or dependence: 0% (excluded)


Drug abuse or dependence: 0% (excluded)",,,Suicide attempt within last 6 months,0,Exclusion criterion,,Current psychotic disorder,0,Exclusion criterion,,,,,,,,,POINT (54.27407 32.57503),Some Concerns,"Farahimanesh S, Moradi A, Sadeghi M, et al. Comparing the efficacy of competitive memory training (COMET) and memory specificity training (MEST) on posttraumatic stress disorder among newly diagnosed cancer patients. Cognit Ther Res. 2021;45(5):918-28. doi: 10.1007/s10608-020-10175-4.",1561688,2022
fecteau1999,1999,Psychotherapy,PTSD,23,,1,,CAPS-2,74.1,19.7,,Additional definitions of PTSD severity at baseline reported in the study,,,mean 18.8 months [range 3 to 95 months] since target motor vehicle accident,,,,,1,Community,,41.3,,,0.7,,0.3,,,,,,,,,,,,,,,0%,,Accidents,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-106.3468 56.13037),High,"Fecteau GW, Nicki RM. Cognitive behavioural treatment of post traumatic stress disorder after motor vehicle accident. Behav. Cogn. Psychother. 1999 Jul;27(3):201-14.",21968,2019
feder2014,2014,Pharmacotherapy,PTSD,41,,1,,CAPS,80,13.1,,Additional definitions of PTSD severity at baseline reported in the study,13.1,13.1,,,,,,1,Community,,36.1,10.4,,0.4634,,0.5366,Race and Ethnicity data reported,0.1707,0.561,,,,0.2683,,0.122,,,,,,,,Mixed,"combat-related. rape/sexual assault, accidents, community/school violence, other (fire, witnessed assault or death, witnessed 9/11 attacks)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Low,"Feder A, Parides MK, Murrough JW, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2014 Jun;71(6):681-8. doi: 10.1001/jamapsychiatry.2014.62. PMID: 24740528.",42218,2019
feder2021,2021,Pharmacotherapy,PTSD,30,,1,,CAPS-5,41,6,Past month,Additional definitions of PTSD severity at baseline reported in the study,14.9,13.5,Duration of PTSD,,,,,1,Community,"No specifics provided on status; some participants did report ""combat exposure"" as primary trauma",38.9,13.4,,0.7667,,0.2333,Race and Ethnicity data reported,0.5333,0.1667,,0.1667,,0.1333,,0.1,,20.00%,No prior treatment,0.7,Current MDD,,,Mixed,"Combat-related; Rape/sexual assault; Accidents; Community/school violence; Terrorism/political violence/forced displacement; Other (""witnessed violent assault or death"")",,,,,,,,,Excluded,Current AUD or SUD (within 3 months): 0% (excluded),,,"C-SSRS past week, positive response to at least one item",0.3333,"C-SSRS past week, positive response to question 1 (wish to be dead): 23.33%





C-SSRS past week, positive response to question 2 (non-specific suicidal ideation): 6.67%





C-SSRS past week, positive response to question 3 (active suicidal ideation without intent): 3.33%





C-SSRS past week, positive response to question 4 (active suicidal ideation with some intent, no plan): 3.33%",,"Psychotic disorder, lifetime",0,Lifetime psychotic disorder an exclusion criterion,,,,See detail,,"Panic disorder: 10.00%


Social anxiety disorder: 16.67%


Obsessive-compulsive disorder: 3.33%


GAD: 16.67%",,,POINT (-95.71289 37.09024),Low,"Feder A, Costi S, Rutter SB, et al. A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder. Am J Psychiatry. 2021 02 01;178(2):193-202. doi: 10.1176/appi.ajp.2020.20050596. PMID: 33397139.",1563573,2022
feng2019,2019,Other mixed,PTSD,240,,1,,CAPS,71.6,13.6,,Additional definitions of PTSD severity at baseline reported in the study,0.9,1.2,,0,0,,0,1,Community,,41.75,12.73,,0.7042,,0.2958,,,,,,,,,,,,,0.9333,,0%,,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)",,,,,,,,,Excluded,0% abuse,,,,,,,,,,,,,,,,,,POINT (103.8191 36.56177),Low,"Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",51941,2020
feske2008,2008,Psychotherapy,PTSD,27,,1,,PDS-I,35.05,8.03,,Additional definitions of PTSD severity at baseline reported in the study,17.5,,range 1.5 to 40,,,,,1,Community,,43.1,,,1,,0,Race data reported,0.0476,0.9524,,,,,,,,,,0.6667,,,,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, community/school violence",,,,,,,,,,,,,,,,,,,,Borderline personality disorder: SCID-II for DSM-IV,0.524,,,,"Panic disorder: SCID-I for DSM-IV: 38.1%;


Social phobia: SCID-I for DSM-IV: 28.6%;


Generalized anxiety disorder: SCID-I for DSM-IV: 23.8%",,,POINT (-95.71289 37.09024),High,Feske U. Treating low-income and minority women with posttraumatic stress disorder: a pilot study comparing prolonged exposure and treatment as usual conducted by community therapists. J Interpers Violence. 2008 Aug;23(8):1027-40. doi: 10.1177/0886260507313967. PMID: 18292398.,82117,2019
flanagan2018,2018,Psychotherapy & pharmacotherapy,PTSD,17,,1,,CAPS-5,39.29,10.65,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,0.588,0.412,Mixed,,43.82,14.54,,0.177,,0.823,Race data reported,0.353,0.353,,,,0.235,,,,,,,,,,Mixed,"combat-related, rape/sexual assault, accidents, terrorism/political violence/forced displacement, other (assault)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Low,"Flanagan JC, Sippel LM, Wahlquist A, et al. Augmenting prolonged exposure therapy for PTSD with intranasal oxytocin: a randomized, placebo-controlled pilot trial. J Psychiatr Res. 2018 Mar;98:64-9. doi: 10.1016/j.jpsychires.2017.12.014. PMID: 29294429.",49583,2019
foa1991,1991,Psychotherapy,PTSD,55,,1,,PSS-I,24.74,5.89,,Additional definitions of PTSD severity at baseline reported in the study,,,mean 6.2 [SD 6.7] years since assault,,,,,1,Community,,31.8,8.2,,1,,0,Race and Ethnicity data reported,0.727,0.25,,,,0.023,,0.023,,,,,,,,Rape/sexual assault,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.",2437,2019
foa1999,1999,Psychotherapy,PTSD,96,,1,,PSS-I,30.25,8.19,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,34.9,10.6,,1,,0,Race data reported,0.63,0.36,,,,,,,,,,,,,,Mixed,"rape/sexual assault, community/school violence",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",9724,2019
foa2005,2005,Psychotherapy,PTSD,104,,1,,PSS-I,64,18.7,,Additional definitions of PTSD severity at baseline reported in the study,,,mean 9.0 [SD 11.3] years since index trauma,,,,,1,Community,,31.3,9.8,,1,,0,Race data reported,0.4916,0.4358,,,,0.0726,,,,,,0.412,,,,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,"Social anxiety disorder: SCID 20.4%;


Specific phobias: SCID 20.4%;


GAD: SCID 13.9%;


Panic Disorder: SCID 11.9%",,,POINT (-95.71289 37.09024),High,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2013,2013,Psychotherapy & pharmacotherapy,PTSD+SUD,165,,1,,PSS-I,28.14,7.86,,Additional definitions of PTSD severity at baseline reported in the study,14.55,15.26,,0,,,0.1152,0.8848,Mixed,,42.78,9.76,,0.3455,,0.6545,Race and Ethnicity data reported,0.303,0.6364,0.0061,,,0.0545,,0.0424,,,,,,,,Mixed,Combat-related; Rape/sexual assault; Community/school violence; Other (not specified),,,,,,,Alcohol,Alcohol,Included,"Alcohol dependence: 100%


Other SUD: 21.21%",,,,,,,,,,Current personality disorder,0.2485,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.",40905,2020
foa2017,2017,Psychotherapy & pharmacotherapy,PTSD+SUD,142,,1,,PSS-I,28.34,6.6,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,42.7,9.9,,0.3944,,0.6056,Race and Ethnicity data reported,0.2253,0.7394,0.0211,,,0.0704,,0.0704,,,,0.5563,,,,Mixed,"Combat-related; Child sexual abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (imprisonment, torture, other)",,,,,,>1 event: 97.9%,Drug,Nicotine,Included,"Nicotine: 100%;


AUD: 34.50%;


Other SUD: 42.96%;",,,,,,,,,,,,,Comorbid anxiety disorder,0.3451,,,,POINT (-95.71289 37.09024),Some Concerns,"Foa EB, Asnaani A, Rosenfield D, et al. Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: a randomized controlled trial. J Consult Clin Psychol. 2017 Sep;85(9):862-72. doi: 10.1037/ccp0000213. PMID: 28569519.",48569,2020
foa2018,2018,Psychotherapy,PTSD,370,,1,,PSS-I,25.41,7.01,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,,,,32.69,7.39,,0.1202,,0.8798,Race and Ethnicity data reported,0.612,0.235,,0.0082,,0.1448,,0.194,,,,,,0%,,Mixed,"combat-related, other (not specified)",,,,,,,,,,,,,"Columbia Suicide Severity Rating Scale, lifetime suicide attempts",0.0892,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2022,2022,Psychotherapy,PTSD,160,,1,,CAPS-5,36.37,,,Additional definitions of PTSD severity at baseline reported in the study,8.34,7.1,Time from traumatic event,1,,,0,0,Active Duty Military,,31.94,7.9,,0.281,,0.719,Race and Ethnicity data reported,0.544,0.263,0.031,0.006,0.038,0.119,,0.145,Data available for 159 patients,,,,,0%,"Severe TBI excluded
Mild/Moderate TBI: NR",Mixed,Combat-related; Rape/sexual assault; Other (not specified),,,,,,,,,Excluded,Current severe alcohol use (score ≥4 on items 4-6 and total score ≥20 on AUDIT): 0% (excluded),,,,,"Excluded: ""current suicidal ideation severe enough to warrant immediate crisis intervention""",,,,"Excluded: current psychotic symptoms requiring
immediate stabilization or hospitalization (assessed using MINI)",,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Foa EB, Bredemeier K, Acierno R, et al. The efficacy of 90-min versus 60-min sessions of prolonged exposure for PTSD: A randomized controlled trial in active-duty military personnel. J Consult Clin Psychol. 2022;90(6):503-12. doi: 10.1037/ccp0000739. PMID: 35771512.",1595676,2023
fonzo2017,2017,Psychotherapy,PTSD,66,,1,,CAPS,68.62,15.09,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,,,,36.52,10.28,,0.6515,,0.3485,,,,,,,,,,,,,0.5303,,,,Mixed,"combat-related, illness/medical procedure, community/school violence, natural or manmade disasters, rape/sexual assault",,,33.33% reported multiple criterion A events,,,31.82% reported repeated that index trauma was repeated,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Fonzo GA, Goodkind MS, Oathes DJ, et al. PTSD psychotherapy outcome predicted by brain activation during emotional reactivity and regulation. Am J Psychiatry. 2017 Dec 1;174(12):1163-74. doi: 10.1176/appi.ajp.2017.16091072. PMID: 28715908.",48700,2019
forbes2012,2012,Psychotherapy,PTSD,59,,1,,CAPS,70.72,17.46,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,53.37,13.66,,0.0339,,0.9661,Race data reported,1,,,,,,,,,,,,,,,Other,"""military-related""",,,,,,,,,Included,44.07%,,,,,,,,,,,,,Other anxiety disorders diagnozed by MINI,0.7288,,,,POINT (134.491 -25.73289),High,"Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..",38353,2019
ford2018,2018,Psychotherapy,PTSD,31,,1,,CAPS,79.52,19.45,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,0,Mixed,,36.5,9.8,,0,,1,Race and Ethnicity data reported,0.8387,0.0968,,,,0.0645,,0.0645,,,,0.5151,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,"OCD, current: MINI 16.13%;


Panic disorder, current: MINI 41.94%;


Social/specific phobia, current: MINI 19.35%",,,POINT (-95.71289 37.09024),High,"Ford JD, Grasso DJ, Greene CA, et al. Randomized clinical trial pilot study of prolonged exposure versus present centred affect regulation therapy for PTSD and anger problems with male military combat veterans. Clin Psychol Psychother. 2018 Sep;25(5):641-9. doi: 10.1002/cpp.2194. PMID: 29687524.",50258,2019
fortney2015,2015,Collaborative care,PTSD,265,,1,,CAPS,75,12.7,,Additional definitions of PTSD severity at baseline reported in the study,,,,,0.508,,1,,Veteran,,52.2,13.8,,0.102,,0.898,Race and Ethnicity data reported,0.638,0.196,,,,0.166,,0.076,,21.90%,,0.789,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,"GAD: 67.2%;


Panic disorder: 44.2%",,,POINT (-95.71289 37.09024),High,"Fortney JC, Pyne JM, Kimbrell TA, et al. Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Jan;72(1):58-67. doi: 10.1001/jamapsychiatry.2014.1575. PMID: 25409287.",43084,2019
franklin2017,2017,Psychotherapy,PTSD,27,,1,,CAPS,68.3,13.6,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,46.1,15.5,,0.074,,0.926,Race data reported,0.692,0.231,,,,0.077,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
friedman2007,2007,Pharmacotherapy,PTSD,169,,1,,CAPS-2,72.9,19.45,,Additional definitions of PTSD severity at baseline reported in the study,18.3,11.5,,0,,,1,0,Veteran,,45.3,9.6,,0.2282,,0.7718,Race data reported,0.7101,,,,,,,,,,,0.4734,,,,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")",,,,,,,,,Excluded,0%,,,,,,,,,,,,,Current DSM-III-R anxiety disorder,0.1893,,,,POINT (-95.71289 37.09024),Some Concerns,"Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.",29522,2019
frommberger2004,2004,Psychotherapy & pharmacotherapy,PTSD,21,,1,,CAPS,67.62,10.9,,Additional definitions of PTSD severity at baseline reported in the study,2.83,2.55,,,,,,1,Community,,42.7,15,,0.5714,,0.4286,,,,,,,,,,,,,0.5238,,,,Mixed,"rape/sexual assault, accidents, community/school violence",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (10.38578 51.10698),High,"Frommberger UH, Stieglitz R-D, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int. J. Psychiatry Clin. Pract. 2004;8(1):19-24. doi: 10.1080/13651500310004803. PMID: 24937579.",27144,2019
fruchtmansteinbok2021,2021,Nonpharmacologic biological,PTSD,59,,1,,CAPS-5,36.36,2.59,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,36.6,14.56,,0.45,,0.55,Not reported,,,,,,,,,,,,,,,,Mixed,"Accidents; Combat-related; Community/school violence; Terrorism/political violence/forced displacement; Other (""life threatening injury"", ""witness trauma"", ""traumatic grief"", ""repeated exposure"")",,,,,,,,,,,,,,,Excluded: serious suicidal ideations,,Schizophrenia,0,Psychosis and schizophrenia excluded,,,,,,,,,POINT (35.00445 31.4611),High,"Fruchtman-Steinbok T, Keynan JN, Cohen A, et al. Amygdala electrical-finger-print (AmygEFP) neurofeedback guided by individually-tailored trauma script for post-traumatic stress disorder: proof-of-concept. Neuroimage Clin. 2021 Oct 15;32:102859. doi: 10.1016/j.nicl.2021.102859. PMID: 34689055.",1581869,2023
frueh2007,2007,Psychotherapy,PTSD,38,,1,,PCL-M,64.45,11.4,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,56,5,,0,,1,,,,,,,,,,,,,0.8421,,,,Combat-related,,,,,,,,,,Included,23.68%,,,,,,,Psychotic disorders diagnosed by MINI,0.2895,,,,,Anxiety disorders diagnosed by MINI,0.7368,,,,POINT (-95.71289 37.09024),High,"Frueh BC, Monnier J, Yim E, et al. A randomized trial of telepsychiatry for post-traumatic stress disorder. J. Telemed. Telecare. 2007 Apr 1;13(3):142-7. doi: 10.1258/135763307780677604. PMID: 17519056.",29644,2019
gallegos2020,2020,CIH,PTSD,29,,1,,PCL-5,49.76,14.75,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,42.69,13.11,,1,,0,Race and Ethnicity data reported,0.5172,0.1724,,0.0345,,0.2759,,0.1379,,,,,,,,Intimate partner violence,,,,,,,,,,Excluded,Current substance dependence (past 3 months): 0% (excluded),,,,,Active suicidality an exclusion criterion,,,,History of schizophrenia an exclusion criterion,,,,,,,,,POINT (-95.71289 37.09024),High,"Gallegos AM, Heffner KL, Cerulli C, et al. Effects of mindfulness training on posttraumatic stress symptoms from a community-based pilot clinical trial among survivors of intimate partner violence. Psychol Trauma. 2020 Nov;12(8):859-68. doi: 10.1037/tra0000975. PMID: 32969703.",1558890,2022
galovski2012,2012,Psychotherapy,PTSD,100,,1,,CAPS,75.65,17.62,,Additional definitions of PTSD severity at baseline reported in the study,19.07,15.98,,,,,,1,Community,,39.8,11.74,,0.69,,0.31,Race and Ethnicity data reported,0.42,0.51,,,,0.07,,0.07,,,,0.48,,,,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",,,,,,,,,Excluded,"Current: 0%





Lifetime


Alcohol dependence: 36%


Alcohol abuse: 14%


Substance dependence: 34%


Substance abuse: 13%",,,,,,,,,,,,,Current panic disorder diagnosed by SCID,0.25,,,,POINT (-95.71289 37.09024),High,"Galovski TE, Blain LM, Mott JM, et al. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012 Dec;80(6):968-81. doi: 10.1037/a0030600. PMID: 23106761.",39611,2019
galovski2016,2016,Psychotherapy & CIH,PTSD,92,,1,,"CAPS, total score without sleep item (D-1)",70.78,15.4,,Additional definitions of PTSD severity at baseline reported in the study,16.33,14.32,,,,,,1,Community,,36.87,11.8,,1,,0,Race and Ethnicity data reported,,,,,,1,"""Participants described themselves as predominantly Black [50%] or White [50%], with 20% of the sample identifying as multiracial""",0.03,,,,,,,,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Galovski TE, Harik JM, Blain LM, et al. Augmenting cognitive processing therapy to improve sleep impairment in PTSD: a randomized controlled trial. J Consult Clin Psychol. 2016 Feb;84(2):167-77. doi: 10.1037/ccp0000059. PMID: 26689303.",44664,2019
gamito2010,2010,Psychotherapy,PTSD,10,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,63.5,4.43,,0,,1,,,,,,,,,,,,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-8.501055 39.5955),High,"Gamito P, Oliveira J, Rosa P, et al. PTSD elderly war veterans: a clinical controlled pilot study. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):43-8. doi: 10.1089/cyber.2009.0237. PMID: 20528292.",33784,2019
gapen2016,2016,Nonpharmacologic biological,PTSD,23,,1,,DTS,69.14,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,,,,0.6522,,0.3478,Race data reported,0.8261,,,,,0.1739,,,,0%,,,,0%,TBI leading to functional impairments,Mixed,"child physical abuse, child sexual abuse, child other abuse, other (not specified)",6.59,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Gapen MA, van der Kolk BA, Hamlin E, et al. A pilot study of neurofeedback for chronic PTSD. Appl Psychophysiol Biofeedback. 2016 Sep;41(3):251-61. doi: 10.1007/s10484-015-9326-5. PMID: 26782083.",44803,2019
gelkopf2013,2013,CIH,PTSD,42,,1,,Modified Stanford Acute Stress Reaction,113.24,21.7,,Additional definitions of PTSD severity at baseline reported in the study,,,all had traumatic event >5 years prior,0,,,1,0,Veteran,,38.3,12.9,,0,,1,,,,,,,,,,,11.90%,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (35.00445 31.4611),High,"Gelkopf M, Hasson-Ohayon I, Bikman M, et al. Nature adventure rehabilitation for combat-related posttraumatic chronic stress disorder: a randomized control trial. Psychiatry Res. 2013 Oct 30;209(3):485-93. doi: 10.1016/j.psychres.2013.01.026. PMID: 23541513.",40581,2019
geronilla2016,2016,CIH,PTSD,58,,1,,PCL-M,66,7.4,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,50,15.1,,0.1207,,0.8793,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Geronilla L, Minewiser L, Mollon P, et al. EFT (Emotional Freedom Techniques) remediates PTSD and psychological symptoms in veterans: A randomized controlled replication trial. Energy Psychology. 2016;8(2):29.",1549292,2019
gersons2000,2000,Psychotherapy,PTSD,44,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,3,,,,,,,1,Community,,36,7,,0.119,,0.881,Race data reported,1,,,,,,,,,83.33%,,,,,,Other,occupational events,,,,21,,,,,Included,"Alcohol dependence: 26%


SUD: NR",,,,,,,,,,,,,,,,,,POINT (5.281473 52.10081),Some Concerns,"Gersons BP, Carlier IV, Lamberts RD, et al. Randomized clinical trial of brief eclectic psychotherapy for police officers with posttraumatic stress disorder. J Trauma Stress. 2000 Apr;13(2):333-47. doi: 10.1023/A:1007793803627. PMID: 10838679..",15124,2019
ghafoori2017,2017,Psychotherapy,PTSD,71,,1,,PCL-5,56.1,9.9,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,35.2,12,,0.831,,0.169,Race and Ethnicity data reported,0.282,0.197,,,,0.521,,0.437,,,,,,0%,,Mixed,"natural or manmade disaster, accidents, rape/sexual assault, community/school violence, illness/medical procedure, combat-related, terrorism/political violence/forced displacement",,,,6.49,3.45,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Ghafoori B, Hansen MC, Garibay E, et al. Feasibility of training frontline therapists in prolonged exposure: a randomized controlled pilot study of treatment of complex trauma in diverse victims of crime and violence. J Nerv Ment Dis. 2017 Apr;205(4):283-93. doi: 10.1097/NMD.0000000000000659. PMID: 28157725.",1523171,2019
gibert2022,2022,Other study class,PTSD,34,,1,,PCL-5,38.9,14.7,,Additional definitions of PTSD severity at baseline reported in the study,,,"Trauma for all participants was Paris terrorist attack on 11/13/15, and treatment began on 11/18/17 (approximately 2 years later)",,,,,1,Community,,35,6.3,,0.6471,,0.3529,Not reported,,,,,,,,,,,,,,,,Terrorism/political violence/forced displacement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (2.536185 46.18701),High,"Gibert L, Coulange M, Reynier JC, et al. Comparing meditative scuba diving versus multisport activities to improve post-traumatic stress disorder symptoms: a pilot, randomized controlled clinical trial. Eur J Psychotraumatol. 2022 Feb 7;13(1):2031590. doi: 10.1080/20008198.2022.2031590. PMID: 35145610.",1587267,2023
goldstein2018,2018,Other study class,PTSD,47,,0.8936,,CAPS,61,17.27,,Additional definitions of PTSD severity at baseline reported in the study,18.07,14.49,,,,,1,,Veteran,,46.8,14.93,,0.1915,,0.8085,Race and Ethnicity data reported,0.5319,0.2553,0.0213,0.0638,0.0213,0.0851,,0.0239,,,,0.3478,,0%,,,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Goldstein LA, Mehling WE, Metzler TJ, et al. Veterans group exercise: a randomized pilot trial of an integrative exercise program for veterans with posttraumatic stress. J Affect Disord. 2018 Feb;227:345-52. doi: 10.1016/j.jad.2017.11.002. PMID: 29145076.",49403,2019
golier2012,2012,Pharmacotherapy,PTSD,9,,1,,CAPS,68.5,9.53,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,48.88,12.68,,,,,Race and Ethnicity data reported,0.125,0.75,,,,0.125,,0.25,,,,,,0%,moderate or severe,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Golier JA, Caramanica K, Demaria R, et al. A pilot study of mifepristone in combat-related PTSD. Depress Res Treat. 2012;2012:393251. doi: 10.1155/2012/393251. PMID: 22611490.",39051,2019
gray2019a,2019,Psychotherapy,PTSD,74,,1,,PSS-I,37.51,6.69,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,48.6,13.3,,0,,1,Race and Ethnicity data reported,0.4776,0.2836,0.0448,0.0299,,0.1642,,0.1343,,,,,,,,Mixed,"MST, combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (not specified)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Low,"Gray R, Budden-Potts D, Bourke F. Reconsolidation of traumatic memories for PTSD: a randomized controlled trial of 74 male veterans. Psychother Res. 2019 29(5): 621-639. DOI: 10.1080/10503307.2017.1408973",49545,2020
gray2021,2021,Psychotherapy,PTSD,30,,1,,PSS-I,43.05,2.35,,Additional definitions of PTSD severity at baseline reported in the study,,,,0.47,,,0.5,0.03,Mixed,"All participants were 'military-related females', ""community"" here is ""military spouse""",33.7,14,,1,,0,Race and Ethnicity data reported,0.83,0.03,0.07,0.03,,0.03,,0.1,,20%,"""80% had previously participated in group, individual, or pharmacotherapy""",,,,,Mixed,"MST, Other (not specified)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Low,"Gray RM, Budden-Potts D, Schwall RJ, et al. An open-label, randomized controlled trial of the reconsolidation of traumatic memories protocol (RTM) in military women. Psychol Trauma. 2021 Sep;13(6):641-51. doi: 10.1037/tra0000986. PMID: 33211519.",1561429,2022
hall2019a,2019,Other study class,PTSD,54,,1,,PCL-5,42.3,14.61,,Additional definitions of PTSD severity at baseline reported in the study,45,,,0,,,1,0,Veteran,,67.4,3.6,,0.9074,,0.0926,Race and Ethnicity data reported,,0.8519,,,,0.1481,,0,,,,,,,,,,,,,,,,,,Excluded,Active alcohol or substance abuse: 0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Hall KS, Morey MC, Bosworth HB, et al. Pilot randomized controlled trial of exercise training for older veterans with PTSD. J Behav Med. 2019 Jul 1doi: 10.1007/s10865-019-00073-w. PMID: 31264055.",52094,2020
hamner2009,2009,Pharmacotherapy,PTSD,29,,1,,CAPS,77.11,22.94,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,52.4,7,,0.0345,,0.9655,Race data reported,0.9286,0.0714,,,,,,,,,,0.6897,,,,Mixed,"combat-related, MST",,,,,,,,,Excluded,"Current (past 1 month): 0%





Lifetime: 17.24%",,,,,,,,,,,,,Anxiety disorder,0.2414,,,,POINT (-95.71289 37.09024),High,"Hamner MB, Faldowski RA, Robert S, et al. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry. 2009 Apr-Jun;21(2):89-94. PMID: 19439158.",33535,2019
hamner2019,2019,Pharmacotherapy,PTSD,24,,1,,CAPS,64.59,14.63,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,45.35,,,,,,Race data reported,0.5,,,,,0.5,,,,,,,,0%,,,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Hamner MB, Hernandez-Tejada MA, Zuschlag ZD, et al. Ziprasidone augmentation of SSRI antidepressants in posttraumatic stress disorder: a randomized, placebo-controlled pilot study of augmentation therapy. J Clin Psychopharmacol. 2019 Mar/Apr;39(2):153-7. doi: 10.1097/JCP.0000000000001000. PMID: 30640209.",51867,2020
hanling2016,2016,Nonpharmacologic biological,PTSD,42,,1,,CAPS,86.76,14.38,,Additional definitions of PTSD severity at baseline reported in the study,,,,0.881,,,0.119,0,Mixed,,,,,0.1905,,0.8095,Race and Ethnicity data reported,0.619,0.119,,,,0.2619,,0.1905,,,,,,,,Mixed,"combat-related, other (noncombat unspecified)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.",46472,2019
harb2019,2019,Psychotherapy,PTSD,108,,1,,CAPS,85.5,15.6,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0.755,,1,0,Veteran,,37.1,9.9,,0.139,,0.861,Race data reported,0.583,0.37,,,,0.0463,,,,,,0.639,,,"Any TBI: 65.7%


Mild TBI: 64.8%


Moderate TBI: 3.7%",Combat-related,,,,,,,,,,Included,"Alcohol abuse: 7.4%


Substance dependence: 0%",,,,,,,,,,,,,Generalized anxiety disorder: SCID for DSM-IV,0.222,,,,POINT (-95.71289 37.09024),Some Concerns,"Harb GC, Cook JM, Phelps AJ, et al. Randomized controlled trial of imagery rehearsal for posttraumatic nightmares in combat veterans. J Clin Sleep Med. 2019 May 15;15(5):757-67. doi: 10.5664/jcsm.7770. PMID: 31053215.",52095,2020
harris2018,2018,Psychotherapy & CIH,PTSD,138,,,,CAPS,61.22,19.29,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,57.1,13.68,,0.2391,,0.7609,Race data reported,0.8333,0.0724,,,,0.0942,,,,,,,,,,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (adverse childhood experiences, not specified)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Harris JI, Usset T, Voecks C, et al. Spiritually integrated care for PTSD: a randomized controlled trial of ""Building Spiritual Strength"". Psychiatry Res. 2018 Jun 20;267:420-8. doi: 10.1016/j.psychres.2018.06.045. PMID: 29980120.",50585,2019
haynes2020,2020,Psychotherapy,PTSD,43,,1,,CAPS,73.44,17.61,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,48.42,13.51,,0,,1,Race and Ethnicity data reported,0.5581,0.0698,0.0698,0.0233,,0.2791,"Study reported Hispanic as a race category, abstracted here with ""Other.""


Asian/PI reported together, abstracted as ""Asian.""",0.2326,,,,1,Required to meet DSM-IV-TR criteria for MDD for study inclusion,"Moderate/severe TBI: 0%


History of head injury: 58.14%","Excluded recent or sustained moderate/severe TBI, or mild TBI within last 3 months",Combat-related,,,,,,,,,,Excluded,"History of substance use disorder: 76.74%


Recent substance abuse or dependence (past 30 days): 0% (excluded)",,,History of suicide attempt,0.2325,,,Current psychotic disorder,0,Excluded,,,,History of anxiety disorder,0.4651,,,,POINT (-95.71289 37.09024),Low,"Haynes PL, Burger SB, Kelly M, et al. Cognitive behavioral social rhythm group therapy versus present centered group therapy for veterans with posttraumatic stress disorder and major depressive disorder: a randomized controlled pilot trial. J Affect Disord. 2020 Dec 1;277:800-9. doi: 10.1016/j.jad.2020.09.009. PMID: 33065820.",1559053,2022
henseldittmann2011,2011,Psychotherapy,PTSD,28,,1,,CAPS,91.21,14.6,,Additional definitions of PTSD severity at baseline reported in the study,,,,,0,,,1,Community,,,,,,,,,,,,,,,,,,,,0.8214,,,,Terrorism/political violence/forced displacement,,,,,,,,,,Included,10.71%,,,,,,,Psychotic disorder: MINI,0.0357,,,,,Anxiety disorder or OCD: MINI,0.5357,,,,POINT (10.38578 51.10698),Some Concerns,"Hensel-Dittmann D, Schauer M, Ruf M, et al. Treatment of traumatized victims of war and torture: a randomized controlled comparison of narrative exposure therapy and stress inoculation training. Psychother Psychosom. 2011 Oct;80(6):345-52. doi: 10.1159/000327253. PMID: 21829046.",37590,2019
herescolevy2002,2002,Pharmacotherapy,PTSD,11,,1,,CAPS,59,11.9,,Additional definitions of PTSD severity at baseline reported in the study,7.7,7.1,,,,,,1,Community,,38.45,11.47,,0.1818,,0.8182,,,,,,,,,,,,,0,,,,Mixed,"accidents, terrorism/political violence/forced displacement, other (physical abuse)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (35.00445 31.4611),Some Concerns,"Heresco-Levy U, Kremer I, Javitt DC, et al. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2002 Dec;5(4):301-7. doi: 10.1017/S1461145702003061. PMID: 12466030.",25345,2019
herescolevy2009,2009,Pharmacotherapy,PTSD,22,,1,,CAPS,91.9,15.9,,Additional definitions of PTSD severity at baseline reported in the study,13.6,7.2,,,,,,1,Community,,45.9,11,,0.1364,,0.8636,,,,,,,,,,,,,0,,,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (not specified)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (35.00445 31.4611),Some Concerns,"Heresco-Levy U, Vass A, Bloch B, et al. Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2009 Oct;12(9):1275-82. doi: 10.1017/S1461145709000339. PMID: 19366490.",33582,2019
hertzberg1999,1999,Pharmacotherapy,PTSD,15,,1,,SI-PTSD,44,,range 36 to 55,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,0.71,0.29,Mixed,,43,,range 28 to 53,0.36,,0.64,Race data reported,0.29,0.71,,,,,,,,,,,,,,Mixed,"combat-related, rape/sexual assault, other (abduction)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Hertzberg MA, Butterfield MI, Feldman ME, et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol psychiatry. 1999 May 1;45(9):1226-9. PMID: 10331117.",9744,2019
hertzberg2000,2000,Pharmacotherapy,PTSD,12,,1,,SI-PTSD,45.5,9.5,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0.4167,,1,0,Veteran,,46,,range 44 to 48,0,,1,Race data reported,0.4167,0.5833,,,,,,,,50.00%,naive to psychotropic medication,0.6667,,,,Combat-related,,,,,,,,,,Included,8.33%,,,,,,,,,,,,,,,"Simple phobia: 33.33%;


Obsessive-compulsive disorder: 16.67%",,,POINT (-95.71289 37.09024),High,"Hertzberg MA, Feldman ME, Beckham JC, et al. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry. 2000 Jun;12(2):101-5. doi: 10.1023/A:1009076231175. PMID: 10907802.",22432,2019
hien2004,2004,Psychotherapy,PTSD+SUD,96,"characteristics reported for sample who completed at least one session, N=75",,,CAPS,71.36,18.46,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,36.2,8.8,,1,,0,Race and Ethnicity data reported,0.36,0.4267,,,,0.2133,,0.2,,,,0.5067,,,,,,,,,,,,Mixed Alcohol/Drug,Mixed Alcohol/Drug,Included,100%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Hien DA, Cohen LR, Miele GM, et al. Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry. 2004 Aug;161(8):1426-32. doi: 10.1176/appi.ajp.161.8.1426. PMID: 15285969.",26661,2020
hien2009,2009,Psychotherapy,PTSD+SUD,353,,0.804,,CAPS,62.9,19.4,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,39.2,9.3,,1,,0,Race and Ethnicity data reported,0.456,0.34,,,,0.204,,0.065,,,,,,,,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",,,,,,,Mixed Alcohol/Drug,Mixed Alcohol/Drug,Included,"Current drug or alcohol abuse or dependence: 100%


Cocaine abuse or dependence: 70.5%


Stimulants abuse or dependence: 7.7%


Opiates abuse or dependence: 25.6%


Marijuana abuse or dependence: 27.2%


Alcohol abuse or dependence: 56.1%


Current alcohol abuse or dependence (without substance abuse or dependence): 8.8%",,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hijazi2014,2014,Psychotherapy,PTSD,63,,0.8571,(HTQ score ≥2.5),,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,0,,,1,Community,,48.2,8.9,,0.556,,0.444,,,,,,,,,,,,,,,,,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, combat-related",,,,19.8,6.4,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Hijazi AM, Lumley MA, Ziadni MS, et al. Brief narrative exposure therapy for posttraumatic stress in Iraqi refugees: a preliminary randomized clinical trial. J Trauma Stress. 2014 Jun;27(3):314-22. doi: 10.1002/jts.21922. PMID: 24866253.",42387,2019
hinton2009,2009,Psychotherapy,PTSD,24,,1,,CAPS,76.33,12.51,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,49.5,8.44,,0.5833,,0.4167,Race data reported,,,,1,,,,,,0%,,,,,,Terrorism/political violence/forced displacement,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Hinton DE, Hofmann SG, Pollack MH, et al. Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. CNS Neurosci Ther. 2009 Fall;15(3):255-63. doi: 10.1111/j.1755-5949.2009.00100.x. PMID: 19691545.",33298,2019
hinton2011,2011,Psychotherapy & CIH,PTSD,24,,1,,PCL,70.5,7.2,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,49.5,7.1,,1,,0,Ethnicity data reported,,,,,,,,1,,0%,,,,,,,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Hinton DE, Hofmann SG, Rivera E, et al. Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: a pilot study comparing CA-CBT to applied muscle relaxation. Behav Res Ther. 2011 Apr;49(4):275-80. doi: 10.1016/j.brat.2011.01.005. PMID: 21333272.",36143,2019
hoffart2013,2013,Psychotherapy,PTSD,65,,1,,PSS-I,34.21,7.56,,Additional definitions of PTSD severity at baseline reported in the study,17.5,13.3,,,,,,1,Community,,45.2,9.7,,0.5846,,0.4154,,,,,,,,,,,,,0.615,,,,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence",,,,,,,,,Included,"Substance abuse or dependence: 13.9%





Alcohol abuse or dependence: 27.7%",,,,,,,,,,,,"Avoidant personality disorder: SCID-II 16.9%;


Obsessive-compulsive personality disorder: SCID-II 13.9%",,,"Panic disorder with or without agoraphobia or agoraphobia without a history of panic disorder: MINI 67.7%


Social phobia: MINI 60.0%


Obsessive– compulsive disorder (Axis I): MINI 24.6%


Generalized anxiety disorder: MINI 16.9%",,,POINT (15.34833 68.75014),Some Concerns,"Hoffart A, Øktedalen T, Langkaas TF, et al. Alliance and outcome in varying imagery procedures for PTSD: a study of within-person processes. J Couns Psychol. 2013 Oct;60(4):471-82. doi: 10.1037/a0033604. PMID: 23957768.",44042,2019
hogberg2007,2007,Psychotherapy,PTSD,24,,1,,IES,39.22,15.52,,Additional definitions of PTSD severity at baseline reported in the study,2.4,1.6,,,,,,1,Community,,43,9.49,,0.2083,,0.7917,,,,,,,,,,,95.83%,,0,,,,Mixed,"accidents, community/school violence",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (16.74371 62.79232),High,"Hogberg G, Pagani M, Sundin O, et al. On treatment with eye movement desensitization and reprocessing of chronic post-traumatic stress disorder in public transportation workers--a randomized controlled trial. Nord J Psychiatry. 2007;61(1):54-61. doi:  10.1080/08039480601129408. PMID: 17365790.",38652,2019
hollifield2007,2007,Psychotherapy & CIH,PTSD,84,,1,,PSS-SR,31.56,8.86,,Additional definitions of PTSD severity at baseline reported in the study,,,62% experienced trauma before age 12; 21% between ages 12 and 17; 17% age 18,,,,,1,Community,,42.2,13,,0.6786,,0.3214,Race and Ethnicity data reported,0.8929,0.0357,,,,0.0714,,0.25,,,,,,,,,,,,,,,32% reported ≥3 events,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.",29609,2019
hyer1996,1996,Other mixed,PTSD,219,,1,,M-PTSD,121.84,,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,41.6,,,0,,1,Race data reported,0.8539,0.0822,,,,0.0639,,,,,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,POINT (-95.71289 37.09024),High,"Hyer L, Boyd S, Scurfield R, et al. Effects of Outward Bound experience as an adjunct to inpatient PTSD treatment of war veterans. J Clin Psychol. 1996 May;52(3):263-78. doi: 10.1002/(SICI)1097-4679(199605)52:3<263::AID-JCLP3>3.0.CO;2-T. PMID: 8835688.",8065,2019
isserles2013,2013,Nonpharmacologic biological,PTSD,30,,1,,CAPS-2,86.67,20.78,,Additional definitions of PTSD severity at baseline reported in the study,15.8,15.1,,,,,,,,,43.4,11,,0.2308,,0.7692,,,,,,,,,,,0%,,,,,,Mixed,"combat-related, other (not specified)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (35.00445 31.4611),Some Concerns,"Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.",39466,2019
isserles2021,2021,Nonpharmacologic biological,PTSD,125,,1,,CAPS-5,41.97,9.17,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,44.23,12.71,,0.664,,0.336,Race and Ethnicity data reported,0.856,0.056,,,,0.048,,0.056,,,49.6% had past psychotherapy; 40% taking antidepressant medications during study,,,0%,head trauma with loss of consciousness >5 minutes: 0% (excluded),Mixed,"Other (""Childhood trauma""), Other (not specified)",,,,,,,,,Excluded,Excluded substance or alcohol abuse withing the past 6 months,,,,,Excluded significant suicidal risk,,"Psychotic disorders, SCID",0,Excluded,"Severe personality disorder, SCID",0,Excluded,"Obsessive-compulsive disorder, SCID",0,Excluded,,,,High,"Isserles M, Tendler A, Roth Y, et al. Deep transcranial magnetic stimulation combined with brief exposure for posttraumatic stress disorder: a prospective multisite randomized trial. Biol Psychiatry. 2021 Nov 15;90(10):721-8. doi: 10.1016/j.biopsych.2021.04.019. PMID: 34274108.",1572922,2023
ivarsson2014,2014,Other study class,PTSD,62,,1,,PDS,30.87,7.73,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,46,11.7,,0.823,,0.177,,,,,,,,,,,,40.3% psychotherapy-naïve; 46.8% pharmacotherapy-naïve (not limited to PTSD treatment),,,,,Mixed,"intimate partner violence, accidents, illness/medical procedure, combat-related, natural or manmade disasters, community/school violence, other (torture, multiple stressors)",,,,,,,,,Excluded,"AUD: 0%


SUD: NR",,,,,,,,,,,,,,,,,,POINT (16.74371 62.79232),High,"Ivarsson D, Blom M, Hesser H, et al. Guided internet-delivered cognitive behavior therapy for post-traumatic stress disorder: a randomized controlled trial. Internet Interv. 2014 March;1(1):33-40. doi: 10.1016/j.invent.2014.03.002.",44101,2019
jacob2014,2014,Psychotherapy,PTSD,76,,1,,CAPS,73.87,17.19,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,37.57,9.88,,0.9211,,0.0789,,,,,,,,,,,,,,,,,Mixed,"rape/sexual assault, terrorism/political violence/forced displacement",14.34,3.74,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (29.91989 -1.990332),Some Concerns,"Jacob N, Neuner F, Maedl A, et al. Dissemination of psychotherapy for trauma spectrum disorders in postconflict settings: a randomized controlled trial in Rwanda. Psychother Psychosom. 2014 Nov;83(6):354-63. doi: 10.1159/000365114. PMID: 25323203.",43991,2019
jahanpour2019,2019,CIH,PTSD,60,,1,,PCL,59,6.45,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,49,10.35,,0.233,,0.767,Not reported,,,,,,,,,,,,,,,,,,,,,,,,,,Excluded,"Excluded ""addiction""",,,,,,,,,,,,,,1,"""anxiety"" was an inclusion criteria (details NR)",,Patients hospitalized for myocardial infarction,POINT (54.27407 32.57503),High,"Jahanpour F, Armoon B, Mozafari N, et al. The comparison of the effect of poetry therapy on anxiety and post-traumatic stress disorders in patients with myocardial infarction. J Poet Ther. 2019 Dec;32(4):214-22. doi: 10.1080/08893675.2019.1639884.",1620169,2023
jain2020,2020,Psychotherapy,PTSD,26,,0.875,probable PTSD (PCL-5 score >33),PCL-5,45.5,14.6,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,55.12,14.21,"Range, 26-74 years",0.15,"For overall sample, identified as:


heterosexual: 88.5%


mostly heterosexual: 7.7%


gay: 3.8%",0.85,Race and Ethnicity data reported,0.346,0.077,0.038,0.154,0.154,0.154,,0.077,,,,,70.8% with probable depression (BDI-II score >20),,,,,,,,,,,,,Excluded,Current substance dependence (last 3 months): 0% (excluded),,,,,"High risk for suicide (presence of intent, plan, and means) an exclusion criterion",,"SCID, no threshold reported",0,Excluded,,,,,,,,,POINT (-95.71289 37.09024),High,"Jain S, Ortigo K, Gimeno J, Baldor DA, Weiss BJ, Cloitre M. A Randomized Controlled Trial of Brief Skills Training in Affective and Interpersonal Regulation (STAIR) for Veterans in Primary Care. J Trauma Stress. 2020 Aug;33(4):401-409. doi: 10.1002/jts.22523. Epub 2020 Jun 7. PMID: 32506563.",1554457,2022
jak2019,2019,Psychotherapy,PTSD,100,,1,,PCL-S,59.35,10.65,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,34.39,7.89,,0.11,,0.89,Race and Ethnicity data reported,0.47,0.13,0.02,0.09,0.04,0.25,,0.23,,43.00%,,,,100%,,,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Jak AJ, Jurick S, Crocker LD, et al. SMART-CPT for veterans with comorbid post-traumatic stress disorder and history of traumatic brain injury: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):333-41. doi: 10.1136/jnnp-2018-319315. PMID: 30554135.",51464,2020
jalal2020,2020,Psychotherapy & CIH,PTSD,30,participants continuously enrolled until there were 10 completers in each arm; total of 10 dropped out,1,,PCL-C,55.85,10.39,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,0,1,Community,,28.2,,,0.75,,0.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (25.08388 -29.00034),High,"Jalal B, Kruger Q, Hinton DE. Culturally adapted CBT (CA-CBT) for traumatised indigenous South Africans (Sepedi): a randomised pilot trial comparing CA-CBT to applied muscle relaxation. Intervention 2020;18:61-5",1587977,2022
jamshidi2021,2021,Psychotherapy,PTSD,30,,1,,Civilian Mississippi Scale for PTSD,92.66,12.44,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,21.39,4.03,,1,,0,Not reported,,,,,,,,,,,,,,,,Mixed,Child physical abuse; Child sexual abuse; Child other abuse,,,,,,"Single event: 20.00%
Multiple events: 80.00%",,,Excluded,"SUD: 0% (excluded ""addiction to drugs or substances"")",,,"Any ""suicide history"" (not further defined)",0.4,"""Suicide history"":
>2 times: 10.00%
1-2 times: 30.00%
None: 60.00%",,History of psychotic disorder,0,Excluded,,,,,,,,Patients recruited in residential facility staffed by psychologists and nurses,POINT (54.27407 32.57503),High,"Jamshidi F, Rajabi S, Dehghani Y. How to heal their psychological wounds? Effectiveness of EMDR therapy on post-traumatic stress symptoms, mind-wandering and suicidal ideation in Iranian child abuse victims. Counselling & Psychotherapy Research. 2021 Jun;21(2):412-21. doi: 10.1002/capr.12339.",1556672,2023
jarero2019,2019,Psychotherapy,PTSD,60,,1,,PCL-5,38.74,7.18,,Additional definitions of PTSD severity at baseline reported in the study,,,Time working as a first responder ranged from 3 months to 24 years,0,,,,1,Community,,33.73,9.7,,0.317,,0.683,,,,,,,,,,,,,,,Excluded,,Other,"traumas experienced as first responders (e.g. witnessing deaths; witnessing victims of child physical abuse, rape/sexual assault, intimate partner violence, accidents, pregnancy loss, community/school violence, and natural or manmade disasters (fire); threat of own death in a fire)",,,,,,,,,Excluded,Substance abuse: 0%,,,,,"Excluded ""ongoing self-harm/suicidal…ideation""",,Psychotic disorder diagnosis,0,Excluded,,,,,,,,,POINT (-102.5235 23.94754),High,"Jarero I, Schnaider S, Givaudan M. Randomized controlled trial: Provision of EMDR protocol for recent critical incidents and ongoing traumatic stress to first responders. Journal of EMDR Practice and Research. 2019;13(2):100-10. doi: 10.1891/1933-3196.13.2.100.",,2022
jensen1994,1994,Psychotherapy,PTSD,25,,1,,SI-PTSD,33.36,10.26,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0.36,,1,0,Veteran,,43.1,2.84,,0,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,0.88,,POINT (-95.71289 37.09024),High,Jensen JA. An investigation of Eye Movement Desensitization Reprocessing (EMD/R) as a treatment for posttraumatic stress disorder (PTSD) symptoms of Vietnam combat veterans. Behav Ther. 1994 Spring;25(2):311-25. doi: 10.1016/S0005-7894(05)80290-4.,4669,2019
jespersen2012,2012,CIH,PTSD,19,,0.8,based on completers,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,37,10.98,,0.6,completers only,0.4,,,,,,,,,,,,,,,,,Terrorism/political violence/forced displacement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (10.02799 55.98126),High,"Jespersen KV, Vuust P. The effect of relaxation music listening on sleep quality in traumatized refugees: a pilot study. J Music Ther. 2012;49(2):205-29.  PMID: 26753218.",1548481,2019
jiang2023,2023,Other mixed,PTSD,57,"60 randomized, 3 later excluded for stroke progression: 1 in group A, 2 in group B (assuming 1:1:1 randomization resulted in 20:20:20 groups); sample characteristics reported for n=57",1,,IES-R,49.1,9.2,,Additional definitions of PTSD severity at baseline reported in the study,0.81,0.33,"time since stroke (index trauma) ""Stroke duration""",,,,,1,Community,,55.6,8.5,,0.3684,,0.6316,Not reported,,,,,,,,,,,,,,,,Illness/medical procedure,,,,,,,,,,Excluded,Drug abuse: 0% (excluded),,,,,,,History of psychotic disorder,0,Excluded,,,,,,,,,POINT (103.8191 36.56177),Some Concerns,"Jiang C, Li Z, Wang J, et al. Effectiveness of repetitive transcranial magnetic stimulation combined with a brief exposure procedure for post-stroke posttraumatic stress disorder. Journal of affective disorders. 2023;326:89-95. doi: 10.1016/j.jad.2023.01.096. PMID: 36717030.",1615634,2023
jindani2015,2015,CIH,PTSD,80,,1,,PCL-17,57.7,10.5,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,,,,0.8875,,0.1125,,,,,,,,,,,,,,,,,Mixed,"rape/sexual assault, child sexual abuse, intimate partner violence, terrorism/political violence/forced displacement, illness/medical procedure, accidents, other (emotional abuse, systemic discrimination, compassion fatigue)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-106.3468 56.13037),High,"Jindani FA, Turner N, Khalsa SBS. A yoga intervention for posttraumatic stress: a preliminary randomized control trial. Evid Based Complement Alternat Med. 2015;2015:351746. doi: 10.1155/2015/351746. PMID: 26366179.",48111,2019
johnson2011,2011,Psychotherapy,PTSD,70,,0.8714,,CAPS,58.02,24.84,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,32.55,8,,1,,0,Race and Ethnicity data reported,0.4286,0.5,,,,0.0714,,0.0429,,,,0.6714,,,,Intimate partner violence,,,,number of prior lifetime trauma other than index interpersonal violence 6.31 [SD 3.98],,,,,,Included,11.43%,,,,,,,,,,,,,Other anxiety disorder: SCID-I/P,0.514,,,,POINT (-95.71289 37.09024),Some Concerns,"Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.",37002,2019
johnson2020,2020,Psychotherapy,PTSD,172,,1,,CAPS,75.06,14.43,Calculated SD from reported SEM,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,0,1,Community,,35.13,9.12,,1,"Sexual orientation


Straight/heterosexual: 93.0%


Bisexual: 7.0%",0,Race and Ethnicity data reported,0.465,0.442,,,,0.093,"NR for one patient in intervention arm, included in ""Other""",0.035,,,,0.564,"Current major depression, SCID for DSM-IV-TR",,,Intimate partner violence,,3.55,2.16,Prior lifetime trauma types other than index IPV,,,,,,Excluded,"Current drug dependence, SCID-I/P: 0% (excluded)


Current alcohol dependence, SCID-I/P: 0% (excluded)",,,Modified Scale for Suicidal Ideation: severe risk (suicidal ideation with intent and plan),0,exclusion criterion,,Current psychotic symptoms on SCID-I/P,0,exclusion criterion,Borderline personality disorder: SCID-II,0.1395,,Anxiety disorder other than PTSD: SCID-I/P,0.2558,,,,POINT (-95.71289 37.09024),Low,"Johnson DM, Zlotnick C, Hoffman L, et al. A randomized controlled trial comparing HOPE treatment and present-centered therapy in women residing in shelter with PTSD from intimate partner violence. Psychol Women Q. 2020 Dec;44(4):539-53. doi: 10.1177/0361684320953120",1558706,2022
jung2013,2013,Psychotherapy,PTSD,34,,1,,CAPS,81.6,18.5,,Additional definitions of PTSD severity at baseline reported in the study,22.34,11.67,,,,,,1,Community,,37.18,10.85,,1,,0,Race data reported,0.8929,,,0.1071,,,,,,0%,,0.571,,,,Child sexual abuse,,,,,,,,,,Excluded,"Current substance dependence: 0%


Substance abuse, alcohol use or abuse disorders: NR",,,,,,,,,,Borderline personality disorder: Borderline Section of IPDE,0.321,,Social anxiety disorder: SCID-I,0.25,,,,POINT (10.38578 51.10698),Some Concerns,"Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.",41611,2019
kaplan1996,1996,Pharmacotherapy,PTSD,17,,1,,IES (Hebrew version),35.35,13,,Additional definitions of PTSD severity at baseline reported in the study,,,range 0.5 to 28 years since the trauma,,,,,1,Community,,39.7,,range 25 to 56,0.3846,,0.6154,,,,,,,,,,,46.15%,,0,,,,Mixed,"combat-related, accidents, community/school violence, other (not specified)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,General anxiety,0.0769,,,,POINT (35.00445 31.4611),High,"Kaplan Z, Amir M, Swartz M, et al. Inositol treatment of post-traumatic stress disorder. Anxiety. 1996;2(1):51-2. doi: 10.1002/(SICI)1522-7154(1996)2:1<51::AID-ANXI8>3.0.CO;2-G. PMID: 9160600.",6980,2019
karatzias2011,2011,CIH,PTSD,46,,1,,CAPS,65.2,14.2,,Additional definitions of PTSD severity at baseline reported in the study,8.1,11.1,,,,,,1,Community,,40.6,10.89,,0.5652,,0.4348,,,,,,,,,,,65.22%,psychotherapy-naive,,,,,Mixed,"accidents, community/school violence, other (not specified)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-2.865634 54.12387),Some Concerns,"Karatzias A, Power KG, Brown KW, et al. A controlled comparison of the effectiveness and efficiency of two psychological therapies for posttraumatic stress disorder: Eye Movement Desensitization and Reprocessing vs. Emotional Freedom Techniques. J. Nerv. Ment. Dis. 2011 Jun;199(6):372-8. doi: 10.1097/NMD.0b013e31821cd262. PMID: 21629014.",36614,2019
karatzias2019,2019,Psychotherapy,PTSD,29,,1,,PCL-5,47.29,12.98,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,,,,42.1,11.52,,0.62,,0.38,,,,,,,,,,,,,,,,,,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-2.865634 54.12387),High,"Karatzias T, Brown M, Taggart L, et al. A mixed-methods, randomized controlled feasibility trial of Eye Movement Desensitization and Reprocessing (EMDR) plus Standard Care (SC) versus SC alone for DSM-5 Posttraumatic Stress Disorder (PTSD) in adults with intellectual disabilities. J Appl Res Intellect Disabil. 2019 Jul;32(4):806-18. doi: 10.1111/jar.12570. PMID: 30714684.",52277,2020
katz1994,1994,Pharmacotherapy,PTSD,64,(baseline characteristics reported only for 45 patients; see Comments),1,,CAPS,81.8,18.3,,Additional definitions of PTSD severity at baseline reported in the study,,,Median 2.8 (range 1.0 to 34),,,,,1,Community,,,,Median 39 (range 22 to 62),0.2444,,0.7556,,,,,,,,,,,,,,,,,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (not specified)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,,High,"Katz RJ, Lott MH, Arbus P, et al. Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety. 1994;1(4):169-74.  PMID: 9160569.",5306,2019
katz2014,2014,Psychotherapy,PTSD,51,,0.8627,,PCL,57.38,14.89,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,42,12.34,,1,,0,Race and Ethnicity data reported,0.4314,0.1961,,,,0.3725,,0.1176,,,,,,,,Mixed,"MST, rape/sexual assault, child sexual abuse, intimate partner violence",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Katz LS, Douglas S, Zaleski K, et al. Comparing holographic reprocessing and prolonged exposure for women veterans with sexual trauma: a pilot randomized trial. J Contemp Psychother. 2014 Mar;44(1):9-19. doi: 10.1007/s10879-013-9248-6.",1548483,2019
keane1989,1989,Psychotherapy,PTSD,24,,1,,Minnesota Multiphasic Personality Inventory PTSD subscale,36.5,8.7,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0.5417,,1,0,Veteran,,34.6,3.3,,0,,1,Race and Ethnicity data reported,0.7917,0.1667,,,,0.0417,,0.0417,,,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Keane TM, Fairbank JA, Caddell JM, et al. Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. Behav Ther. 1989 Spring;20(2):245-60. doi: 10.1016/S0005-7894(89)80072-3.",1015,2019
kearney2013,2013,CIH,PTSD,47,,1,,PCL-C,61.3,11,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,1,,Veteran,,52,12.6,,0.2128,,0.7872,Race and Ethnicity data reported,0.6809,0.1489,,,,0.1702,,0.0638,,,,,,,,,,10,5,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Kearney DJ, McDermott K, Malte C, et al. Effects of participation in a mindfulness program for veterans with posttraumatic stress disorder: a randomized controlled pilot study. J Clin Psychol. 2013 Jan;69(1):14-27. doi: 10.1002/jclp.21911. PMID: 22930491.",39341,2019
kearney2016,2016,CIH,PTSD,55,,0.8182,,PSS-I,27.5,10.9,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0.9091,,1,0,Veteran,,49.9,7.1,,0.1455,,0.8545,Race data reported,0.6182,0.1818,,0.0545,0.0182,0.0727,,,,,,0.6,,,,,,,,,4.49,3.3,,,,Excluded,Active substance/alcohol abuse that posed a safety threat (current drinking and a past-year history of alcohol-related seizures or delium tremens): 0%,,,Current suicidal ideation,0,,,History of psychosis,0,,,,,Anxiety disorder other than PTSD,0.1818,,,,POINT (-95.71289 37.09024),Some Concerns,"Kearney DJ, Simpson TL, Malte CA, et al. Mindfulness-based stress reduction in addition to usual care is associated with improvements in pain, fatigue, and cognitive failures among veterans with Gulf War illness. Am J Med. 2016 Feb;129(2):204-14. doi: 10.1016/j.amjmed.2015.09.015. PMID: 26519614.",45996,2020
kearney2021,2021,Psychotherapy & CIH,PTSD,184,,1,,CAPS-5,35.5,11.8,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0.67,Service-connected disability >50%,1,0,Veteran,,57.1,13.1,,0.168,Transgender: 0.54% (1/184); not included in Male or Female Percent,0.832,Race and Ethnicity data reported,0.5815,0.2391,0.0163,0.0326,,0.125,Pacific Islander grouped with Asian by study,0.0489,,,,,,,,Mixed,"Combat-related, Rape/sexual assault, Community/school violence, Accidents, Other (sudden death; other unspecified)",,,,,,,,,Excluded,Substance use dependence disorder (other than alcohol): 0% (excluded),,,,,,,,,,,,,,,,0.3696,Prior mental health or SUD inpatient admission,POINT (-95.71289 37.09024),Some Concerns,"Kearney DJ, Malte CA, Storms M, et al. Loving-kindness meditation vs cognitive processing therapy for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA Netw Open. 2021 Apr 1;4(4):e216604. doi: 10.1001/jamanetworkopen.2021.6604. PMID: 33861329.",1568095,2022
kehleforbes2019,2019,Psychotherapy,PTSD+SUD,183,,1,,PSS-I,36.3,6.7,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,44.1,13.1,,0.0765,,0.9235,Race and Ethnicity data reported,0.4098,0.4809,,,0.0109,0.0984,,0.0492,,,,,,,,,,,,,,,,Mixed Alcohol/Drug,Mixed Alcohol/Drug,Included,"Alcohol dependence: 85.2%


Alcohol abuse without alcohol dependence: 8.7%


Drug dependence: 18%


Drug abuse: 0%",,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Kehle-Forbes SM, Chen S, Polusny MA, et al. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders. Drug Alcohol Depend. 2019 Dec 1;205:107647. doi: 10.1016/j.drugalcdep.2019.107647. PMID: 31675546.",1546433,2020
kelly2021,2021,Psychotherapy & CIH,PTSD,104,"104 randomized but 1 had no CAPS or PCL data, only contributes to baseline demographics",1,,CAPS-5,34.88,7.85,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,48.38,11.1,,1,,0,Race data reported,0.01,0.913,,0.01,,0.067,,,,,,,,,,MST,,,,,,,,,,Excluded,,,,,0,Excluded,,,0,Excluded,,,,,,,,,POINT (-95.71289 37.09024),High,"Kelly U, Haywood T, Segell E, et al. Trauma-sensitive yoga for post-traumatic stress disorder in women veterans who experienced military sexual trauma: interim results from a randomized controlled trial. J Altern Complement Med. 2021 Mar;27(S1):S45-S59. doi: 10.1089/acm.2020.0417. PMID: 33788599.",1567680,2022
kent2011,2011,Psychotherapy,PTSD,39,,1,,CAPS,78.99,21.38,,Additional definitions of PTSD severity at baseline reported in the study,12,,,0,,,1,0,Veteran,,54,8.34,,0.33,,0.67,Race data reported,0.758,,,,,0.242,,,,,,,,,,Mixed,"combat-related, child physical abuse, child other abuse, rape/sexual assault, accidents, community/school violence",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Kent M, Davis MC, Stark SL, et al. A resilience-oriented treatment for posttraumatic stress disorder: results of a preliminary randomized clinical trial. J Trauma Stress. 2011 Oct;24(5):591-5. doi: 10.1002/jts.20685. PMID: 21898603.",85582,2019
khan2021,2021,Psychotherapy,PTSD,30,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,35.44,,,0.167,,0.833,Not reported,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (69.33958 29.94975),High,"Khan A, Ullah F, Abid O, et al. Efficacy of cognitive behavioral therapy in post-traumatic stress disorder among spinal cord injury patients: a randomized controlled pilot study. J Evid Based Psychother. 2021 Sep;21(2):143-62. doi: 10.24193/jebp.2021.2.16.",1620170,2023
kip2013,2013,Psychotherapy,PTSD,57,,0.93,,PCL-M,56.9,15.2,,Additional definitions of PTSD severity at baseline reported in the study,,,49.1% reported living with traumatic memories for >10 years,0.2982,,,0.7018,0,Mixed,,41.4,12.6,,0.193,,0.807,Race and Ethnicity data reported,0.8421,0.1053,,,,0.0526,,0.1053,,31.58%,,0.5614,,35.09%,,Mixed,"MST, combat-related, community/school violence",,,,,,12.28% experienced ≥3 traumas,,,Included,"SUD: 12.28%


AUD: 36.84%",,,,,,,"Psychosis: subscale of PDSQ, ≥2 items",0.14,,,,,,,"Obsessive Compulsive Disorder: subscale of PDSQ, ≥5 items: 61.4%;


Panic disorder: subscale of PDSQ, ≥4 items: 36.8%;


Agoraphobia: subscale of PDSQ, ≥4 items: 61.4%;


Social phobia:  subscale of PDSQ, ≥4 items: 54.4%;


Generalized anxety disorder: subscale of PDSQ, ≥7 items: 59.6%",,,POINT (-95.71289 37.09024),High,"Kip KE, Rosenzweig L, Hernandez DF, et al. Randomized controlled trial of Accelerated Resolution Therapy (ART) for symptoms of combat-related post-traumatic stress disorder (PTSD). Mil Med. 2013 Dec;178(12):1298-309. doi: 10.7205/MILMED-D-13-00298. PMID: 24306011.",88001,2019
knaevelsrud2015,2015,Other study class,PTSD,159,,1,,PDS,30.5,8.1,,Additional definitions of PTSD severity at baseline reported in the study,,,time since index trauma: <6 months: 11.54%; 6 months to 3 years: 19.87%; >3 years: 68.59%,,,,,1,Community,,28.1,7.43,,0.7233,,0.2767,,,,,,,,,,,92.45%,,,,,,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, community/school violence",,,,3.35,2.82,,,,Excluded,0%,,,,,,,,,,,,,,,,,,,High,"Knaevelsrud C, Brand J, Lange A, et al. Web-based psychotherapy for posttraumatic stress disorder in war-traumatized Arab patients: randomized controlled trial. J Med Internet Res. 2015 Mar 20;17(3):e71. doi: 10.2196/jmir.3582. PMID: 25799024.",46782,2019
knaevelsrud2017,2017,Other study class,PTSD,94,,0.931,,PDS,22.3,8.4,,Additional definitions of PTSD severity at baseline reported in the study,65.9,1.74,,,,,,1,Community,,71.4,4.7,,0.6489,,0.3511,,,,,,,,,,,,,,,,,Terrorism/political violence/forced displacement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (10.38578 51.10698),High,"Knaevelsrud C, Böttche M, Pietrzak RH, et al. Efficacy and feasibility of a therapist-guided internet-based intervention for older persons with childhood traumatization: a randomized controlled trial. Am J Geriatr Psychiatry. 2017 Aug;25(8):878-88. doi: 10.1016/j.jagp.2017.02.024. PMID: 28365000.",47282,2019
kobayashi2021,2021,Other mixed,PTSD,27,,1,,CAPS-5 past week,25.69,10.44,,Additional definitions of PTSD severity at baseline reported in the study,8,10,,,,,,1,Community,,33,9,,0.7,,0.3,Race and Ethnicity data reported,0.44,0.44,,0.04,,0.07,Other: multiracial,0.11,,,"Exclusion criterion for ""completion of exposure-based therapy targeting the index traumatic event""",0.259,MDD,,,Mixed,"Child sexual abuse; Rape/sexual assault; Intimate partner violence; Community/school violence; Other (""sudden violent death of someone close""; ""sudden accidental death of someone close"", not specified)",,,,,,,,,Included,"Mild alcohol use disorder: 22%
Mild cannabis use disorder: 14.8%
Mild opioid use disorder: 3.7%
Moderate/severe AUD within past 6 months: 0% (excluded)
Moderate/severe drug use disorder within the past year: 0% (excluded)",,,,,,,History of psychotic disorder,0,Excluded,,,,GAD,0.074,"Additional anxiety disorders:
Agoraphobia: 7.4%
Social anxiety disorder: 7.4%
Obsessive compulsive disorder: 7.4%",,,POINT (-95.71289 37.09024),Low,"Kobayashi I, Mellman TA, Cannon A, et al. Blocking the orexin system following therapeutic exposure promoted between session habituation, but not PTSD symptom reduction. J Psychiatr Res. 2021 Dec 14;145:222-9. doi: 10.1016/j.jpsychires.2021.12.027. PMID: 34933185.",1585481,2023
koch2020,2020,Psychotherapy,PTSD,44,,0.818,DSM-5 criteria on MINI,PCL-5,45.48,,SE 2.35,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,18.39,1.65,,0,,1,,,,,,,,,,,,,0.523,DSM-5 criteria for depression,,,Mixed,"Combat-related, Terrorism/political violence/forced displacement, Community/school violence, Accidents, Other (""being close to death"", ""lack of shelter"", ""lack of food and water"")",12.21,2.68,,,,,,,,,,,,,serious suicidal ideations was exclusion criterion,,Psychosis or serious dissociation,0,Excluded,,,,,,,,,POINT (10.38578 51.10698),High,"Koch T, Ehring T, Liedl A. Effectiveness of a transdiagnostic group intervention to enhance emotion regulation in young Afghan refugees: A pilot randomized controlled study. Behav Res Ther. 2020 Jun 27;132:103689. doi: 10.1016/j.brat.2020.103689. Epub ahead of print. PMID: 32688046.",1556201,2022
koebach2021,2021,Psychotherapy,PTSD,448,,0.8728,Inclusion criteria were PTSD and/or appetitive aggression,PSS-I for DSM-5,38.1,15.2,,Additional definitions of PTSD severity at baseline reported in the study,,,"Mean age at study baseline 33, mean age at military recruitment 18",,,,,1,Community,All participants were former child or adult combatants,33,9,,0,,1,Not reported,,,,,,,"Study reports ""ethnicity"": Nande, Hunde, Hutu, Bwisha, Other",,,,,,,,,Mixed,Combat-related; Other (not specified),,,,31,4,"Perpetrated acts, reported separately: mean 15.5 (SD 4)",,,Excluded,acute intoxication (either alcohol or other drugs): 0% (excluded),,,,,,,,,Excluded: acute psychotic symptoms,,,,,,,,,,High,"Koebach A, Carleial S, Elbert T, et al. Treating trauma and aggression with narrative exposure therapy in former child and adult soldiers: A randomized controlled trial in Eastern DR Congo. J Consult Clin Psychol. 2021 Mar;89(3):143-55. doi: 10.1037/ccp0000632. PMID: 33829803.",1567894,2023
koochaki2018,2018,Psychotherapy,PTSD,90,,1,,PSS,7.48,4.79,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,,,,23.37,3.75,,1,,0,,,,,,,,,,,,,,,,,Illness/medical procedure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (54.27407 32.57503),High,"Koochaki M, Mahmoodi Z, Esmaelzadeh–Saeieh S, et al. Effects of cognitive-behavioral counseling on posttraumatic stress disorder in mothers with infants hospitalized at neonatal intensive care units: a randomized controlled trial. Iran J Psychiatry Behav Sci. 2018;12(4):e65159. doi: 10.5812/ijpbs.65159.",1547364,2020
kosten1991,1991,Pharmacotherapy,PTSD,60,,1,,IES,33.6,,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,39,2.6,,0,,1,Race data reported,0.867,,,,,,,,,,,,"MDD: 0%


Dysthymia: 47%",,,Combat-related,,,,,,,,,,Excluded,"Current SUD: 0%


Past SUD: 57%",,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Kosten TR, Frank JB, Dan E, et al. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991;179(6):366-70. PMID: 2051152.",2658,2019
kozel2018,2018,Other mixed,PTSD,103,,1,,CAPS,74.61,24.07,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,32.65,6.91,,,,,Race and Ethnicity data reported,0.8155,0.1262,,,,0.0583,,0.2136,,60.19%,,0.3301,,0%,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,Psychotic disorder: SCID for DSM-IV,0,,,,,,,"Generalized anxiety disorder: SCID for DSM-IV 4.85%;


Obsessive compulsive disorder: SCID for DSM-IV 0%;


Panic disorder: SCID for DSM-IV 0.97%",,,POINT (-95.71289 37.09024),Some Concerns,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2019,2019,Nonpharmacologic biological,PTSD,35,,1,,CAPS-5,47.7,12.19,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,38.51,6.35,,0.2857,,0.7143,Race and Ethnicity data reported,0.5714,,,,,0.4286,,0.2857,,0%,,,,0%,Moderate or severe,,,,,,,,,,,Excluded,Current: 0% (except caffeine and nicotine),,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Kozel FA, Van Trees K, Larson V, et al. One hertz versus ten hertz repetitive TMS treatment of PTSD: a randomized clinical trial. Psychiatry Res. 2019 Mar;273:153-62. doi: 10.1016/j.psychres.2019.01.004. PMID: 30641346.",51540,2020
krakow2000,2000,Psychotherapy,PTSD,169,,0.95,,,29.25,11.43,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0,,0,1,Community,,37.02,10.85,,1,,0,Race data reported,0.6272,,,,,0.3728,,,,,,,,,,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Krakow BJ, Hollifield M, Schrader R, et al. A controlled study of imagery rehearsal for chronic nightmares in sexual assault survivors with PTSD: a preliminary report. Journal of Traumatic Stress. 2000 Oct;13(4):589-609. doi: 10.1023/A:1007854015481. PMID: 11109233.",15539,2020
krupnick2008,2008,Psychotherapy,PTSD,48,,1,,CAPS-1,64.32,19.58,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,32,10.2,,1,,0,Race and Ethnicity data reported,0.0625,0.7917,,0.0417,,0.1042,,0.125,,,,,,,,Mixed,"child physical abuse, child sexual abuse, other (interpersonal trauma)",6.4,4,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Krupnick JL, Green BL, Stockton P, et al. Group interpersonal psychotherapy for low-income women with posttraumatic stress disorder. Psychother Res. 2008 Sep;18(5):497-507. doi: 10.1080/10503300802183678. PMID: 18816001.",32335,2019
krupnick2017,2017,Other study class,PTSD,34,,1,,"PCL-M, average item score",3.8,0.4,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,40.25,,,0.0882,,0.9118,Race and Ethnicity data reported,0.4412,0.4118,,0.0882,,0.0588,,0.0294,,,,,,,,Mixed,"MST, combat-related",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Krupnick JL, Green BL, Amdur RL, et al. An internet-based writing intervention for PTSD in veterans: a feasibility and pilot effectiveness trial. Psychol Trauma. 2017 Jul;9(4):461-70. doi: 10.1037/tra0000176. PMID: 27607767.",45679,2019
krystal2011,2011,Pharmacotherapy,PTSD,296,,1,,CAPS,78.2,14.8,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,VA disability pension: 83.5%,1,0,Veteran,,54.4,10.7,,0.09,,0.91,Race and Ethnicity data reported,0.663,0.187,,,,0.17,,0.101,,0%,,0.697,,,,Mixed,"combat-related, other (physical or sexual abuse)",,,,,,,,,Excluded,"Current: 0%





Lifetime


Alchol abuse or dependence: 62.5%


Alcohol dependence: 43.4%


Cannabis dependence 11.2%


Cocaine dependence 10.5%",,,,,,,,,,"Antisocial personality disorder (threshold), based on lifetime DSM-IV diagnosis",0.06,,,,"GAD (threshold), based on lifetime DSM-IV diagnosis: 10.1%;


Social phobia (threshold), based on lifetime DSM-IV diagnosis: 3.4%",,,POINT (-95.71289 37.09024),Low,"Krystal JH, Rosenheck RA, Cramer JA, et al. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA. 2011;306(5):493-502. doi: 10.1001/jama.2011.1080. PMID: 21813427.",36863,2019
kubany2004,2004,Psychotherapy,PTSD,107,,1,,CAPS,75,20.1,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,,,,43.6,9.8,,1,,0,Race data reported,0.528,0.048,0.016,0.064,0.208,0.136,,,,,,,,,,Intimate partner violence,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kuckertz2014,2014,Other mixed,PTSD,37,,1,,PCL-M,62.28,9.08,,Additional definitions of PTSD severity at baseline reported in the study,,,,1,0,,0,0,Active Duty Military,,25.62,5.79,,0.069,,0.931,Race and Ethnicity data reported,0.8276,,,0.1177,,,,0.1034,,,,,,,,,,,,,,,,,,Included,62.07%,,,,,,,,,,,,,,,,1,,POINT (-95.71289 37.09024),Some Concerns,"Kuckertz JM, Amir N, Boffa JW, et al. The effectiveness of an attention bias modification program as an adjunctive treatment for post-traumatic stress disorder. Behav Res Ther. 2014 Dec;63:25-35. doi: 10.1016/j.brat.2014.09.002. PMID: 25277496.",43075,2019
lang2019,2019,CIH,PTSD,37,,1,,CAPS-5,36.9,12.9,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0.642,,1,0,Veteran,,49.1,14.5,,0.25,,0.75,Race and Ethnicity data reported,0.5,0.214,,0.071,0.036,0.179,,0.357,,21.40%,,,,,,Mixed,"combat-related; Accidents; Community/ school violence; Other (sudden violent death, causing serious harm to another)",,,,10.3,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Lang AJ, Malaktaris AL, Casmar P, et al. Compassion meditation for posttraumatic stress disorder in veterans: a randomized proof of concept study. J Trauma Stress. 2019 Apr;32(2):299-309. doi: 10.1002/jts.22397. PMID: 30929283.",51896,2020
langkaas2017,2017,Psychotherapy,PTSD,65,,1,,PSS-I,34.04,7.6,,Additional definitions of PTSD severity at baseline reported in the study,17.5,13.3,,,,,,1,Community,,45.2,9.7,,0.5846,,0.4154,,,,,,,,,,,,21.54% psychotherapy-naïve; 44.62% pharmacotherapy-naive,,,,,Mixed,"rape/sexual assault, accidents, community/school violence, other (war-related)",,,,,,,,,Excluded,0%,,,History of one or more suicide attempts,0.3692,,,,,,,,"Axis II disorder, any cluster: SCID-II 41.54%;


Cluster C, Axis II disorder: SCID-II 32.31%",Anxiety disorder: MINI,0.8308,,1,,POINT (15.34833 68.75014),Low,"Langkaas TF, Hoffart A, Øktedalen T, et al. Exposure and non-fear emotions: a randomized controlled study of exposure-based and rescripting-based imagery in PTSD treatment. Behav Res Ther. 2017 Oct;97:33-42. doi: 10.1016/j.brat.2017.06.007. PMID: 28689041.",48570,2019
latif2021,2021,Psychotherapy,PTSD,50,,1,,IES-R,35.4,1.6,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,0,1,Community,,26.9,4.2,,1,,0,,,,,,,,,,,,,,,,,Intimate partner violence,,,,,,,,,,Excluded,0% (exclusion criterion: DSM-5 diagnosis of SUD),,,,,,,,,Active psychosis was an exclusion criterion,,,,,,,,,POINT (69.33958 29.94975),High,"Latif M, Husain MI, Gul M, et al. Culturally adapted trauma-focused CBT-based guided self-help (CatCBT GSH) for female victims of domestic violence in Pakistan: feasibility randomized controlled trial. Behav. 2021 Jan;49(1):50-61. doi: 10.1017/S1352465820000685. PMID: 32993831",1559302,2022
lee2002,2002,Psychotherapy,PTSD,27,,1,,SI-PTSD,39.92,6.86,,Additional definitions of PTSD severity at baseline reported in the study,14.92,15.71,,0,,,,,Mixed,,35.29,15.47,,0.4583,,0.5417,,,,,,,,,,,,,,,,,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",,,,,,"70.8% with trauma prior to current episode, 29.2% with multiple previous traumas",,,,,,,,,,,,,,,,,,,,,,POINT (134.491 -25.73289),High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
leem2021,2021,Nonpharmacologic biological,PTSD,22,population characteristics reported for completers (n=19),1,,PCL-5,39.95,15,PCL-5-K (Korean version),Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,44,16.44,,0.8947,,0.1053,Not reported,,,,,,,,,,,,,,,,Mixed,Intimate partner violence; Accidents; Community/school violence,,,,,,,,,Excluded,History of alcohol dependency or abuse: 0% (excluded),,,,,"Excluded: ""risk of suicide""",,,,"Excluded: ""past or recent hallucinations or delusions""",,,,,,,,,POINT (127.8392 36.38525),High,"Leem J, Cheong MJ, Lee H, et al. Effectiveness, cost-utility, and safety of neurofeedback self-regulating training in patients with post-traumatic stress disorder: a randomized controlled trial. Healthcare (Basel). 2021 Oct 11;9(10):1351. doi: 10.3390/healthcare9101351. PMID: 34683031.",1581886,2023
lehavot2021,2021,Other study class,PTSD,102,,1,,CAPS-5,34.7,7.6,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0.82,,1,0,Veteran,,49.4,11.7,,1,"Cisgender women: 100% (inclusion criterion)


Sexual orientation


Heterosexual: 75%


Lesbian/gay: 11%


Bisexual: 12%


Other: 2%",0,Race and Ethnicity data reported,0.69,0.14,0.04,0.01,0.01,0.12,"Mixed-race: 9%


Other: 3%


Both entered as ""other""",0.11,,,"98% ""ever received mental health treatment"" (not specified as PTSD treatment)",,,,,Mixed,"MST, Combat-related, Child physical abuse, Child sexual abuse, Rape/sexual assault, Community/school violence, Other (""other military"", ""other"" not specified)",11.3,3.3,,,,,,,Excluded,"Current moderate or severe AUD or SUD, excluding mild cannabis abuse or nicotine abuse: 0% (excluded)",,,,,Current imminent danger to self was exclusion criterion,,,,Psychotic episode or psychotic disorder diagnosis within last year was exclusion criterion,,,,,,,,,POINT (-95.71289 37.09024),High,"Lehavot K, Millard SP, Thomas RM, Yantsides K, Upham M, Beckman K, Hamilton AB, Sadler A, Litz B, Simpson T. A randomized trial of an online, coach-assisted self-management PTSD intervention tailored for women veterans. J Consult Clin Psychol. 2021 Feb;89(2):134-142. doi: 10.1037/ccp0000556. PMID: 33705169; PMCID: PMC8238393.",1566567,2022
lehrner2021,2021,Psychotherapy & pharmacotherapy,PTSD,60,,1,,CAPS for DSM-IV,85.59,14.07,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,"Enrolled veterans, but report one participant discontinued due to deployment.",35.35,7.88,,0.1,,0.9,Race and Ethnicity data reported,0.55,0.3333,,,,0.1167,"Reported as ""mixed/more than one"" or ""other,"" abstracted as ""other""",0.55,,,35% currently on psychiatric medication at baseline,0.5167,"Current MDD, MINI",45.00%,"Mild TBI with current post-concussive symptoms: 45.00%
Moderate or severe TBI: 0% (excluded)",Other,"""deployment-related""",,,,,,,,,Excluded,Current substance abuse or dependence (prior 3 months): 0% (excluded),,,,,"Excluded: ""acute suicide risk""",,Psychotic disorder,0,"Excluded: ""lifetime history of primary psychotic disorder""",,,,"Obsessive-compulsive disorder, lifetime history",0,Exclusion criterion,,,POINT (-95.71289 37.09024),Low,"Lehrner A, Hildebrandt T, Bierer LM, et al. A randomized, double-blind, placebo-controlled trial of hydrocortisone augmentation of prolonged exposure for PTSD in U.S. combat veterans. Behav Res Ther. 2021 Sep;144:103924. doi: 10.1016/j.brat.2021.103924. PMID: 34298438.",1574125,2023
lely2019,2019,Psychotherapy,PTSD,33,,1,,CAPS,69.87,22.94,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0,,0,1,Community,,62.57,6.05,,0.2727,,0.7273,,,,,,,,,,,,,0.6061,,,,Mixed,"intimate partner violence, terrorism/political violence/forced displacement, other (unspecified child abuse, persecution)",,,,9.09,3.85,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (5.281473 52.10081),Some Concerns,"Lely JCG, Knipscheer JW, Moerbeek M, et al. Randomised controlled trial comparing narrative exposure therapy with present-centred therapy for older patients with post-traumatic stress disorder. Br J Psychiatry. 2019 Jun;214(6):369-77. doi: 10.1192/bjp.2019.59. PMID: 30957736.",1552210,2020
leong2020,2020,Nonpharmacologic biological,PTSD,31,,1,,CAPS-IV,66.07,20.01,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0,,0,1,Community,,43.7,11.5,,0.8276,,0.1724,,,,,,,,,,,,,0.931,,,,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",,,,,,,,,Excluded,SUD in last 3 months (except nicotine): 0%,,,,,,,,,,,,,,,"GAD: 41.38%


Social phobia: 31.03%


Panic disorder: 68.97%


Obsessive compulsive disorder: 10.34%",,,POINT (-106.3468 56.13037),Some Concerns,"Leong K, Chan P, Ong L, et al. A aandomized sham-controlled trial of 1-Hz and 10-Hz repetitive transcranial magnetic stimulation (rTMS) of the right dorsolateral prefrontal cortex in civilian post-traumatic stress disorder. Can J Psychiatry. 2020 Nov;65(11):770-8. doi: 10.1177/0706743720923064. PMID: 32379487.",1576966,2020
lewis2017,2017,Other study class,PTSD,42,,1,,CAPS-5,36.56,6.63,,Additional definitions of PTSD severity at baseline reported in the study,3.11,3.91,,,,,,1,Community,,39.29,12.7,,0.595,,0.405,,,,,,,,,,,,,,,,,Mixed,"accidents, illness/medical procedure, rape/sexual assault, terrorism/political violence/forced displacement, community/school violence",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-2.865634 54.12387),Some Concerns,"Lewis CE, Farewell D, Groves V, et al. Internet-based guided self-help for posttraumatic stress disorder (PTSD): randomized controlled trial. Depress Anxiety. 2017 Jun;34(6):555-65. doi: 10.1002/da.22645. PMID: 28557299.",48301,2019
li2017,2017,Pharmacotherapy,PTSD,72,,1,,IES-R,64.35,3.9,,Additional definitions of PTSD severity at baseline reported in the study,19.9,2.1,,0.375,,,,0.625,Mixed,,46,5.95,,0.125,,0.875,Race data reported,,,,1,,,,,,,,,,,,Mixed,"combat-related, other (chemical burn)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (103.8191 36.56177),Low,"Li W, Ma YB, Yang Q, et al. Effect and safety of sertraline for treat posttraumatic stress disorder: a multicenter randomised controlled study. Int. J. Psychiatry Clin. Pract. 2017 Jun;21(2):151-5. doi: 10.1080/13651501.2017.1291838. PMID: 28266242.",49934,2019
lindauer2005,2005,Psychotherapy,PTSD,24,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,mean 4.4 (SD 6.88) years since trauma,0,0,,0,1,Community,,38.95,9.57,,0.5417,,0.4583,,,,,,,,,,,,,0.1667,,,,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (unspecified)",,,,3.7,3.47,,,,Excluded,0% psychoactive SUD,,,,,,,,,,,,,,,,,,POINT (5.281473 52.10081),High,"Lindauer RJ, Gersons BP, van Meijel EP, et al. Effects of brief eclectic psychotherapy in patients with posttraumatic stress disorder: randomized clinical trial. Journal of traumatic stress. 2005 Jun;18(3):205-12. doi: 10.1002/jts.20029. PMID: 16281214.",19181,2020
lindley2007,2007,Pharmacotherapy,PTSD,40,,1,,CAPS,61.6,18.2,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,53.4,0.6,,0,,1,Race and Ethnicity data reported,0.625,0.175,,,,0.2,,0.15,,,,,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,Schizophrenia,0,,,,,,,,,,POINT (-95.71289 37.09024),High,"Lindley SE, Carlson EB, Hill K. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Dec;27(6):677-81. doi: 10.1097/jcp.0b013e31815a43ee. PMID: 18004136..",50965,2019
littleton2016,2016,Other study class,PTSD,87,,1,,PSS-I,23.4,6.9,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,22,,,1,,0,Race and Ethnicity data reported,0.4598,0.2529,0.0115,,,0.2759,,0.0805,,,,,,,,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, intimate partner violence",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Littleton HL, Grills AE, Kline KD, et al. The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord. 2016 Oct;43:41-51. doi: 10.1016/j.janxdis.2016.07.010. PMID: 27513363.",45583,2019
litz2012,2012,Psychotherapy & pharmacotherapy,PTSD,26,,1,,CAPS,71.62,20.09,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,32.19,9.31,,0,,1,Race data reported,0.7692,0.1538,,,0.0385,0.0385,,,,,,0.2692,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,Social anxiety,0.0769,,,,POINT (-95.71289 37.09024),Low,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2021,2021,Psychotherapy,PTSD,122,,1,,CAPS-4,75.54,18.85,,Additional definitions of PTSD severity at baseline reported in the study,,,,1,0,,0,0,Active Duty Military,Marines/Sailors,29.8,6.39,,0.083,,0.917,Race data reported,0.6311,,,,,0.3689,Reported for White and Nonwhite,,,,,,,,,,,,,,,,,,,Excluded,,,,,0,Excluded,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Litz BT, Rusowicz-Orazem L, Doros G, Grunthal B, Gray M, Nash W, Lang AJ. Adaptive disclosure, a combat-specific PTSD treatment, versus cognitive-processing therapy, in deployed marines and sailors: A randomized controlled non-inferiority trial. Psychiatry Res. 2021 Mar;297:113761. doi: 10.1016/j.psychres.2021.113761. Epub 2021 Jan 24. PMID: 33540206.",1564968,2022
liu2019,2019,Psychotherapy,PTSD,207,,1,,CAPS,71.9,17.8,,Additional definitions of PTSD severity at baseline reported in the study,20.83,15.67,,0,0.344,,1,0,Veteran,,48.4,14.1,,0.226,,0.774,Race and Ethnicity data reported,0.552,0.155,,,,0.293,,0.206,,13.10%,,,,54.10%,,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",,,,,,,,,Included,"Alcohol abuse: 1%


Other substance abuse: 1.5%",,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",52097,2020
ludascher2015,2015,Pharmacotherapy,PTSD,30,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,30.7,7.6,,1,,0,,,,,,,,,,,,,0.0667,,,,Mixed,"child sexual abuse, rape/sexual assault, child physical abuse, child other abuse",,,,,,,,,Excluded,0%,,,,,,,,,,Borderline personality disorder,0.3667,,,,"Agoraphobia, current: 10.00%;


Social phobia, current: 40.00%;


Obsessive-compulsive disorder, lifetime: 3.33%",,,POINT (10.38578 51.10698),Some Concerns,"Ludascher P, Schmahl C, Feldmann RE, Jr., et al. No evidence for differential dose effects of hydrocortisone on intrusive memories in female patients with complex post-traumatic stress disorder--a randomized, double-blind, placebo-controlled, crossover study. J Psychopharmacol. 2015 Oct;29(10):1077-84. doi: 10.1177/0269881115592339. PMID: 26152322.",49607,2019
maguen2017,2017,Psychotherapy,PTSD,33,,1,,PCL-M,50.75,13,,Additional definitions of PTSD severity at baseline reported in the study,,,,,0.333,,1,,Veteran,,61.2,13,,0,,1,Race and Ethnicity data reported,0.6061,0.2121,,0.0303,,0.1515,,0.0303,,0%,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Maguen S, Burkman KM, Madden E, et al. Impact of killing in war: a randomized, controlled pilot trial. J Clin Psychol. 2017 Sep;73(9):997-1012. doi: 10.1002/jclp.22471. PMID: 28294318.",47285,2019
mahabir2016,2016,Pharmacotherapy,PTSD,41,,1,,CAPS,79.3,20.4,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,43.4,11.7,,0.7317,,0.2683,,,,,,,,,,,,,0.2927,,,,Mixed,"accidents, rape/sexual assault, combat-related, community/school violence, other (non-specified)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-106.3468 56.13037),High,"Mahabir M, Ashbaugh AR, Saumier D, et al. Propranolol's impact on cognitive performance in post-traumatic stress disorder. J Affect Disord. 2016 Mar 1;192:98-103. doi: 10.1016/j.jad.2015.11.051. PMID: 26707354.",46886,2019
maieritsch2016,2016,Psychotherapy,PTSD,90,,1,,CAPS,80,15.4,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,1,,Veteran,,30.93,6.05,,0.067,,0.933,,,,,,,,,,,,,,,,,Mixed,"MST, combat-related, community/school violence",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Maieritsch KP, Smith TL, Hessinger JD, et al. Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016 Jun;22(4):238-43. doi: 10.1177/1357633x15596109. PMID: 26231819.",45182,2019
manteghi2014,2014,Pharmacotherapy,PTSD,40,,1,,CAPS,61.35,15.35,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,44.82,7.35,,0,,1,,,,,,,,,,,,,,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (54.27407 32.57503),High,"Manteghi AA, Hebrani P, Mortezania M, et al. Baclofen add-on to citalopram in treatment of posttraumatic stress disorder. J Clin Psychopharmacol. 2014 Apr;34(2):240-3. doi: 10.1097/jcp.0000000000000089. PMID: 24525635.",42065,2019
marcus1997,1997,Psychotherapy,PTSD,67,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,40.98,,,0.791,,0.209,Race and Ethnicity data reported,0.6567,0.1343,0.0149,,,0.194,,0.1194,,,,,,,,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.",9960,2019
margolies2013,2013,Psychotherapy,PTSD,40,,1,,PSS-SR,40.8,12.88,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,37.77,9.1,,0.1,,0.9,Race data reported,0.4,0.6,,,,,,,,,,,,,,,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Margolies SO, Rybarczyk B, Vrana SR, et al. Efficacy of a cognitive-behavioral treatment for insomnia and nightmares in Afghanistan and Iraq veterans with PTSD. Journal of Clinical Psychology. 2013 Oct;69(10):1026-42. doi: 10.1002/jclp.21970. PMID: 23629959.",40515,2020
markowitz2015a,2015,Psychotherapy & CIH,PTSD,110,,1,,CAPS,70,17,,Additional definitions of PTSD severity at baseline reported in the study,14.1,14.4,,,,,,1,Community,,40.1,11.57,,0.7,,0.3,Race and Ethnicity data reported,0.6545,0.1727,,,,0.1727,,0.2818,,,,0.5,,,,Mixed,"rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)",,,,2.8,1.81,,,,Excluded,"Current SUD: 0%


Lifetime


SUD: 10.91%


AUD: 20.00%",,,,,,,,,,,,"Any Axis II diagnosis: 49.09%;


Paranoid: 25.45%;


Narcissistic: 13.64%;


Borderline: 4.55%;


Avoidant: 20.91%;


Dependent: 2.73%;


Obsessive-compulsive: 24.55%;


Depressive: 24.55%;


Passive-aggressive: 14.55%",Generalized anxiety disorder,0.127,,,,POINT (-95.71289 37.09024),Some Concerns,"Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.",43409,2019
marks1998,1998,Psychotherapy & CIH,PTSD,87,,1,,"CAPS-2, severity",2.89,0.73,,Additional definitions of PTSD severity at baseline reported in the study,3.8,4.8,,,,,,1,Community,,38,10,,0.36,,0.64,,,,,,,,,,,,prior exposure or cognitive therapy was an exclusion criterion,0.49,,,,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",,,,,,79% had single episode; 15% discrete multiple episodes; 5% other,,,,,,,,,,,,,,,,,,,,,,POINT (-2.865634 54.12387),Some Concerns,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",9640,2019
marshall2001,2001,Pharmacotherapy,PTSD,563,,1,,CAPS-2,74.7,15.9,,Additional definitions of PTSD severity at baseline reported in the study,15.7,14.8,,,,,,1,Community,,41.8,11.6,,0.6842,,0.3158,,,,,,,,,,,,,,approximately 45%,,,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, witnessing injury or death)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,"GAD: 28% to 32%;


Agoraphobia: 21% to 25%;


Panic disorder: 14% to 17%",,,POINT (-95.71289 37.09024),High,"Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158(12):1982-8. doi: 10.1176/appi.ajp.158.12.1982. PMID: 11729013.",23882,2019
marshall2007,2007,Pharmacotherapy,PTSD,63,,1,,CAPS,83.5,26.1,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,39.8,11.2,,0.6731,,0.3269,Race and Ethnicity data reported,0.25,0.0962,,,,0.6538,,0.6538,,,,0.625,,,,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing events, fire)",,,,,,,,,Excluded,0%,,,,,,,,,,At least one personality disorder diagnosis,0.409,,,,"Social phobia: 22.9%


Panic disorder: 14.6%",,,POINT (-95.71289 37.09024),Some Concerns,"Marshall RD, Lewis-Fernández R, Blanco C, et al. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depress Anxiety. 2007;24(2):77-84. doi: 10.1002/da.20176. PMID: 16892419.",29847,2019
martenyi2002,2002,Pharmacotherapy,PTSD,301,,1,,CAPS,80.7,15.5,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,0.4817,0.5183,Mixed,,37.9,9.3,,0.19,,0.81,Race data reported,0.91,,,,,0.09,,,,,,,,,,Mixed,"combat-related, other (""victim of war or witness of war event,"" ""witness of another person's death"")",,,,,,47% with ≥2 traumas,,,Excluded,0%,,,,,,,,,,,,,,,,,,,High,"Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.  PMID: 11926718",24911,2019
martenyi2007,2007,Pharmacotherapy,PTSD,411,,1,,CAPS,77.9,15.9,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,,,,40.71,11.81,,0.7153,,0.2847,Race and Ethnicity data reported,0.7689,0.129,,,,0.1022,,0.0706,,,,,,,,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
mathew2011,2011,Pharmacotherapy,PTSD,47,,1,,CAPS,73,13.7,,Additional definitions of PTSD severity at baseline reported in the study,11.4,14.2,,,,,,1,Community,,40.8,11.9,,0.5897,,0.4103,Race and Ethnicity data reported,0.359,0.359,,0.0256,,0.2564,,0.2564,,,,,,,,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death)",,,,,,,,,Excluded,"Current


SUD (except nicotine): 0% Lifetime AUD: 12.82%


Lifetime SUD:12.82%",,,,,,,,,,,,,Current anxiety disorder,0.3846,,,,POINT (-95.71289 37.09024),High,"Mathew SJ, Vythilingam M, Murrough JW, et al. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur. Neuropsychopharmacol. 2011;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. PMID: 21194898.",35587,2019
maxwell2016,2016,Psychotherapy,PTSD,18,,1,,MPSS,58.82,21.86,,Additional definitions of PTSD severity at baseline reported in the study,3.96,,,,,,,1,Community,,22.38,4.02,,0.8125,,0.1875,Race and Ethnicity data reported,0.5625,0.1875,,,,0.25,,0.125,,6.25%,,,,,,Mixed,"rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence, other (military-related, not specified)",,,,,,,,,,,,,,,,,,,,,,,,,,0.1875,,POINT (-95.71289 37.09024),Some Concerns,"Maxwell K, Callahan JL, Holtz P, et al. Comparative study of group treatments for posttraumatic stress disorder. Psychotherapy (Chic). 2016 Dec;53(4):433-45. doi: 10.1037/pst0000032. PMID: 26390014.",50402,2019
mccall2018,2018,Pharmacotherapy,PTSD,20,,1,,CAPS,46.1,8.4,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,0.1,0.9,Mixed,,39.8,14.5,,0.85,,0.15,Race data reported,0.7,,,,,0.3,,,,,,0.5,,,,Mixed,"combat-related, other (not specified)",,,,,,,,,Excluded,0% (active SUD),,,"Mild-moderate intensity of suicidal ideation was confirmed with a Scale for Suicide Ideation score of ≥ 3, but without imminent intent to commit suicide, i.e. a Columbia Suicide Severity Rating Scale suicidal ideation level of ≤4.",1,,,,,lifetime schizophrenia excluded,,,,,,"GAD: 65%


Obsessive-compulsive disorder: 5%",,,POINT (-95.71289 37.09024),High,"McCall WV, Pillai A, Case D, et al. A pilot, randomized clinical trial of bedtime doses of prazosin versus placebo in suicidal posttraumatic stress disorder patients with nightmares. J Clin Psychopharmacol. 2018 Dec;38(6):618-21. doi: 10.1097/JCP.0000000000000968. PMID: 30335633.",51299,2020
mcdonagh2005,2005,Psychotherapy,PTSD,74,,1,,CAPS,69.9,16.4,,Additional definitions of PTSD severity at baseline reported in the study,33.9,,,,,,,1,Community,,40.4,9.8,,1,,0,Race data reported,0.9324,0.0135,0.0405,,,0.0135,,,,,,,,,,Child sexual abuse,,3.3,1.1,,,,,,,,,,,,,,,,,,Borderline personality disorder: SCID for DSM-IV,0.108,,,,,,,POINT (-95.71289 37.09024),High,"McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.",27712,2019
mcfall2010,2010,Psychotherapy & pharmacotherapy,PTSD+SUD,943,,1,,CAPS,75.2,12.9,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,54.5,5.9,,0.0636,,0.9364,Race and Ethnicity data reported,0.5801,0.3659,0.0117,,,0.0424,,0.0414,,,,0.4612,,,,Other,"""related to military service""",,,,,,,Drug,Nicotine,Excluded,"Nicotine dependence: 100%


Current alcohol or substance abuse other than nicotine not in partual remission: 0%


Current alcohol abuse/dependence in partial remission: 5.21%


Alcohol disorder past only: 76.01%


Stimulant disorder past only: 30.94%


Cannabis disorder past only: 29.08%


Opioid disorder past only: 14.25%",,,,,,,Psychotic disorder (past only): SCID for DSM-IV,0.0301,,,,,,,"Anxiety disorder (current), excluding PTSD: SCID for DSM-IV: 22.36%


Anxiety disorder (past only), excluding PTSD: SCID for DSM-IV: 11.82%",,,POINT (-95.71289 37.09024),Some Concerns,"McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.",35450,2020
mcgeary2022,2022,Psychotherapy,PTSD,193,,0.8238,DSM-5 criteria on CAPS-5; 82.38% of all participants; 85% of participants with nonmissing data,PCL-5,48.43,14.22,,Additional definitions of PTSD severity at baseline reported in the study,,,,0.0415,0.9378,type of disability not specified; VA disability rating mean 81.68 (SD 26.02),0.9585,0,Mixed,"Active Duty, Reserve, and National Guard counted as Active Duty",39.7,8.4,,0.1347,,0.8653,Race and Ethnicity data reported,0.57,0.176,0.026,0.036,0.031,0.161,,0.42,,,,0.513,Depression listed as comorbid mental health condition,100%,mTBI was an inclusion criterion,,,,,,,,,,,,Alcohol use disorder: 1.04%,,,,,,,Psychosis,0.0104,Psychosis listed as comorbid mental health condition,,,,Generalized anxiety,0.4508,"Additional anxiety disorders:
Panic listed as comorbid mental health condition: 2.59%",,,POINT (-95.71289 37.09024),High,"McGeary DD, Resick PA, Penzien DB, et al. Cognitive behavioral therapy for veterans with comorbid posttraumatic headache and posttraumatic stress disorder symptoms: a randomized clinical trial. JAMA Neurol. 2022;79(8):746-57. doi: 10.1001/jamaneurol.2022.1567. PMID: 35759281.",1595720,2023
mcgovern2011,2011,Psychotherapy,PTSD+SUD,53,,1,,CAPS,79.06,21.02,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0,,0,1,Community,,37.66,10.61,,0.566,,0.434,Race data reported,0.9057,,,,,0.0943,,,,,,,,,,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents",,,,,,,Mixed Alcohol/Drug,Mixed Alcohol/Drug,Included,100%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"McGovern MP, Lambert-Harris C, Alterman AI, et al. A randomized controlled trial comparing integrated cognitive behavioral therapy versus individual addiction counseling for co-occurring substance use and posttraumatic stress disorders. J Dual Diagn. 2011 Jan 1;7(4):207-27. doi: 10.1080/15504263.2011.620425. PMID: 22383864.",85821,2020
mcgovern2015,2015,Psychotherapy,PTSD+SUD,221,,1,,CAPS,77.35,20.1,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0,,0,1,Community,,35.3,10.42,,0.593,,0.407,Race and Ethnicity data reported,0.955,,,,,0.045,,0.018,,,,,"Current MDD: 60.6%


MDD, recurrent: 16.7%


Current dysthymia: 12.2%",,,Mixed,"child sexual abuse, community/school violence, other (not specified)",,,,,,,Mixed Alcohol/Drug,Mixed Alcohol/Drug,Included,"Prescription opioids: 51.1%


Cocaine: 45.2%


Cannabis: 40.7%


Heroin: 32.1%


Sedatives: 22.2%


Amphetamines: 17.6%


Hallucinogens: 6.8%


Other: 9.5%


Alcohol: 61.1%",,,Suicide attempt in the past month,0,,,Acute psychotic symptoms,0,,,,,,,"Generalized anxiety disorder: MINI 43.0%


Panic with agoraphobia: MINI 28.1%


Social anxiety: MINI 27.6%


Panic: MINI 15.4%


OCD: MINI 14.9%


Agoraphobia: MINI 13.1%",,,POINT (-95.71289 37.09024),Low,"McGovern MP, Lambert-Harris C, Xie H, et al. A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder. Addiction. 2015 Jul;110(7):1194-204. doi: 10.1111/add.12943. PMID: 25846251.",44027,2020
mcguirestanbury2020,2020,Psychotherapy,PTSD,20,,1,,CAPS,82.3,18.61,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,42.15,10.94,,,,,,,,,,,,,,,,"Naïve to EMDR or PE for trauma: 100%


Naïve to other PTSD treatment: NR",,,,,Mixed,"Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)",,,,,,,,,Excluded,Substance dependency disorder: 0%,,,,,,,,,,Cluster B,0,,,,,0.25,,POINT (134.491 -25.73289),High,"McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",1587978,2020
mclay2011,2011,Psychotherapy,PTSD,20,,1,,CAPS,83.2,16,,Additional definitions of PTSD severity at baseline reported in the study,,,,1,0,,0,0,Active Duty Military,,28.4,,range 22 to 45,0.05,,0.95,,,,,,,,,,,,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"McLay RN, Wood DP, Webb-Murphy JA, et al. A randomized, controlled trial of virtual reality-graded exposure therapy for post-traumatic stress disorder in active duty service members with combat-related post-traumatic stress disorder. Cyberpsychol Behav Soc Netw. 2011 Apr;14(4):223-9. doi: 10.1089/cyber.2011.0003. PMID: 21332375.",36339,2019
mclay2017,2017,Psychotherapy,PTSD,81,,1,,CAPS,75.6,15.8,,Additional definitions of PTSD severity at baseline reported in the study,,,,1,0,,0,0,Active Duty Military,,33,8.05,,0.037,,0.963,Race data reported,0.5309,,,,,0.4691,,,,,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"McLay RN, Baird A, Webb-Murphy J, et al. A randomized, head-to-head study of virtual reality exposuretherapy for posttraumatic stress disorder. Cyberpsychol Behav Soc Netw. 2017 Apr;20(4):218-24. doi: 10.1089/cyber.2016.0554. PMID: 28394217.",49936,2019
mclean2020,2020,Other mixed,PTSD,40,,1,,PCL-5,47.2,13.4,,Additional definitions of PTSD severity at baseline reported in the study,,,,0.925,0.975,,0.075,0,Mixed,"""All but one participant in the PCT group were seeking disability through the Department of Veteran Affairs for posttraumatic stress disorder""; interpreted this to mean 39 of 40 participants for service-connected veteran percent.",40.2,7.7,,0.25,,0.75,Race and Ethnicity data reported,0.4,0.4,0.025,0.05,0.025,0.1,,0.225,,,,,,"Moderate/severe: 0%


Mild: NR",Excluded moderate/severe TBI,,Inclusion required exposure to a Criterion A combat-related traumatic event but index trauma could be non-combat-related,,,,,,,,,Excluded,Current alcohol dependence: 0% (excluded),,,,,Severe current suicidal ideation was an exclusion criterion,,Psychotic disorder,0,Excluded,,,,,,,,,POINT (-95.71289 37.09024),High,"McLean CP, Foa EB, Dondanville KA, et al. The effects of web-prolonged exposure among military personnel and veterans with posttraumatic stress disorder. Psychol Trauma. 2020 Nov 19;19:19. doi: 10.1037/tra0000978. PMID: 33211517.",1561431,2022
mclean2022,2022,Other study class,PTSD,93,,1,,PCL-5,,,Only reported graphically in Figure 8,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,"Inclusion criteria required veteran status, demographic table reports Military Status as Veteran, Retired, or National Guard; entered as 100% Veteran based on inclusion criterion (n=1 participant listed for National Guard)",49,9.3,,0.69,"""No participants identified as transgender, nonbinary, or another gender identity""",0.31,Race and Ethnicity data reported,0.63,0.24,0.05,0.03,,0.13,"Other includes ""another racial identity"" and ""middle eastern/north African)""; study states that participants were allowed to select more than one race (total sums to n=101)",0.11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"McLean C, Davis CA, Miller M, et al. The effects of an exposure-based mobile app on symptoms of posttraumatic stress disorder in veterans: pilot randomized controlled trial. JMIR Mhealth Uhealth. 2022;10(11):e38951. doi: 10.2196/38951. PMID: 36331540.",1605000,2023
mcrae2004,2004,Pharmacotherapy,PTSD,37,,1,,CAPS,71.31,,,Additional definitions of PTSD severity at baseline reported in the study,21.96,,,,,,,1,Community,,40.27,,,0.7692,,0.2308,,,,,,,,,,,,,,,,,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-6. doi: 10.1002/da.20008. PMID: 15129422.",26720,2019
meffert2021,2021,Psychotherapy,PTSD,256,,1,,PCL-C,56.34,16.19,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,0,1,Community,,36.95,9.4,,1,,0,,,,,,,,,,,,2.3% (6/256) had ever received any mental health care (not restricted to PTSD treatment),1,MDD,,,Intimate partner violence,,,,"91% had 2 or more types of lifetime trauma and 34% had 4 or more types, assessed on Trauma History Questionnaire",,,,,,Excluded,,,,,,,,,,,,,,,,,,,POINT (37.79594 0.5998746),High,"Meffert SM, Neylan TC, McCulloch CE, et al. Interpersonal psychotherapy delivered by nonspecialists for depression and posttraumatic stress disorder among Kenyan HIV-positive women affected by gender-based violence: randomized controlled trial. PLoS Med. 2021 Jan;18(1):e1003468. doi: 10.1371/journal.pmed.1003468. PMID: 33428625.",1563915,2022
meredith2016,2016,Collaborative care,PTSD,404,,1,,CAPS,70.6,16,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,42.4,12.2,,0.8056,,0.1944,Race and Ethnicity data reported,0.0592,0.3521,,,,0.5831,,0.5155,,,,0.5099,,,,,,,,,,,"number of events reported, 1: 2.83%; 2: 8.17%; ≥ 3: 87.61%",,,Included,"Hazardous alcohol use: 18.31%


Probable drug abuse/dependence: 8.73%",,,,,,,,,,,,,Severe anxiety symptoms: GAD-7 score ≥15,0.452,,,,POINT (-95.71289 37.09024),Some Concerns,"Meredith LS, Eisenman DP, Han B, et al. Impact of collaborative care for underserved patients with PTSD in primary care: a randomized controlled trial. J Gen Intern Med. 2016 May;31(5):509-17. doi: 10.1007/s11606-016-3588-3. PMID: 26850413.",44675,2019
meredith2022,2022,Collaborative care,PTSD,40,"42 initially randomized, one patient was double counted in both arms and subsequentially excluded from the analysis, and one patient dropped out before completing the baseline, leaving a sample size of 40 at baseline",1,"""Provisional"" diagnosis defined as PCL-5 >32",PCL-5,73.13,14,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,,,,0.8,,0.2,Race data reported,0,1,0,0,0,0,Patient self-identifying as African American was an inclusion criterion,,,,,0.26,,,,,,,,,,,,,,,"ICD-10 codes from medical chart
Drug use: 0%
Alcohol use: 2%",,,,,,,"Psychoses, by ICD-10 codes from medical chart",0.1,,,,,,,,,,POINT (-95.71289 37.09024),High,"Meredith LS, Wong E, Osilla KC, et al. Trauma-informed Collaborative Care for African American Primary Care Patients in Federally Qualified Health Centers: A Pilot Randomized Trial. Med Care. 2022;60(3):232-9. doi: 10.1097/MLR.0000000000001681. PMID: 35157622.",1587537,2023
mills2012,2012,Psychotherapy,PTSD+SUD,103,,1,,CAPS,90.31,11.29,,Additional definitions of PTSD severity at baseline reported in the study,,,Median 10 (range 0.08 to 40),,,,,1,Community,,33.7,7.9,,0.621,,0.379,,,,,,,,,,,65.00%,,,,,,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",,,Median 6.0 (range 2 to 10),,,,Mixed Alcohol/Drug,Mixed Alcohol/Drug,Included,100%,,,,,"Currently suicidal (expressed suicidal ideation accompanied by plan and intent): 0%


Recent (past 6 months) history of self harm: 0%


Attempted suicide, lifetime: 52.4%


Attempted suicide, past year: 9.7%",,Current active symptoms of psychosis,0,,Borderline personality disorder: positive screen on International Personality Disorder Examination Questionnaire,0.728,,,,,,,POINT (134.491 -25.73289),Low,"Mills KL, Teesson M, Back SE, et al. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):690-9. doi: 10.1001/jama.2012.9071. PMID: 22893166..",39123,2020
mitchell2021,2021,Psychotherapy & pharmacotherapy,PTSD,90,"91 randomized, 1 withdrew consent before treatment",1,,CAPS-5,44.1,6.04,,Additional definitions of PTSD severity at baseline reported in the study,14.1,11.5,Duration of PTSD,0,,,0.178,0.822,Mixed,,41,11.9,,0.656,"2.22% (2/90) identified as non-binary gender; these participants are included in the reported value for female sex here and by the study (""sex assigned at birth"")",0.344,Race and Ethnicity data reported,0.767,0.022,0.033,0.078,0,0.089,"Multiple race 8.9% (entered as ""Other"")",0.089,,,No prior psychotherapy: 2.2%,0.911,Comorbid major depression,,,Mixed,"Combat-related; Other (""developmental trauma"", ""multiple trauma"")",,,,,,,,,Excluded,"current AUD: 0% (excluded


current SUD: 0% (excluded)",,,,,"C-SSRS


Suicidal ideation, current, any (baseline): 34.44%


Positive lifetime suicidal ideation: 92.2%


Serious lifetime suicidial ideation: 41.1%


Positive lifetime suicidal behavior: 32.2%",,"Primary psychotic disorder or MDD with psychotic features, MINI for DSM-5",0,Excluded,"Personality disorders, SCID-5-SPQ and SCID-5-PD",0,Excluded,,,,,,,Low,"Mitchell JM, Bogenschutz M, Lilienstein A, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021 Jun;27(6):1025-33. doi: 10.1038/s41591-021-01336-3. PMID: 33972795.",1569198,2022
mithoefer2011,2011,Psychotherapy & pharmacotherapy,PTSD,23,,1,,CAPS,79.4,22.4,,Additional definitions of PTSD severity at baseline reported in the study,20.67,14.42,,,,,,1,Community,,40.4,7.2,,0.85,,0.15,Race data reported,1,,,,,,,,,0%,,0.8,,,,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse, rape/sexual assault, community/school violence, other (family violence)",,,,,,,,,Included,"Current: 0%


Lifetime AUD: 10.00%


Lifetime other SUD: 5.00%",,,,,,,,,,,,,Comorbid anxiety disorder,0.15,,,,POINT (-95.71289 37.09024),High,"Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of ±3,4-psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. [Erratum appears in J Psychopharmacol. 2011;25(6):852.] J Psychopharmacol. 2010 June;25(4):439-52. doi: 10.1177/0269881110378371.",35036,2019
mithoefer2018,2018,Psychotherapy & pharmacotherapy,PTSD,26,,1,,CAPS,87.1,16.13,,Additional definitions of PTSD severity at baseline reported in the study,0.59,0.44,,0,,,0.8462,0.1538,Mixed,,37.2,10.3,,0.2692,,0.7308,Race and Ethnicity data reported,0.8462,,0.0385,,,0.1154,,0.0769,,0%,,0.7692,,,,Mixed,"combat-related, other (firefighter/police officer)",,,,,,,,,Included,0%,,,,,"Lifetime Columbia-Suicide Severity Rating Scale: Positive ideation: 85%;


Lifetime Columbia-Suicide Severity Rating Scale: Serious ideation: 31%;


Lifetime Columbia-Suicide Severity Rating Scale: Positive behaviour: 42%",,,,,,,,,,"Panic disorder: 35%;


GAD: 8%",,,POINT (-95.71289 37.09024),Low,"Mithoefer MC, Mithoefer AT, Feduccia AA, et al. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry. 2018 Jun;5(6):486-97. doi: 10.1016/S2215-0366(18)30135-4. PMID: 29728331.",50277,2019
miyahira2012,2012,Psychotherapy,PTSD,42,,,,CAPS,36.6,18.31,,Additional definitions of PTSD severity at baseline reported in the study,,,,1,0,,0,0,Active Duty Military,,,,,,,,,,,,,,,,,,,,,,,,Combat-related,,,,,,,,,,Excluded,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Miyahira SD, Folen RA, Hoffman HG, et al. The effectiveness of VR exposure therapy for PTSD in returning warfighters. Stud Health Technol Inform. 2012;181:128-32.  PMID: 22954842.",43675,2019
monson2006,2006,Psychotherapy,PTSD,60,,1,,CAPS,77.92,16.9,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0.483,,1,0,Veteran,,54,6.3,,0.1,,0.9,Race data reported,0.9333,,0.0333,0.0167,,0.0167,,,,,,,,,,Other,"""military-related""",,,,,,,,,Included,1.67%,,,,,,,,,,,,,"Other anxiety disorder, lifetime diagnosis: SCID-P for DSM-IV",0.6,,,,POINT (-95.71289 37.09024),Low,"Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006 Oct;74(5):898-907. doi: 10.1037/0022-006X.74.5.898. PMID: 17032094.",28862,2019
monson2012a,2012,Psychotherapy,PTSD,80,40 couples; data for sample characteristics entered for veterans only,1,,CAPS,72.2,13.9,,Additional definitions of PTSD severity at baseline reported in the study,,,median 9.75 years since index trauma,0,,,0.225,0.775,Mixed,,37.1,10.9,,0.75,,0.25,Race data reported,0.725,,,,,0.275,,,,,,,,,,Mixed,"rape/sexual assault, child sexual abuse, accidents, illness/medical procedure, combat-related, community/school violence, other (not specified)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,"Other anxiety disorder, current diagnosis: SCID-P for DSM-IV 30.00%;


Other anxiety disorder, lifetime diagnosis: SCID-P for DSM-IV 47.50%",,,,Low,"Monson CM, Fredman SJ, Macdonald A, et al. Effect of cognitive-behavioral couple therapy for PTSD: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):700-9. doi: 10.1001/jama.2012.9307. PMID: 22893167.",39124,2019
moradi2014,2014,Psychotherapy,PTSD,24,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,45.29,3.83,,0,,1,,,,,,,,,,,,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (54.27407 32.57503),Some Concerns,"Moradi AR, Moshirpanahi S, Parhon H, et al. A pilot randomized controlled trial investigating the efficacy of Memory Specificity Training in improving symptoms of posttraumatic stress disorder. Behav Res Ther. 2014 May;56:68-74. doi: 10.1016/j.brat.2014.03.002. PMID: 24705337.",46541,2019
moradi2021,2021,Nonpharmacologic cognitive,PTSD,43,,1,,PCL-5,43.88,9.86,,Additional definitions of PTSD severity at baseline reported in the study,,,index trauma occurred 3 to 18 months previously,,,,,1,Community,,29.37,5.94,,0.6744,,0.3256,Race data reported,0,0,0,1,0,0,"""All participants identified as Asian in ethnicity""",,,,,0.186,Comorbid MDD,0%,Excluded,Accidents,,1,,Inclusion criterion: single-incident trauma,1,,Inclusion criterion: single-incident trauma,,,,,,,,,,,"Current psychosis, determined via SCID",0,Excluded,,,,Comorbid anxiety disorder,0.0465,,,,POINT (54.27407 32.57503),High,"Moradi AR, Piltan M, Choobin MH, et al. Proof of concept for the autobiographical memory flexibility (MemFlex) intervention for posttraumatic stress disorder. Clin Psychol Sci. 2021 Jul;9(4):686-98. doi: 10.1177/2167702620982576. PMID: 34354873.",1574865,2022
morath2014,2014,Psychotherapy,PTSD,34,,1,,CAPS,84.65,15.46,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,30,,,0.7,,0.3,,,,,,,,,,,,,,,,,Terrorism/political violence/forced displacement,,,,,7,2,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (10.38578 51.10698),High,"Morath J, Gola H, Sommershof A, et al. The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: evidence from a randomized controlled trial. J Psychiatr Res. 2014 Jul;54:1-10. doi: 10.1016/j.jpsychires.2014.03.016. PMID: 24726027.",49697,2019
morland2014,2014,Psychotherapy,PTSD,125,,1,,CAPS,70.4,13.8,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,55.3,12.5,,0,,1,Race data reported,0.464,,,0.152,0.136,0.248,,,,,,0.288,,,,Combat-related,,,,,,,,,,Included,17.60%,,,,,,,,,,,,,,,"Anxiety disorder, current: SCID for DSM-IV 19.2%;


Anxiety disorder, lifetime: SCID for DSM-IV 22.4%",,,POINT (-95.71289 37.09024),Low,"Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.",42407,2019
morland2015,2015,Psychotherapy,PTSD,126,,1,,CAPS,67.1,16,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,0.17,0.83,Mixed,,46.4,11.9,,1,,0,Race data reported,0.476,,,0.143,0.119,0.262,,,,,,0.292,,,,,,6.2,,,,,,,,Included,3.20%,,,,,,,,,,,,,,,"Anxiety disorder, current: SCID for DSM-IV 26.8%;


Anxiety disorder, lifetime: SCID for DSM-IV 33.6%",,,POINT (-95.71289 37.09024),Some Concerns,"Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.",44260,2019
morland2019,2019,Psychotherapy,PTSD,175,,1,,CAPS-5,41.3,7.63,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0.463,,1,0,Veteran,,46.5,14.11,,0.251,,0.749,Race and Ethnicity data reported,0.406,0.286,0.029,0.08,0.023,0.097,,0.274,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",1549280,2020
morland2022,2022,Psychotherapy,PTSD,137,137 couples randomized (veteran with PTSD + intimate partner without PTSD); sample characteristics reported for veteran with PTSD unless otherwise specified,1,,CAPS-5,37.5,9.49,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,41.9,13.4,,0.1898,Same-gender couples: 7.30%,0.8102,Race and Ethnicity data reported,0.58,0.185,,,,0.235,Numerators unclear and calculation based on percent and sample size do not give whole number. Weighted average percents calculated based on full N's for arms. Only Black and White reported.,0.346,Numerators unclear and calculation based on percent and sample size do not give whole number. Weighted average percents calculated based on full N's for arms.,,"At time of enrollment, 25% of veterans were in nontrauma focused individual psychotherapy, 45% were taking psychotropic medication",,,,,,,,,,,,,,,Excluded,"Current (past 3 months) SUD, score ≥3 on Drug Abuse Screening Test: 0% (excluded)
Current (past 3 months) AUD, score ≥20 on AUDIT: 0% (excluded)",,,,,Excluded: imminent suicidality,,,,"Excluded: current uncontrolled psychotic symptoms, measured by the prime screen-resived (PS-R; threshold NR)",,,,,,,,,POINT (-95.71289 37.09024),High,"Morland LA, Knopp KC, Khalifian CE, et al. A randomized trial of brief couple therapy for PTSD and relationship satisfaction. J Consult Clin Psychol. 2022 May;90(5):392-404. doi: 10.1037/ccp0000731. PMID: 35604746.",1593669,2023
mueser2008,2008,Psychotherapy,PTSD,108,,1,,CAPS,75.31,17.32,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,44.21,10.64,,0.787,,0.213,Race data reported,0.8426,,,,,0.1574,,,,,,0.6111,,,,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",,,,,,,,,Included,40.74%,,,,,,,,,"Schizophrenia: SCID for DSM-IV: 7.4%;


Schizoaffective disorder: SCID for DSM-IV: 8.3%",Borderline personality disorder: SCID-II,0.25,,,,,0.898,,POINT (-95.71289 37.09024),Some Concerns,"Mueser KT, Rosenberg SD, Xie HY, et al. A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol. 2008 Apr;76(2):259-71. doi: 10.1037/0022-006X.76.2.259. PMID: 18377122.",30794,2019
mueser2015,2015,Psychotherapy,PTSD,201,,1,,CAPS,85.92,13.29,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,43.67,10.99,,0.6866,,0.3134,Race and Ethnicity data reported,0.3433,0.5622,0.01,0.01,0.005,0.0697,,0.1791,,,,,,,,,,,,,,,,,,Included,"AUD: 4.48%


SUD (excludes alcohol): 1.49%


AUD and SUD: 0.50%",,,,,,,,,"Schizophrenia spectrum only: 27.75%;


Schizophrenia spectrum and borderline personality disorder: 7.33%",,,"Major mood disorder and borderline personality disorder: 21.47%;


Schizophrenia spectrum and borderline personality disorder: 7.33%",,,,,,POINT (-95.71289 37.09024),Low,"Mueser KT, Gottlieb JD, Xie H, et al. Evaluation of cognitive restructuring for post-traumatic stress disorder in people with severe mental illness. Br J Psychiatry. 2015 Jun;206(6):501-8. doi: 10.1192/bjp.bp.114.147926. PMID: 25858178.",43698,2019
nacasch2011,2011,Psychotherapy,PTSD,30,,1,,PSS-I,37,5.1,,Additional definitions of PTSD severity at baseline reported in the study,9.7,10.9,,0,,,1,0,Veteran,,34.3,11.7,,0.0667,,0.9333,,,,,,,,,,,,,,,,,Mixed,"combat-related, terrorism/political violence",,,,,,,,,,,,,,,,,,,,,,,"Anxiety disorders, current: MINI",0.4333,,,,POINT (35.00445 31.4611),Some Concerns,"Nacasch N, Foa EB, Huppert JD, et al. Prolonged exposure therapy for combat- and terror-related posttraumatic stress disorder: a randomized control comparison with treatment as usual. J Clin Psychiatry. 2011 Sep;72(9):1174-80. doi: 10.4088/JCP.09m05682blu. PMID: 21208581.",35512,2019
nacasch2015,2015,Psychotherapy,PTSD,39,,1,,PSS-I,31.9,6.17,,Additional definitions of PTSD severity at baseline reported in the study,7.91,11.79,,0,,,1,0,Veteran,,38.67,13.4,,0.3846,,0.6154,,,,,,,,,,,,,0.2308,,,,Mixed,"combat-related, rape/sexual assault, child sexual abuse, community/school violence, terrorism/political violence/forced displacement, accidents",,,,,,,,,,,,,,,,,,,,,,,,,"Any anxiety disorder other than PTSD: MINI 33.33%;


Obsessive–compulsive disorder: MINI 23.08%",,,POINT (35.00445 31.4611),Low,"Nacasch N, Huppert JD, Su Y-J, et al. Are 60-minute prolonged exposure sessions with 20-minute imaginal exposure to traumatic memories sufficient to successfully treat PTSD? A randomized nonininferiority clinical trial. Behav Ther. 2015 May;46(3):328-41. doi: 10.1016/j.beth.2014.12.002. PMID: 25892169.",43927,2019
najavits2018,2018,Psychotherapy,PTSD+SUD,52,,1,,PCL,51.56,13.28,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,48.75,10.77,,0.2692,,0.7308,Race and Ethnicity data reported,0.6,0.301,,,0.02,0.079,,0.04,,,,0.476,,,,Mixed,"combat-related, rape/sexual assault, other (NR)",9.88,4.62,,,,,Mixed Alcohol/Drug,Mixed Alcohol/Drug,Included,"Current diagnoses





Any substance dependence: 94.2%


Alcohol dependence: 75%


Cocaine dependence: 26.4%


Cannabis dependence: 6.1%


Heroin dependence: 2.0%


Opiates dependence: 2.0%


Any substance abuse: 21.1%


Alcohol abuse: 7.7%


Cannabis abuse: 9.6%


Opiates abuse: 3.8%


Cocaine abuse: 1.9%",,,,,,,,,,,,"SCID for DSM-IV Personality Disorders:


Any personality disorder: 37.0%


Paranoid: 21.7%


Borderline: 11.5%


Avoidant: 11.5%


Obsessive-compulsive: 7.7%


Antisocial: 6.5%


Narcissistic: 6.5%",,,"Panic disorder: MINI 19.0%


Generalized anxiety: MINI 33.3%


Agoraphobia: MINI 11.9%",,,POINT (-95.71289 37.09024),High,"Najavits LM, Krinsley K, Waring ME, et al. A randomized controlled trial for veterans with PTSD and substance use disorder: creating change versus seeking safety. Subst Use Misuse. 2018 Sep 19;53(11):1788-800. doi: 10.1080/10826084.2018.1432653. PMID: 29461920.",49779,2020
nam2013,2013,Nonpharmacologic biological,PTSD,18,,1,,CAPS,105.19,5.93,,Additional definitions of PTSD severity at baseline reported in the study,3.3,1.4,,,,,,1,Community,,34.31,7.46,,0.625,,0.375,,,,,,,,,,,,,,,,,Mixed,"intimate partner violence, accidents, community/school violence",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (127.8392 36.38525),Some Concerns,"Nam D-H, Pae C-U, Chae J-H. Low-frequency, repetitive transcranial magnetic stimulation for the treatment of patients with posttraumatic stress disorder: a double-blind, sham-controlled study. Clin Psychopharmacol Neurosci. 2013 Aug;11(2):96-102. doi: 10.9758/cpn.2013.11.2.96. PMID: 24023554.",46490,2019
naylor2015,2015,Pharmacotherapy,PTSD,16,,1,,CAPS,86.45,5.8,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,33.82,4.33,,0.3571,,0.6429,Race and Ethnicity data reported,0.5,0.4286,,,,0.0714,,0.0714,,0%,antidepressant-naive,0.8571,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.",46407,2019
neuner2008,2008,Psychotherapy,PTSD,277,,1,,PDS,25.3,12.4,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,35,12.8,,0.5126,,0.4874,,,,,,,,,,,,,,,,,Terrorism/political violence/forced displacement,,14.1,5.15,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (32.36908 1.27469),Some Concerns,"Neuner F, Onyut PL, Ertl V, et al. Treatment of posttraumatic stress disorder by trained lay counselors in an African refugee settlement: a randomized controlled trial. J Consult Clin Psychol. 2008 Aug;76(4):686-94. doi: 10.1037/0022-006X.76.4.686. PMID: 18665696.",31216,2019
neuner2010,2010,Psychotherapy,PTSD,32,,0.85,,PDS,37.9,7.2,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,31.4,7.8,,0.3125,,0.6875,,,,,,,,,,,,,,,,,Terrorism/political violence/forced displacement,,,,,,,,,,Included,18.75%,,,,,"Suicidal tendency, plans or attempts: 40.63%;


Suicidal tendency, ideation or no tendecy: 59.38%",,,,,,,,,,,,,POINT (10.38578 51.10698),Some Concerns,"Neuner F, Kurreck S, Ruf M, et al. Can asylum-seekers with posttraumatic stress disorder be successfully treated? A randomized controlled pilot study. Cogn Behav Ther. 2010;39(2):81-91. doi: 10.1080/16506070903121042. PMID: 19816834.",33877,2019
neylan2006,2006,Pharmacotherapy,PTSD,63,,1,,CAPS,68.3,20.7,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Neylan TC, Lenoci M, Samuelson KW, et al. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Am J Psychiatry. 2006 Dec;163(12):2186-8. doi: 10.1176/appi.ajp.163.12.2186. PMID: 17151174.",28964,2019
nicholson2020,2020,Nonpharmacologic biological,PTSD,36,"PTSD patients only, excludes 36 healthy controls",1,,CAPS-5,38.4,9.18,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,0.1667,0.8333,Mixed,"Veteran percent represents 6 participants (6/36) with trauma type listed as ""military occupational trauma""; no other information on veteran status provided",43.28,12.29,,0.7222,,0.2777,,,,,,,,,,,,,0.3333,Current MDD,0%,Excluded: previous head injury with loss of consciousness,Mixed,"Rape/sexual assault; Community/school violence; Other (first responder occupational trauma, military occupational trauma)",,,,,,,,,Excluded,Excluded:alcohol or substance abuse/dependence not in sustained full remission in the 3 months before the study,,,,,,,,0,Exclusion criterion,,,,"""Specific Phobia""",0.0278,current,,,POINT (-106.3468 56.13037),Low,"Nicholson AA, Ros T, Densmore M, et al. A randomized, controlled trial of alpha-rhythm EEG neurofeedback in posttraumatic stress disorder: a preliminary investigation showing evidence of decreased PTSD symptoms and restored default mode and salience network connectivity using fMRI. Neuroimage Clin. 2020;28:102490. doi: 10.1016/j.nicl.2020.102490. PMID: 33395981.",1562230,2022
nidich2018,2018,Psychotherapy & CIH,PTSD,202,,1,,CAPS,79.7,17.8,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,47,15.4,,0.1683,,0.8317,Race and Ethnicity data reported,0.5594,0.2574,0.0248,0.0693,,0.0891,,0.2228,,,31.68% with no prior PTSD medications,0.4802,,23.27%,,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),,,,,,,,,Included,35.15%,,,Suicidal ideation,0.1287,,,Schizophrenia,0.0347,,,,,Anxiety disorder,0.3465,,,,POINT (-95.71289 37.09024),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nijdam2012,2012,Psychotherapy,PTSD,140,,1,,SI-PTSD,39.75,6.23,,Additional definitions of PTSD severity at baseline reported in the study,30.3,56.3,,,,,,1,Community,,37.8,11.4,,0.564,,0.436,,,,,,,,,,,,,0.6,,,,Mixed,"rape/sexual assault, accidents, natural or manmade disasters, community/school violence, other (war-related)",,,,,,"inclusion criteria states a single event, but baseline characteristics also show % with earlier trauma and complex trauma",,,,,,,,,,,,,,,,,Anxiety disorder other than PTS according to SCID for DSM-IV Axis I Disorders,0.1571,,,,POINT (5.281473 52.10081),High,"Nijdam MJ, Gersons BP, Reitsma JB, et al. Brief eclectic psychotherapy v. Eye Movement Desensitization and Reprocessing therapy for post-traumatic stress disorder: randomised controlled trial. Br J Psychiatry. 2012 Mar;200(3):224-31. doi: 10.1192/bjp.bp.111.099234. PMID: 22322458.",38273,2019
niles2012,2012,Psychotherapy & CIH,PTSD,33,,1,,CAPS,66.92,19.46,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,52,13,,0,,1,Race and Ethnicity data reported,0.7576,0.1515,,,,0.1515,,0.0606,,,,,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Niles BL, Klunk-Gillis J, Ryngala DJ, et al. Comparing mindfulness and psychoeducation treatments for combat-related PTSD using a telehealth approach. Psychol Trauma. 2012 Sep;4(5):538-47. doi: 10.1037/a0026161",37920,2019
noohi2017,2017,Nonpharmacologic biological,PTSD,30,,1,,IES-R,49.1,6.6,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,,,range 30 to 50,0,,1,,,,,,,,,,,,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (54.27407 32.57503),High,"Noohi S, Miraghaie AM, Arabi A, et al. Effectiveness of neuro-feedback treatment with alpha/theta method on PTSD symptoms and their executing function. Biomed Res. 2017;28(5):2019-27.",47468,2019
nordbrandt2020,2020,Other mixed,PTSD,318,,1,,HTQ,3.17,0.04,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0,,0,1,Community,,44.6,10.3,,0.528,,0.472,,,,,,,,,,,,,0.97,,82.20%,,Mixed,"combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")",,,,,,,,,Excluded,Current abuse of drugs or alcohol: 0%,,,,,,,,,,,,,,,,,,POINT (10.02799 55.98126),High,"Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-a pragmatic randomised controlled trial. PLoS One. 2020;10:846. doi: 10.1371/journal.pone.0230300. PMID: 32163509.",1551115,2020
norman2019,2019,Psychotherapy,PTSD+SUD,119,,0.958,,CAPS-5,42.7,9.5,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,41.6,12.6,,0.1008,,0.8992,Race and Ethnicity data reported,0.6555,0.1345,,0.0504,,0.1513,,0.2941,,,,,,,,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, illness/medical procedure",,,,8.3,2.7,,Alcohol,Alcohol,Included,"AUD: 100%


SUD: 11.8%",,,Prior suicide attempt,0.245,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.",52065,2020
norman2022,2022,Psychotherapy,PTSD,145,,0.848,CAPS-5 to determine presence of PTSD (threshold NR),CAPS-5,38.4,9.5,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,39.2,8.1,,0.062,,0.924,Race and Ethnicity data reported,0.634,0.09,,,,0.248,"Asian reported combined with Pacific Islander (9.0%), abstracted here with ""Other"" which also includes categories of ""biracial/ multiracial"" (5.5%) and ""other"" (10.3%) reported in the paper.",0.221,,,"48.3% had previous participation in PE or CPT, 69.0% currently taking psychotropic medication",,,,,Mixed,Combat-related; Rape/sexual assault;  Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (life-threatening injury),11.4,2.8,,,,,,,Included,"Mild-moderate SUD assessed with SCID, if willing to set goals to reduce use: NR (allowed)
Current severe SUD assessed with SCID: 0% (excluded)",,,,,Excluded: acute suicide risk assessed by C-SSRS (threshold NR),,,,Excluded: unmanaged psychosis assessed by SCID,,,,,,8% on anti-anxiety medications,,,POINT (-95.71289 37.09024),Low,"Norman SB, Capone C, Panza KE, et al. A clinical trial comparing trauma-informed guilt reduction therapy (TrIGR), a brief intervention for trauma-related guilt, to supportive care therapy. Depress Anxiety. 2022 Apr;39(4):262-73. doi: 10.1002/da.23244. PMID: 35075738.",1586433,2023
numata2014,2014,Pharmacotherapy,PTSD,43,,1,,IES-R,46.6,12.7,,Additional definitions of PTSD severity at baseline reported in the study,2,,,,,,,1,Community,,50.1,17.5,,0.4884,,0.5116,,,,,,,,,,,,,,,,,Natural or manmade disasters,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (138.0309 37.5923),High,"Numata T, GunFan S, Takayama S, et al. Treatment of posttraumatic stress disorder using the traditional Japanese herbal medicine saikokeishikankyoto: a randomized, observer-blinded, controlled trial in survivors of the great East Japan earthquake and tsunami. Evid Based Complement Alternat Med. 2014;2014:683293. doi: 10.1155/2014/683293. PMID: 24790634.",46973,2019
oehen2013,2013,Psychotherapy & pharmacotherapy,PTSD,14,,1,,CAPS,65.3,11.9,,Additional definitions of PTSD severity at baseline reported in the study,18.3,12,,,,,,1,Community,,41.4,11.2,,0.8333,,0.1667,,,,,,,,,,,0%,,0.8333,,,,Mixed,"child sexual abuse, rape/sexual assault, accidents, illness/medical procedure",,,,,,,,,Included,"AUD: 8.33%


Cannabis abuse/dependency: 16.67%",,,,,,,,,,,,,Panic disorder,0.08,,,,POINT (8.20866 46.79785),High,"Oehen P, Traber R, Widmer V, et al. A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol. 2013 Jan;27(1):40-52. doi: 10.1177/0269881112464827. PMID: 23118021.",41195,2019
onder2006,2006,Pharmacotherapy,PTSD,103,,1,,CAPS,83.6,13.2,,Additional definitions of PTSD severity at baseline reported in the study,,,range 0.33 to 1 year,,,,,1,Community,,31.4,7.2,,0.5049,,0.4951,,,,,,,,,,,,,0,,,,Natural or manmade disasters,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (35.16896 39.0616),Some Concerns,"Önder E, Tural Ü, Aker AT. A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake. Eur Psychiatry. 2006 Apr;21(3):174-9. doi: 10.1016/j.eurpsy.2005.03.007. PMID: 15964747.",28188,2019
oprel2021,2021,Psychotherapy,PTSD,149,150 randomized; 1 excluded after randomization for not meeting inclusion criteria,1,,CAPS-5,41.4,13.1,,Additional definitions of PTSD severity at baseline reported in the study,15.06,12.49,,,,,,1,Community,,36.86,11.75,,0.765,,0.235,,,,,,,,,,,,,0.571,"Current depression, MINI diagnosis",,,Mixed,Child physical abuse; Child sexual abuse; Community/school violence; Other (sexual abuse in adulthood),,,,,,,,,Excluded,"Alcohol/drug use disorder, past year: 22.8%


Excluded: ""severe disorder in the use of alcohol or drugs in last 3 months"" on MINI",,,Severe suicidality past month,0.43,,,"Current psychotic disorder, MINI",0.128,,Any personality disorder diagnosis on SCID,0.604,,,,,,,POINT (5.281473 52.10081),Some Concerns,"Oprel DAC, Hoeboer CM, Schoorl M, et al. Effect of prolonged exposure, intensified prolonged exposure and STAIR+prolonged exposure in patients with PTSD related to childhood abuse: a randomized controlled trial. Eur J Psychotraumatol. 2021;12(1) doi: 10.1080/20008198.2020.1851511. PMID: 34630934.",1580811,2022
orang2018,2018,Psychotherapy,PTSD,45,,1,,,26.68,5.76,based on 34 completers,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0,,0,1,Community,,37.69,8.91,,1,,0,,,,,,,,,,,,,,,,,Intimate partner violence,,,,,10.77,3.43,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (54.27407 32.57503),High,"Orang T, Ayoughi S, Moran JK, et al. The efficacy of narrative exposure therapy in a sample of Iranian women exposed to ongoing intimate partner violence-a randomized controlled trial. Clin Psychol Psychother. 2018 Nov;25(6):827-41. doi: 10.1002/cpp.2318. PMID: 30079583.",1529973,2020
otalora2018,2018,Psychotherapy & pharmacotherapy,PTSD,28,,0.9643,,CAPS-IV,91.9,18.1,,Additional definitions of PTSD severity at baseline reported in the study,29.4,,,0,0,,0,1,Community,,42,12.9,,0.679,,0.321,Race and Ethnicity data reported,0.929,,0.036,,,0.036,,0.036,,0%,,0.429,,,,Mixed,"Combat-related; Child physical abuse; Child sexual abuse; Accidents; Community/school violence; Other (ritual abuse, witnessing a crime)",,,majority ≥2,,,,,,Included,"Substance abuse: 10.7%


Alcohol abuse: 7.1%",,,,,"C-SSRS Positive  ideation: 96.4%


C-SSRS Serious ideation 46.4%


C-SSRS Positive behavior: 28.6%",,Pre-study drugs for psychosis,0.214,,,,,Pre-study drugs for anxiety,0.536,,,,POINT (-95.71289 37.09024),Low,"Ot'alora GM, Grigsby J, Poulter B, et al. 3,4-methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial. J Psychopharmacol. 2018 Dec;32(12):1295-307. doi: 10.1177/0269881118806297. PMID: 30371148.",51494,2020
padala2006,2006,Pharmacotherapy,PTSD,20,,1,,CAPS,79.89,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,41.3,,,1,,0,Race data reported,0.7,0.25,,,,0.05,,,,,,,,,,Mixed,"rape/sexual assault, intimate partner violence, child physical abuse, community/school violence, other (violent death of a loved one)",,,,,,,,,Excluded,0%,,,,,,,Psychotic symptoms in conjunction with depression,0.05,,,,,,,,,,POINT (-95.71289 37.09024),High,"Padala PR, Madison J, Monnahan M, et al. Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol. 2006 Sep;21(5):275-80. PMID: 16877898.",50966,2019
panahi2011,2011,Pharmacotherapy,PTSD,70,,1,,IES-R,65.2,4.3,,Additional definitions of PTSD severity at baseline reported in the study,24.1,2.7,,0.6857,,,0.3143,0,Mixed,,45.55,5.25,,0,,1,,,,,,,,,,,,,,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (54.27407 32.57503),Some Concerns,"Panahi Y, Moghaddam BR, Sahebkar A, et al. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychol Med. 2011;41(10):2159-66. doi: 10.1017/S0033291711000201. PMID: 21349225.",36061,2019
paunovic2001,2001,Psychotherapy,PTSD,20,,1,,"CAPS, total severity",97,20.1,,Additional definitions of PTSD severity at baseline reported in the study,7.8,7,,,,,,1,Community,,37.9,7.6,,0.1875,,0.8125,,,,,,,,,,,18.75%,,,,,,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (exposure to toxic substance)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (16.74371 62.79232),High,"Paunovic N, Öst L-G. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001 Oct;39(10):1183-97. doi: 10.1016/S0005-7967(00)00093-0. PMID: 11579988.",7357,2019
perezdandieu2014,2014,Psychotherapy,PTSD+SUD,12,,1,,PCL-S,57.25,7.39,,Additional definitions of PTSD severity at baseline reported in the study,19.67,5.49,,,,,,1,Community,,29.5,3.04,,1,,0,,,,,,,,,,,,,,,,,Mixed,"other (sexual abuse, physical abuse or physical threatening or negligence, emotional abuse)",,,,,,,,,Included,100%,,,,,,,,,,,,,,,,,,POINT (2.536185 46.18701),High,"Perez-Dandieu B, Tapia G. Treating trauma in addiction with EMDR: a pilot study. J Psychoactive Drugs. 2014 Oct-Dec;46(4):303-9. doi: 10.1080/02791072.2014.921744. PMID: 25188700.",1548480,2019
peterson2023,2023,Psychotherapy,PTSD,234,,0.9957,"1 participant in Intensive Outpatient Program withdrawn for ""no PTSD"", but not excluded from analysis",CAPS-5,37.58,0.79,,Additional definitions of PTSD severity at baseline reported in the study,,,,0.65,,,0.35,0,Mixed,Active Duty Military also includes participants in Army Reserve or National Guard,39.2,7.72,,0.22,,0.78,Race and Ethnicity data reported,0.44,0.26,,,,0.28,"""Other"" abstracted combines study-reported Hispanic (25%) and Other (3%) categories; study-reported ""Non-Hispanic White"" entered as ""White""",0.25,,,,,,0%,Moderate or severe TBI excluded,Combat-related,,,,,,,,,,Excluded,Substance use: 0% (excluded),,,,,Severe current suicidal ideation excluded,,,,Current psychotic symptoms excluded,,,,,,,,,POINT (-95.71289 37.09024),High,"Peterson AL, Blount TH, Foa EB, et al. Massed vs intensive outpatient prolonged exposure for combat-related posttraumatic stress disorder: a randomized clinical trial. JAMA Netw Open. 2023;6(1):e2249422. doi: 10.1001/jamanetworkopen.2022.49422. PMID: 36602803.",1614713,2023
petrakis2012,2012,Pharmacotherapy,PTSD+SUD,88,,1,,CAPS,71.1,5.01,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,0.9205,0.0795,Mixed,,47.1,8.9,,0.0909,,0.9091,Race data reported,0.75,0.2159,,,,0.0341,,,,,,,,,,,,,,,,,,Alcohol,Alcohol,Included,"Alcohol dependence: 100%


SUD: NR",,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. PMID: 22089316.",36777,2019
petrakis2016,2016,Pharmacotherapy,PTSD+SUD,96,,1,,CAPS,73.79,,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,43.97,,,0.0625,,0.9375,Race data reported,0.8211,0.1474,,,,0.0316,,,,,,0.3854,,,,,,,,,,,,Alcohol,Alcohol,Included,"AUD: 100%


Marijuana abuse/dependence: 11.46% 


Cocaine abuse/dependence: 16.67%",,,,,"(data reported for total N=84)


Lifetime presence of suicidal ideation: Columbia-Suicide Severity Rating Scale, ""Yes"" answer on Item 1 or 2: 59.52%


History of suicide attempt: 22.62%",,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Petrakis IL, Desai N, Gueorguieva R, et al. Prazosin for veterans with posttraumatic stress disorder and comorbid alcohol dependence: a clinical trial. Alcohol Clin Exp Res. 2016 Jan;40(1):178-86. doi: 10.1111/acer.12926. PMID: 26683790.",44663,2020
petrakis2020,2020,Psychotherapy & pharmacotherapy,PTSD+SUD,24,3:1 drug:placebo,1,,CAPS for DSM-IV,68.7,22.5,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,45.2,12.5,,0.0833,,0.9167,Race and Ethnicity data reported,0.4167,0.3333,,,,0.25,"Hispanic reported as a race category, abstracted as ""other""",0.25,,,,,,,,,,,,,,,,Alcohol,Alcohol,Included,AUD: 100% (inclusion criterion),,,,,,,Psychotic disorder or psychosis: SCID criteria,0,Exclusion criterion,,,,,,,,,POINT (-95.71289 37.09024),High,"Petrakis I, Ralevski E, Arias AJ, et al. Zonisamide as an adjunctive treatment to cognitive processing therapy for veterans with posttraumatic stress disorder and comorbid alcohol use disorder: a pilot study. Am J Addict. 2020 11;29(6):515-24. doi: 10.1111/ajad.13061. PMID: 32462773",1553678,2022
philip2019a,2019,Nonpharmacologic biological,PTSD,50,,1,,CAPS-5,47.7,10.3,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0.62,,1,0,Veteran,,51,13,,0.16,,0.84,Race and Ethnicity data reported,0.84,0.04,0.02,,,0.1,,0.04,,,,0.9,,,"Mild TBI: 24.00%


Moderate or severe TBI: 0%",Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (unspecified childhood trauma, ""serious injury, harm, or death you caused to someone else"", ""other very stressful event/experiences"")",,,,,,,,,Included,"Substance use disorder, mild severity: 54.00%


Substance use disorder, moderate or severe severity: 0%


Opioid use disorder: 22.00%",,,History of suicide attempt(s),0.24,,,,,,,,,,,,0.56,,POINT (-95.71289 37.09024),Low,"Philip NS, Barredo J, Aiken E, et al. Theta-burst transcranial magnetic stimulation for posttraumatic stress disorder. Am J Psychiatry. 2019 Jun 24;176(11):939-48. doi: 10.1176/appi.ajp.2019.18101160. PMID: 31230462.",52101,2020
philip2019b,2019,Nonpharmacologic biological,PTSD,23,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,54.2,12,,0.22,,0.78,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Philip NS, Aiken EE, Kelley ME, et al. Synchronized transcranial magnetic stimulation for posttraumatic stress disorder and comorbid major depression. Brain Stimul. 2019 Sep-Oct;12(5):1335-7. doi: 10.1016/j.brs.2019.06.010. PMID: 31204205.",1511859,2020
pigeon2022,2022,Psychotherapy,PTSD,110,,0.982,,CAPS for DSM-IV,71.93,14.89,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,35.48,10.86,,0.973,,0.027,Race data reported,0.491,0.391,0.018,0.009,,0.091,"Other includes ""Other"" and ""More than one race""",,,,27.3% taking antidepressant at baseline,0.946,MINI criteria,,,,,,,,,,,,,Excluded,Active alcohol dependence or remission <3 months: 0% (excluded),,,,,Excluded current suicidality,,History of schizophrenia,0,Exclusion criterion,,,,,,,,,POINT (-95.71289 37.09024),High,"Pigeon WR, Crean HF, Cerulli C, et al. A randomized clinical trial of cognitive-behavioral therapy for insomnia to augment posttraumatic stress disorder treatment in survivors of interpersonal violence. Psychother Psychosom. 2022 Jan;91(1):50-62. doi: 10.1159/000517862. PMID: 34265777.",1587109,2023
polak2015,2015,Psychotherapy & CIH,PTSD,8,,1,,IES-R,,,IES-R: median 45 (range 28-62) biofeedback group; median 41.5 (range 21-73) control group,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,,,Median 45 (range 25 to 57),0.75,,0.25,,,,,,,,,,,,,,,,,Mixed,"accidents, other (sexual or physical abuse)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (5.281473 52.10081),Some Concerns,"Polak AR, Witteveen AB, Denys D, et al. Breathing biofeedback as an adjunct to exposure in cognitive behavioral therapy hastens the reduction of PTSD symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2015 Mar;40(1):25-31. doi: 10.1007/s10484-015-9268-y. PMID: 25750106.",47793,2019
polusny2015,2015,Psychotherapy & CIH,PTSD,116,,0.9741,,CAPS,66.2,16.5,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,58.5,9.8,,0.1552,,0.8448,Race data reported,0.8362,0.0776,0.0172,,,0.069,,,,,,,,,,Mixed,"combat-related, rape/sexual assault, illness/medical procedure, community/school violence, natural or manmade disaster, other (not specified)",,,,7.7,3.1,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Polusny MA, Erbes CR, Thuras P, et al. Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA. 2015 Aug 4;314(5):456-65. doi: 10.1001/jama.2015.8361. PMID: 26241597.",44257,2019
popiel2015,2015,Psychotherapy & pharmacotherapy,PTSD,228,,1,,PDS,32.18,9.49,,Additional definitions of PTSD severity at baseline reported in the study,1.49,1.72,,,,,,1,Community,,37.65,12.76,,0.2368,,0.7632,,,,,,,,,,,61.40%,,0.2018,,21.05%,,Accidents,,,,,,,2.08 [SD 1.3] preceding current trauma,,,Included,"SUD: NR


AUD: 1.75%",,,,,,,Schizophrenia,0,,SCID-II diagnosis of comorbid personality disorder,0.4079,,Anxiety disorders other than PTSD,0.3377,,,,POINT (19.39012 52.1276),High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
possemato2016,2016,Other study class,PTSD,20,,1,,PCL-S,53.5,12.1,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,42,12,,0.05,,0.95,Race data reported,0.65,,,,,0.35,,,,,,,,,,Other,military-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Possemato K, Kuhn E, Johnson E, et al. Using PTSD Coach in primary care with and without clinician support: a pilot randomized controlled trial. General hospital psychiatry. 2016 Jan-Feb;38:94-8. doi: 10.1016/j.genhosppsych.2015.09.005. PMID: 26589765.",44682,2019
possemato2022,2022,Psychotherapy & CIH,PTSD,55,,1,,PCL-5,45.77,10.75,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,55.91,14.46,,0.13,,0.87,Race and Ethnicity data reported,0.85,0.09,0.02,,,0.04,,0.05,,,,,,,,,,,,,,,,,,,,,,,,Excluded: past-month suicide attempt or intent,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Possemato K, Bergen-Cico D, Buckheit K, et al. Randomized clinical trial of brief primary care-based mindfulness training versus a psychoeducational group for veterans with posttraumatic stress disorder. J Clin Psychiatry. 2022;84(1) doi: 10.4088/JCP.22m14510. PMID: 36576365.",1614949,2023
power2002,2002,Psychotherapy,PTSD,105,,1,,"SI-PTSD, self-report version",48.5,9.4,completers only,Additional definitions of PTSD severity at baseline reported in the study,3.8,6.8,completers only,,,,,1,Community,,39.2,11.5,completers only,0.4167,completers only,0.5833,,,,,,,,,,,,,,,,,Mixed,"accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-2.865634 54.12387),High,"Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post-traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.",25144,2019
powers2015,2015,Other mixed,PTSD,9,,1,,PSS-I,37,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,34,11.82,,0.8889,,0.1111,Race and Ethnicity data reported,0.8889,,,,,0.1111,,22.22,,,,,,,,,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Powers MB, Medina JL, Burns S, et al. Exercise augmentation of exposure therapy for PTSD: rationale and pilot efficacy data. Cogn Behav Ther. 2015;44(4):314-27. doi: 10.1080/16506073.2015.1012740. PMID: 25706090.",43517,2019
proenca2022,2022,Psychotherapy & pharmacotherapy,PTSD,74,,0.9865,One sertraline patient excluded after randomization for subthreshold PTSD diagnosis,CAPS-5,42.54,9.21,,Additional definitions of PTSD severity at baseline reported in the study,0.139,0.0792,Time since index sexual assault,,,,,1,Community,,24.9,41.3,,1,,0,Race data reported,0.4324,0.1622,,0.0135,,0.3919,"39.19% ""mixed race"", entered as ""Other""",,,,,,,,,Rape/sexual assault,,,,18.9% (14/74) reported childhood sexual abuse in addtion to index sexual assault,,,70/74 women (95%) reported at least one traumatic event in addition to index sexual assault,,,Excluded,Current substance dependence: 0% (excluded),,,,,Severe suicide risk excluded,,Schizophrenia,0,Exclusion criterion,,,,,,,,,POINT (-53.09783 -10.78778),Some Concerns,"Proenca CR, Markowitz JC, Coimbra BM, et al. Interpersonal psychotherapy versus sertraline for women with posttraumatic stress disorder following recent sexual assault: a randomized clinical trial. Eur J Psychotraumatol. 2022;13(2):2127474. doi: 10.1080/20008066.2022.2127474. PMID: 36267873.",1605384,2023
quinones2015,2015,Psychotherapy & CIH,PTSD,100,,1,,PCL-C,55.6,16.47,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,,,,0.27,,0.73,,,,,,,,,,,11.11%,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-73.08115 3.913832),High,"Quinones N, Maquet YG, Velez DM, et al. Efficacy of a Satyananda yoga intervention for reintegrating adults diagnosed with posttraumatic stress disorder. Int J Yoga Therap. 2015;25(1):89-99. doi: 10.17761/1531-2054-25.1.89. PMID: 26667292.",44694,2019
raabe2022,2022,Psychotherapy,PTSD,61,,1,,CAPS for DSM-IV,74.8,16.2,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,35.9,10.7,,0.8852,,0.1148,Not reported,,,,,,,,,,,,0.61,"Depressive disorder, DSM-IV SCID",,,Mixed,Child physical abuse; Child sexual abuse,,,,,,,,,Excluded,"Substance or alcohol dependence (DSM-IV diagnosis) not in full remission for at least 6 months: 0% (excluded)
Substance/alcohol abuse, current, DSM-IV SCID: 2%",,,Life-threatening self-harm or suicide attempts during the previous 12 weeks,0,Exclusion criterion,,Psychotic disorder,0,Exclusion criterion,"Personality disorder, DSM-IV SCID-II",0.23,"Avoidant: 16%
Borderline: 7%
Narcissistic: 2%
Antisocial: 0% (excluded)
None: 77%","GAD, DSM-IV SCID-I diagnosis",0.07,"additional DSM-IV SCID-I diagnoses for anxiety:
Social phobia: 26%
Panic disorder: 20%
Obsessive-compulsive disorder: 7%",,,POINT (5.281473 52.10081),High,"Raabe S, Ehring T, Marquenie L, et al. Imagery rescripting as a stand-alone treatment for posttraumatic stress disorder related to childhood abuse: a randomized controlled trial. J Behav Ther Exp Psychiatry. 2022;77:101769. doi: 10.1016/j.jbtep.2022.101769. PMID: 36113906.",1600567,2023
raeolmsted2020,2020,Nonpharmacologic biological,PTSD,113,,0.8,,CAPS-5,38.4,12.4,,Additional definitions of PTSD severity at baseline reported in the study,4.06,3.94,,1,0,,0,0,Active Duty Military,,37.3,6.7,,0.115,,0.885,,,,,,,,,,,,"Naïve to SGB: 100%


Naïve to other PTSD treatment: NR",,,0%,Moderate or severe,,,,,,,,,,,Included,SUD (moderate to severe in past 30 days): 0%,,,,,,,,,,Personality disorder,0,,,,,,,,Low,"Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of stellate ganglion block treatment on posttraumatic stress disorder symptoms: a randomized clinical trial. JAMA Psychiatry. 2020 Feb 1;77(2):130-8. doi: 10.1001/jamapsychiatry.2019.3474. PMID: 31693083.",1546434,2020
rajan2020,2020,Psychotherapy,PTSD,36,"57 randomized, 21 excluded after randomization (not eligible, some criteria assessed following randomization)",0.9167,IES-R ≥ 34,IES-R,56.8,13.9,,Additional definitions of PTSD severity at baseline reported in the study,2.32,1.42,Time since sexual assault; inclusion required ≤5 years,,,,,1,Community,,24.2,6.3,,1,,0,Race data reported,1,0,0,0,0,0,,,,,,,,,,Rape/sexual assault,,1,,Multiple traumas excluded,1,,Multiple traumas excluded,,,Excluded,Active substance abuse: 0% (excluded),,,,,,,,,Active psychosis excluded,,,,,,,,,POINT (16.74371 62.79232),High,"Rajan G, Wachtler C, Lee S, et al. A one-session treatment of PTSD after single sexual assault trauma. A pilot study of the WONSA MLI project: a randomized controlled trial. J Interpers Violence. 2020 doi: 10.1177/0886260520965973. PMID: 33084475",1560532,2022
ramakrishnan2021,2021,Pharmacotherapy,PTSD,24,,1,,CAPS-5,48.6,9.2,,Additional definitions of PTSD severity at baseline reported in the study,16.2,11,Time since trauma,0,,,0.4583,0.5417,Mixed,Veteran and community,40.9,9.1,,0.5833,,0.4167,Race data reported,0.5417,,,,,0.4583,"Only ""race, Caucasian"" reported",,,,,0.8333,,0%,Excluded,Mixed,Combat-related; Child sexual abuse;  Rape/sexual assault; Community/school violence; Other (not specified),,,,,,,,,Excluded,Current SUD (within 1 month): 0% (excluded),,,,,Excluded: recent suicide attempt or at imminent risk of suicide,,DSM-5 diagnosis of schizophrenia or schizoaffective disorder,0,Exclusion criterion,,,,,,,,,POINT (-95.71289 37.09024),High,"Ramakrishnan N, Lijffijt M, Green CE, et al. Neurophysiological and clinical effects of the NMDA receptor antagonist lanicemine (BHV-5500) in PTSD: a randomized, double-blind, placebo-controlled trial. Depress Anxiety. 2021 Nov;38(11):1108-19. doi: 10.1002/da.23194. PMID: 34254405.",1573927,2023
ramaswamy2016,2016,Pharmacotherapy,PTSD,30,,1,,CAPS,77.65,4.6,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,38.9,12,,0.8667,,0.1333,,,,,,,,,,,,,,,,,Mixed,"rape/sexual assault, community/school violence, other (not specified)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Ramaswamy S, Driscoll D, Smith LM, et al. Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder. Contemp Clin Trials Commun. 2016 Dec;2:1-5. doi: 10.1016/j.conctc.2015.12.003. PMID: 29736440.",1551835,2019
ramaswamy2017,2017,Pharmacotherapy,PTSD,59,,1,,CAPS,75.5,14,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,32.7,7.1,,0.0339,,0.9661,Race and Ethnicity data reported,0.5424,0.1186,0.0169,0.0678,,0.2542,,0.1695,,,,,,0%,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Ramaswamy S, Driscoll D, Reist C, et al. A double-blind, placebo-controlled randomized trial of vilazodone in the treatment of posttraumatic stress disorder and comorbid depression. Prim Care Companion CNS Disord. 2017 Aug 24;19(4):17m02138. doi: 10.4088/PCC.17m02138. PMID: 28858440.",49046,2019
raskind2003,2003,Pharmacotherapy,PTSD,10,,1,,CAPS,81.35,17.3,,Additional definitions of PTSD severity at baseline reported in the study,,,( 25 years),0,,Receiving disability compensation for PTSD: 90.00%,1,0,Veteran,,53,3,,0,,1,,,,,,,,,,,0%,,,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Raskind MA, Peskind ER, Kanter ED, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003 Feb;160(2):371-3. doi: 10.1176/appi.ajp.160.2.371. PMID: 12562588.",25442,2019
raskind2007,2007,Pharmacotherapy,PTSD,40,,1,,CAPS,77,20,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,56,9,,0.05,,0.95,Race and Ethnicity data reported,0.65,0.275,0.025,0.025,,0.025,,0.025,,,,,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007 Apr 15;61(8):928-34. doi: 10.1016/j.biopsych.2006.06.032. PMID: 17069768.",29403,2019
raskind2013,2013,Pharmacotherapy,PTSD,67,,1,,CAPS,81.7,16.7,,Additional definitions of PTSD severity at baseline reported in the study,,,,0.9701,,,0.0299,0,Mixed,,30.4,6.5,,0.1493,,0.8507,Race and Ethnicity data reported,0.6269,0.1343,0.0299,0.0149,,0.194,,0.1194,,,,0.3881,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Raskind MA, Peterson K, Williams T, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013 Sep;170(9):1003-10. doi: 10.1176/appi.ajp.2013.12081133. PMID: 23846759.",41028,2019
raskind2018,2018,Pharmacotherapy,PTSD,304,,1,,CAPS,81.3,16.3,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,Receiving or will receive VA disability for PTSD: 83.22%,1,0,Veteran,,51.9,13.8,,0.023,,0.977,Race and Ethnicity data reported,0.6678,0.2599,,,,0.0724,,0.1711,,0%,,0.3783,,,,Combat-related,,,,,,,,,,Included,"AUD: 1.32%


Cannabis abuse: 0.66%",,,,,,,,,,,,,Anxiety disorder other than PTSD,0.227,,,,POINT (-95.71289 37.09024),High,"Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018 Feb 8;378(6):507-17. doi: 10.1056/NEJMoa1507598. PMID: 29414272.",49659,2019
rasmusson2017,2017,Pharmacotherapy,PTSD,112,,1,,CAPS,73.8,17.7,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,0.125,Mixed,,38.3,10.7,,0.2143,,0.7857,Race and Ethnicity data reported,0.5804,0.3125,,,,0.1071,,0.0893,,,,0.3304,,,mild TBI: 53.57%; moderate or severe TBI: 0%,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Low,"Rasmusson AM, Marx CE, Jain S, et al. A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology (Berl). 2017;234(15):2245-57. doi: 10.1007/s00213-017-4649-y. PMID: 28667510.",48368,2019
rauch2015,2015,Psychotherapy,PTSD,36,,1,,CAPS,78.2,12.1,"completers only, n=26",Additional definitions of PTSD severity at baseline reported in the study,,,,0,,"PTSD: 13.9%;


Medical: 27.8%",1,0,Veteran,,31.9,7.6,,0.0833,,0.9167,Race data reported,0.833,0.139,,,,0.028,,,,,,0.472,,,,,,,,,,,,,,Included,"Alcohol or substance dependence: 0%


Alcohol abuse: 5.6%",,,,,,,,,,,,,,,"Panic disorder: 13.9%;


Agoraphobia: 8.3%; 


Social phobia: 8.3%


GAD: 5.6%",,,POINT (-95.71289 37.09024),High,"Rauch SAM, King AP, Abelson JL, et al. Biological and symptom changes in posttraumatic stress disorder treatment: a randomized clinical trial. Depress Anxiety. 2015 Mar;32(3):204-12. doi: 10.1002/da.22331. PMID: 25639570.",43645,2019
rauch2019,2019,Psychotherapy & pharmacotherapy,PTSD,223,,1,,CAPS,77.27,14.3,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,"Of N=194 analyzed in Simon 2020 (modified ITT, with grief data at baseline):


Service-connected disability for PTSD: 19.59%",,0,Mixed,,34.31,8.28,,0.13,,0.87,Race and Ethnicity data reported,0.578,0.291,,,,0.13,,0.143,,,,0.691,ITT population,,mild TBI allowed,Combat-related,,,,,,,,,,Included,"Substance dependence (past 8 weeks): 0% (excluded)


Alcohol dependence (past 8 weeks): 0% (excluded)


Substance abuse:  2.4%


Alcohol abuse: 10.1%


(ITT population)",,,,,"Of N=194 analyzed in Simon 2020 (modified ITT, with grief data at baseline):


Any suicidal ideation, lifetime: 41.24%


Any suicidal ideation, past month: 14.43%


Any suicidal behavior, lifetime: 10.31%


Any suicidal behavior, past 3 months: 1.03%",,Active psychosis,0,Excluded,,,,,,"Panic disorder: 10.7%


Agoraphobia: 19.8%",,,POINT (-95.71289 37.09024),High,"Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.",51290,2020
ready2010,2010,Psychotherapy,PTSD,11,,1,,CAPS,93.82,13.08,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,58,3.04,,0,,1,Race data reported,0.5455,0.4545,,,,,,,,0%,,,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Ready DJ, Gerardi RJ, Backscheider AG, et al. Comparing virtual reality exposure therapy to present-centered therapy with 11 U.S. Vietnam veterans with PTSD. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):49-54.  PMID: 20528293.",34258,2019
ready2018,2018,Psychotherapy,PTSD,81,,1,,CAPS,81.81,14.71,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,61.4,2.6,,0,,1,Race data reported,0.3827,0.6173,,,,,,,,,,,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268.",1533924,2020
reeve2020,2020,CIH,PTSD,40,,1,,PCL-5,60.06,13.07,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,60.27,12.62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Reeve K, et al. Examining the impact of a Healing Touch intervention to reduce posttraumatic stress disorder symptoms in combat veterans. Psychological Trauma: Theory, Research, Practice, and Policy. 2020. doi: 10.1037/tra0000591.",1555617,2020
reger2016,2016,Psychotherapy,PTSD,162,,1,,CAPS-DX,87.25,13.28,,Additional definitions of PTSD severity at baseline reported in the study,,,,1,0,,0,0,Active Duty Military,,30.27,6.68,,0.037,,0.963,Race and Ethnicity data reported,0.5988,0.0926,0.0309,,,0.2778,,0.1728,,67.28%,,,,,,Combat-related,,,,,,,,,,,,,,"Suicidal ideation, score ≥1 on BDI-II item 9",0.1111,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reich2004,2004,Pharmacotherapy,PTSD,21,,1,,CAPS-1,69.1,12.1,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,0,1,Community,,27.9,6.4,,1,,0,Race data reported,0.8571,0.0952,,0.0476,,,,,,,,0.619,,,,Mixed,"child physical abuse, child sexual abuse, child other abuse",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,"Panic disorder: 19.05%;


Agoraphobia ± panic disorder: 14.29%;


GAD: 14.29%;


Simple phobia: 14.29%;


Social phobia: 4.76%;


Obsessive-compulsive disorder: 4.76%",,,POINT (-95.71289 37.09024),High,"Reich DB, Winternitz S, Hennen J, et al. A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. J Clin Psychiatry. 2004 Dec;65(12):1601-6. PMID: 15641864.",27284,2019
reinhardt2018,2018,CIH,PTSD,51,,1,,CAPS-DX,69.13,20.21,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,0,Mixed,(100% either active duty military or veteran),47.76,13.77,,0.1176,,0.8824,Race and Ethnicity data reported,0.6275,0.1961,,0.0196,,0.1569,,0.0784,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.",48190,2019
resick2002,2002,Psychotherapy,PTSD,171,,1,,CAPS,74.08,19.34,,Additional definitions of PTSD severity at baseline reported in the study,8.5,8.5,,,,,,1,Community,,32,9.9,,1,,0,Race data reported,0.71,0.25,,,,0.04,,,,,,,,,,Mixed,"child sexual abuse, rape/sexual assault",,,,7.4,4.9,,,,,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2008,2008,Psychotherapy,PTSD,162,,1,,CAPS,71.41,18.43,,Additional definitions of PTSD severity at baseline reported in the study,14.6,14.4,,,,,,1,Community,,35.4,12.4,,1,,0,Race and Ethnicity data reported,0.62,0.34,,,,0.04,,0.03,,,,0.5,,,,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",,,,,,"47.3% with >10 childhood victimization events, 46.6% with >10 adulthood incidents",,,Included,"Alcohol abuse: 0.67%


Cannabis abuse: 2%


Alcohol or drug dependence: 1.33%",,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2015,2015,Psychotherapy,PTSD,108,,1,,PSS-I,27.4,7.21,,Additional definitions of PTSD severity at baseline reported in the study,,,,1,0,,0,0,Active Duty Military,,32.09,7.59,,0.0741,,0.9259,Race and Ethnicity data reported,0.5741,0.2037,,,,0.2222,,0.1389,,,,,,0%,,Mixed,"combat-related, child sexual abuse",,,,8.81,3.97,,,,,,,,,,"Current suicide ideation at baseline: endorsement of item 4 and/or item 5 on Beck Scale for Suicide Ideation: 17.6%


History of one or more suicide attempts: 12.0%",,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.",43929,2020
resick2017,2017,Psychotherapy,PTSD,268,,1,,PSS-I,24.3,6,,Additional definitions of PTSD severity at baseline reported in the study,,,"Of N=165 analyzed in Resick, 2020 (complete pre- and post-treatment data): Mean 5.8 (SD 5.4) years since traumatic event",1,,,0,0,Active Duty Military,,33.2,7.4,,0.09,,0.91,Race and Ethnicity data reported,0.403,0.28,,,,0.317,,0.231,,,,,,,Severe TBI: 0%; Postconcussive symptoms (current): 64.6%,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",,,,,,"Of N=165 analyzed in Resick, 2020 (complete pre- and post-treatment data): Mean 10.1 (SD 3.9) trauma events",,,Included,16.80%,,,"Beck Scale for Suicide Ideation, percent with suicidal ideation;  ""scores use a dichotomous rating of 0 for absent and 1 for present""",0.175,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
richards1994,1994,Psychotherapy,PTSD,14,,1,,IES-R,46.3,13.4,,Additional definitions of PTSD severity at baseline reported in the study,2,,,,,,,1,Community,,32,,range 15 to 50,0.6923,(completers only),0.3077,,,,,,,,,,,,,,,,,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-2.865634 54.12387),High,"Richards DA, Lovell K, Marks IM. Post-traumatic stress disorder: evaluation of a behavioral treatment program. J Trauma Stress. 1994 Oct;7(4):669-80. doi: 10.1007/BF02103014. PMID: 7820356.",12187,2019
richerson2023,2023,Other study class,PTSD,213,"characteristics reported for N=181 who received allocated intervention (were paired with dog).
227 initially randomized, n=14 excluded for no longer meeting inclusion criteria following 3-month observation period (after randomization and before pairing with dog); additional n=32 did not receive allocated intervention (not paired with dog)",1,,PCL-5,47.7,15.2,For N=181 paired with dog,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,"Work status listed as ""general medical disability"" for 33% and ""mental health disability"" for 43%",1,0,Veteran,,50.6,13.6,,0.2,,0.8,Race and Ethnicity data reported,0.66,0.12,0.02,0.01,0.01,0.1823,"Reported as unknown (1%), other (1%), or multiple races (17%)",0.07,"91% not Hispanic, 2% unknown",,"Inclusion required participant be in mental health treatment during the study, but not specifically stated as PTSD treatment.",0.37,MDD current (MINI),0%,Moderate/severe excluded,,,,,,,,,,,Excluded,"Moderate or severe AUD or SUD excluded
AUD past 12 months: 4%
SUD past 12 months: 1%",,,,,,,"Psychotic disorder, current or lifetime, on MINI",0,,,,,"current GAD, MINI diagnosis",0.07,"additional anxiety MINI diagnosis
Panic disorder, current: 13%",,,POINT (-95.71289 37.09024),High,"Richerson JT, Wagner TH, Abrams T, et al. Therapeutic and economic benefits of service dogs versus emotional support dogs for veterans with PTSD. Psychiatr Serv. 2023:appips20220138. doi: 10.1176/appi.ps.20220138. PMID: 36718602.",1615319,2023
robjant2019,2019,Psychotherapy,PTSD,92,,1,,PSS-I,38.47,8.96,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0,,0,1,Community,,,,Median 18 (Range 16 to 25),1,,0,,,,,,,,,,,,,,,,,Terrorism/political violence/forced displacement,,,,,,,Median 48 (range 28 to 58),,,,,,,,,,,,,,,,,,,,,,POINT (23.64396 -2.87746),Some Concerns,"Robjant K, Koebach A, Schmitt S, et al. The treatment of posttraumatic stress symptoms and aggression in female former child soldiers using adapted Narrative Exposure therapy - a RCT in Eastern Democratic Republic of Congo. Behav Res Ther. 2019 Dec;123:103482. doi: 10.1016/j.brat.2019.103482. PMID: 31639529.",1545978,2020
rodgman2016,2016,Pharmacotherapy,PTSD,8,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,12.7,,,0,,,1,0,Veteran,,34.8,,SEM 8.3,0,,1,Race and Ethnicity data reported,0.25,0.375,0.125,,,0.25,,0.25,,,,,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Rodgman C, Verrico CD, Holst M, et al. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. J Clin Psychiatry. 2016 May;77(5):e561-5. doi: 10.4088/JCP.14m09681. PMID: 27249080.",49795,2019
rogers1999,1999,Psychotherapy,PTSD,12,,1,,IES,39.2,7.2,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,,,range 47 to 53,,,,,,,,,,,,,,0%,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,POINT (-95.71289 37.09024),Some Concerns,"Rogers S, Silver SM, Goss J, et al. A single session, group study of exposure and Eye Movement Desensitization and Reprocessing in treating posttraumatic stress disorder among Vietnam War veterans: preliminary data. J Anxiety Disord. 1999 Jan-Apr;13(1-2):119-30. doi: 10.1016/S0887-6185(98)00043-7. PMID: 10225504.",14686,2019
rosenbaum2015,2015,Other study class,PTSD,81,,1,,PCL-C,64.3,12.1,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,47.8,12.1,,0.1605,,0.8395,,,,,,,,,,,,,0.7901,,,,Mixed,"other (trauma experienced through occupation, not specified)",,,,,,,,,,,,,,,,,,,,,,,"Depression Anxiety and Stress Scale, anxiety domain, score ≥10 (moderate anxiety)",0.7778,,1,,POINT (134.491 -25.73289),High,"Rosenbaum S, Sherrington C, Tiedemann A. Exercise augmentation compared with usual care for post-traumatic stress disorder: a randomized controlled trial. Acta Psychiatr Scand. 2015 May;131(5):350-9. doi: 10.1111/acps.12371. PMID: 25443996.",44069,2019
rothbaum1997,1997,Psychotherapy,PTSD,21,,1,,PSS-I,35.8,8.5,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,34.2,10.4,,1,,0,,,,,,,,,,,,,,,,,Rape/sexual assault,,,,,,,,,,Excluded,Current alcohol or drug dependence: 0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,Rothbaum BO. A controlled study of Eye Movement Desensitization and Reprocessing in the treatment of posttraumatic stress disordered sexual assault victims. Bull Menninger Clin. 1997 Summer;61(3):317-34.  PMID: 9260344.,9058,2019
rothbaum2005,2005,Psychotherapy,PTSD,72,"(population characteristics reported for completer sample, n=60)",1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,11.94,10.67,,,,,,1,Community,,33.8,11,,1,,0,Race data reported,0.683,,,,,0.317,,,,,,,,,,Rape/sexual assault,,,,,6,4.1,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims. J Trauma Stress. 2005 Dec;18(6):607-16. doi: 10.1002/jts.20069. PMID: 16382428.",19662,2019
rothbaum2006,2006,Psychotherapy & pharmacotherapy,PTSD,65,,1,,SI-PTSD,35.9,8.98,,Additional definitions of PTSD severity at baseline reported in the study,8.1,11.77,,,,,,1,Community,,39.3,10.69,,0.646,,0.354,Race data reported,0.8,0.185,,,,0.015,,,,,,0.63,,,,Mixed,"child sexual abuse, child physical abuse, accidents, combat-related, other (death [not combat-related] of another person)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Rothbaum BO, Cahill SP, Foa EB, et al. Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder. J Trauma Stress. 2006 Oct;19(5):625-38. doi: 10.1002/jts.20170. PMID: 17075912.",80288,2019
rothbaum2008,2008,Pharmacotherapy,PTSD,25,,1,,CAPS,57.76,21.15,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,34,11.3,,0.8,,0.2,Race data reported,0.7,0.25,,,,0.05,,,,0%,,0.8,,,,Mixed,"rape/sexual assault, intimate partner violence, accidents, community/school violence, other (stalking, break-in, witnessed killing or suicide attempt)",,,,,,,,,,,,,Low/medium suicide risk,0.4,,,,,,,,,,,"Any other anxiety disorder: 55.00%;


Panic: 25.00%;


Social phobia: 30.00%;


GAD: 25.00%",,,POINT (-95.71289 37.09024),High,"Rothbaum BO, Killeen TK, Davidson JRT, et al. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J. Clin. Psychiatry. 2008;69(4):520-5. doi: 10.4088/JCP.v69n0402. PMID: 18278987.",30519,2019
rothbaum2014,2014,Psychotherapy & pharmacotherapy,PTSD,156,,1,,CAPS,85.3,18.7,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,35.1,8.7,,0.0513,,0.9487,Race and Ethnicity data reported,0.417,0.506,,0.006,,0.019,,0.0513,,,,,,0%,moderate or severe TBI,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
roullet2021,2021,Other mixed,PTSD,66,,1,,,,,Scores shown in figure only,Additional definitions of PTSD severity at baseline reported in the study,6.3,11.23,Duration of trauma before treatment,,,,,1,Community,,38.9,13.1,,0.6212,,0.3788,,,,,,,,,,,,,,65.15% with comorbid mood disorder diagnosis,0%,Excluded,Mixed,"Combat-related; Rape/sexual assault; Accidents; Community/school violence; Terrorism/political violence/forced displacement; Other (""life threatening event"", ""sudden unexpected death"")",,,,,,,,,Excluded,"Current substance or alcohol dependence: 0% (excluded)


Current substance or alcohol abuse: 12.12%",,,,,Acute suicidal ideation was an exclusion criterion,,Psychotic disorders,0,Excluded,,,,Current comorbid anxiety diagnosis,0.5606,,,,POINT (2.536185 46.18701),Low,"Roullet P, Vaiva G, Very E, et al. Traumatic memory reactivation with or without propranolol for PTSD and comorbid MD symptoms: a randomised clinical trial. Neuropsychopharmacology. 2021 Feb 21;21:21. doi: 10.1038/s41386-021-00984-w. PMID: 33612830.",1575030,2022
roy2022,2022,Psychotherapy,PTSD,20,,1,,PCL-5,52.6,,completer sample mean 52.0 (95% CI 46.3 to 57.7),Additional definitions of PTSD severity at baseline reported in the study,,,,0.4,,,0.6,0,Mixed,Active duty military and Veteran,45.1,,,0.5,,0.5,Race and Ethnicity data reported,0.65,0.25,,,,0.1,"Race categories in publication included Hispanic, which is entered here as ""Other"" for race and also entered under ethnicity",0.1,,,,,,100%,mild TBI was inclusion criterion; excluded moderate or severe TBI,Mixed,"Combat-related; Other (""sexual traumas""; not specified)",,,"""most participants had a history of multiple traumas""",,,,,,,,,,,,Excluded active suicidal ideation,,Psychotic disorder,0,Exclusion criterion,,,,,,,,,POINT (-95.71289 37.09024),High,"Roy MJ, Bellini P, Kruger SE, et al. Randomized controlled trial of motion-assisted exposure therapy for posttraumatic stress disorder after mild traumatic brain injury, with and without an eye movement task. Front Virtual Real. 2022;3 doi: 10.3389/frvir.2022.1005774.",1620650,2023
rudstam2022,2022,CIH,PTSD,45,,0.9333,PCL-5 >33,PCL-5,49.15,12.53,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,43.7,9.93,,1,,0,Not reported,,,,,,,,,,,,,,,,Mixed,Child physical abuse; Child sexual abuse; Child other abuse; Rape/sexual assault; Community/school violence; Other (adult psychological abuse),,,"""typically reported >3 adult trauma types and around three childhood trauma types""",,,,,,Excluded,Ongoing alcohol or drug abuse: 0% (excluded),,,,,,,Severe psychotic disorder,0,Exclusion criterion,Severe personality disorder,0,Excluded,,,,,,POINT (16.74371 62.79232),High,"Rudstam G, Elofsson UOE, Söndergaard HP, et al. Trauma-focused group music and imagery with women suffering from PTSD/Complex PTSD: A randomized controlled study. Eur. J. Trauma Dissociation. 2022;6(3) doi: 10.1016/j.ejtd.2022.100277.",1602811,2023
sack2016,2016,Psychotherapy,PTSD,139,,1,,CAPS (German version),59,19,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,39.6,12.4,,0.64,,0.36,,,,,,,,,,,,,0.46,,,,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",,,,,,,,,Excluded,0%,,,,,,,,,,Personality disorders,0.058,,Anxiety disorders,0.122,,,,POINT (10.38578 51.10698),Some Concerns,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2017,2017,Other mixed,PTSD,35,,1,,IES (German version),46.6,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,39.8,11.2,,1,,0,Race data reported,1,,,,,,,,,,,0.657,,,,Mixed,"rape/sexual assault, child sexual abuse, community/school violence, accidents, natural or manmade disasters, other (""non-sexual violence by a family member"")",,,,,,(82.86% with multiple traumatization),,,Excluded,0%,,,,,,,,,,Borderline personality disorder,0.171,,Anxiety disorder,0.314,,,,POINT (10.38578 51.10698),Low,"Sack M, Spieler D, Wizelman L, et al. Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial. BMC Med. 2017 Feb 17;15:40. doi: 10.1186/s12916-017-0801-0. PMID: 28209155.",47377,2019
sandahl2021,2021,Psychotherapy & pharmacotherapy,PTSD,219,"240 randomized; post-randomization exclusion of 21


Pretreatment characteristics reported for up to N=219 participants; N differs across variables (some participants missing data)",1,,HTQ,3.12,0.44,,Additional definitions of PTSD severity at baseline reported in the study,,,>10 years since trauma for 73% (126/172),,,,,1,Community,"Military status NR; 47 participants with trauma history listed as ""Soldier""",44.4,10.4,,0.49,,0.51,,,,,,,,,,,,"Previous psychotherapy: 46%


Previous psychopharmacological treatment: 68%",0.72,ICD-10 depression diagnosis,,"Trauma history listed as ""Cranial trauma"" for 37% 62/166, NR for N=53",Mixed,"Combat-related; Rape/sexual assault; Terrorism/political violence/forced displacement; Other (""violence from relatives"", ""cranial trauma"")",,,,,,,,,Excluded,Current AUD or SUD by ICD-10: 0% (excluded),,,,,,,,,Excluded severe psychotic disorder,,,,,,,0.12,,POINT (10.02799 55.98126),High,"Sandahl H, Jennum P, Baandrup L, et al. Imagery rehearsal therapy and/or mianserin in treatment of refugees diagnosed with PTSD: results from a randomized controlled trial. J Sleep Res. 2021 Feb 02:e13276. doi: 10.1111/jsr.13276. PMID: 33529449.",1565023,2022
sannibale2013,2013,Psychotherapy,PTSD+SUD,62,,0.9355,,CAPS,68.03,22.3,,Additional definitions of PTSD severity at baseline reported in the study,,,mean 18.53 (SD 13.99) years since index trauma,0,0,,0,1,Community,,41.18,11.91,,0.5323,,0.4677,,,,,,,,,,,,,,,,,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")",,,,,,,Mixed Alcohol/Drug,Mixed Alcohol/Drug,Included,"Alcohol dependence: 95.16%


Other substance dependence: 14.52%",,,,,,,,,,McLean Screening Instrument for Borderline Personality Disorder score ≥7,0.6613,,,,,,,POINT (134.491 -25.73289),Low,"Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.",40190,2020
santarnecchi2019,2019,Psychotherapy,PTSD,37,,1,,CAPS,52.2,,,Additional definitions of PTSD severity at baseline reported in the study,10,,,0,0,,0,1,Community,,36.4,13,,0.3871,,0.6129,,,,,,,,,,,,no prior psychotherapy for trauma,,,,,Natural or manmade disasters,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (12.07001 42.79664),High,"Santarnecchi E, Bossini L, Vatti G, et al. Psychological and brain connectivity changes following trauma-focused CBT and EMDR treatment in single-episode PTSD patients. Front Psychol. 2019;10:129. doi: 10.3389/fpsyg.2019.00129. PMID: 30858808.",52130,2020
saraiya2022,2022,Other mixed,PTSD,39,"40 randomized, 1 participant removed due to medication contraindication; sample characteristics reported for n=39 (ITT sample)",1,,CAPS-5,41.46,8.69,,Additional definitions of PTSD severity at baseline reported in the study,18.89,16.5,mean time since index trauma,,,,,0.2821,Mixed,"71.79% military population, includes veteran, active duty, and reserve (individual proportions NR)",45.31,14.77,,0.4615,,0.5385,Race and Ethnicity data reported,0.6923,0.2051,,,,0.1026,"Other stated as ""consisting of more than one race""",0.0769,,,,,,,,Mixed,"Accidents; Community/school violence; Rape/sexual assault; Combat-related; Illness/medical procedure; Other (""severe human suffering"", ""sudden violent death"", ""sudden accidental death"")",,,,,,,,,,,,,,,excluded if imminent ideation and intent,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Saraiya TC, Jarnecke AM, Rothbaum AO, et al. Technology-enhanced in vivo exposures in Prolonged Exposure for PTSD: A pilot randomized controlled trial. J Psychiatr Res. 2022;156:467-75. doi: 10.1016/j.jpsychires.2022.10.056. PMID: 36347106",1609221,2023
sautter2015,2015,Psychotherapy,PTSD,114,57 couples; data for sample characteristics entered for veterans only,1,,CAPS,84.46,17.83,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,"Employment status, disability: 15.79%",1,0,Veteran,,33.12,6.59,,0.0175,One same-sex female couple,0.9825,Race and Ethnicity data reported,0.6491,0.2281,0.0351,,,0.0877,,0,,,,,,,,,,9.19,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Sautter FJ, Glynn SM, Cretu JB, et al. Efficacy of structured approach therapy in reducing PTSD in returning veterans: A randomized clinical trial. Psychol Serv. 2015 Aug;12(3):199-212. doi: 10.1037/ser0000032. PMID: 26213789.",44509,2019
saygin2002,2002,Pharmacotherapy,PTSD,60,,1,,TOP-8,17.71,3.71,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,41.45,10.16,,0.7593,,0.2407,,,,,,,,,,,,,0.0926,,,,Natural or manmade disasters,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,"Obsessive-compulsive disorder: 9.26%; 


GAD: 5.56%;


Panic disorder: 1.85%;


Social phobia: 1.85%;


Specific phobia: 1.85%",,,POINT (35.16896 39.0616),High,"Saygin MZ, Sungur MZ, Sabol EU, et al. Nefazodone versus sertraline in the treatment of posttraumatic stress disorder. Klinik Psikofarmakol Bülteni. 2002 Jan;12(1):1-5.",24668,2019
schacht2017,2017,Psychotherapy,PTSD,58,,1,,CAPS,72.54,17.17,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,37.43,11.33,,0.7931,,0.2069,Race data reported,0.7069,0.2241,,,,0.069,,,,,,0.4828,,,,Mixed,"child sexual assault, child physical assault, intimate partner violence, other (unexpected death of loved one)",,,,32,15,,,,,,,,,,,,,,,,,"Antisocial personality disorder: 34.48%;


Borderline personality disorder: 31.03%",Obsessive-compulsive disorder,0.1552,,,,POINT (-95.71289 37.09024),Some Concerns,"Schacht RL, Brooner RK, King VL, et al. Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: a randomized controlled trial. J Consult Clin Psychol. 2017 Jul;85(7):689-701. doi: 10.1037/ccp0000208. PMID: 28414485",47904,2019
schneier2012,2012,Psychotherapy & pharmacotherapy,PTSD,37,,1,,CAPS,69.1,12.9,,Additional definitions of PTSD severity at baseline reported in the study,6.5,6.1,,,,,,1,Community,,50.3,8,,0.5405,,0.4595,Race and Ethnicity data reported,0.6757,0.1351,,,,0.1892,,0.1351,,32.43%,for index episode of PTSD,,,,,Terrorism/political violence/forced displacement,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Low,"Schneier FR, Neria Y, Pavlicova M, et al. Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial. Am J Psychiatry. 2012 Jan;169(1):80-8. doi: 10.1176/appi.ajp.2011.11020321. PMID: 21908494.",37261,2019
schneier2015,2015,Pharmacotherapy,PTSD,38,,1,,PCL,59.45,10.75,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,40,12.5,,0.6389,,0.3611,Race and Ethnicity data reported,0.25,0.1944,,,,0.5556,,0.6111,,,No prior medication: 69.44%; No prior psychotherapy: 69.44%,,,0%,severe,Mixed,"rape/sexual assault, community/school violence",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Schneier FR, Campeas R, Carcamo J, et al. Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. PMID: 26115513.",44165,2019
schnurr2003,2003,Psychotherapy,PTSD,360,,1,,CAPS,81.21,18.42,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,Service-connected PTSD disability: 54.5%,1,0,Veteran,,50.7,,SE 3.7,0,,1,Race data reported,0.6986,,,,,0.3014,,,,,,,,,,Combat-related,,,,,,,,,,Included,"Current substance abuse: 4.6%


Current alcohol or drug dependence: 0%





Lifetime substance abuse or dependence: 78.8%",,,,,,,,,,,,,Current anxiety disorder,0.317,,,,POINT (-95.71289 37.09024),Some Concerns,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2007,2007,Psychotherapy,PTSD,284,,1,,CAPS,77.75,16.87,,Additional definitions of PTSD severity at baseline reported in the study,,,"mean 22.9 (SD NR, range 0 to 58) years since index trauma",0.0246,0.2183,,0.9754,0,Mixed,,44.8,9.4,,1,,0,Race and Ethnicity data reported,0.5458,0.3275,,,,0.1268,,0.0599,,,,,,,,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",9.6,3,,,,,,,Included,"Current substance abuse: 2.09%





Lifetime substance abuse or dependence: 54.01%",,,,,,,,,,,,,,,"Anxiety disorder, current: 47.98%


Anxiety disorder, lifetime: 56.69%",,,POINT (-95.71289 37.09024),Low,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2013,2013,Collaborative care,PTSD,195,,0.959,,PDS,33,9,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,"PTSD disability, VA population: 15.90%",1,,Veteran,,45.2,15.4,,0.0872,,0.9128,Race and Ethnicity data reported,0.5641,0.2205,,,,0.2154,,0.1538,,,,0.7026,,,,Mixed,"combat-related, rape/sexual assault, accidents, natural or manmade disaster, community/school violence",4.6,1.6,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Schnurr PP, Friedman MJ, Oxman TE, et al. RESPECT-PTSD: re-engineering systems for the primary care treatment of PTSD, a randomized controlled trial. J Gen Intern Med. 2013 Jan;28(1):32-40. doi: 10.1007/s11606-012-2166-6. PMID: 22865017.",39174,2019
schnurr2022,2022,Psychotherapy,PTSD,916,,1,,CAPS-5,40.1,8.7,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0.4236,PTSD disability claim approved,1,0,Veteran,,45.2,13.4,,0.203,,0.797,Race and Ethnicity data reported,0.6441,0.2718,0.036,0.0273,0.0186,0.0502,,0.1517,,,21.07% receiving psychotherapy at baseline; 67.68% using psychotropic medication at baseline,,"Mood disorder, SCID-5-RV: 69.98%; current mania was an exclusion criterion",62.77%,Positive VA screen for TBI,Mixed,MST; Combat-related; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (life threatening injury; other traumatic event not specified),,,,7.5,2.7,,,,Included,"Current substance use disorders, SCID-5-RV: 7.86%
Lifetime substance use disorders, SCID-5-RV: 26.42%
Substance dependence not in remission for 1 month (not having or needing detoxification): 0% (excluded)",,,BDI-II item 9,0.3483,"Considered as endorsing suicidality if any of the following responses: “I have thoughts of killingmyself, but I would not carry them out,” “I would like to kill myself,” and “I would killmyself if I had the chance”",,,,Excluded: current psychotic symptoms,,,,"Anxiety disorder, SCID-5-RV",0.333,"Additional anxiety diagnoses:
Obsessive compulsive disorder, SCID-5-RV: 5.24%",,,POINT (-95.71289 37.09024),Some Concerns,"Schnurr PP, Chard KM, Ruzek JI, et al. Comparison of prolonged exposure vs cognitive processing therapy for treatment of posttraumatic stress disorder among US veterans: a randomized clinical trial. JAMA Netw Open. 2022 Jan 4;5(1):e2136921. doi: 10.1001/jamanetworkopen.2021.36921. PMID: 35044471.",1586155,2023
schoorl2013,2013,Nonpharmacologic cognitive,PTSD,102,,1,,CAPS,80.6,17.7,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,37.1,11.6,,0.7549,,0.2451,,,,,,,,,,,,,0.6961,,,,Mixed,"other (childhood trauma unspecified, adult trauma unspecified)",,,,,,93.1% experienced ≥2 events,,,,,,,,,,,,,,,,,,,"Panic disorder: 33.33%;


Social anxiety disorder: 36.27%;


GAD: 38.24%;


Obsessive-compulsive disorder: 15.69%",,,POINT (5.281473 52.10081),Some Concerns,"Schoorl M, Putman P, Van Der Does W. Attentional bias modification in posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2013;82(2):99-105. doi: 10.1159/000341920. PMID: 23295710",41171,2019
schuman2023,2023,CIH,PTSD,35,,1,,PCL-5,55.6,10.77,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,50.6,14.38,,0.143,,0.857,Race data reported,0.914,,,,,0.086,"Reported as ""non-White"", entered as ""Other""",,,,,,,,,Mixed,MST; Combat-related; Natural or manmade disasters,,,,,,,,,,Required to abstain from alcohol and substance use before HRV sessions,,,,,,,,,Excluded: active psychosis,,,,,,,,,POINT (-95.71289 37.09024),High,"Schuman DL, Lawrence KA, Boggero I, et al. A pilot study of a three-session heart rate variability biofeedback intervention for veterans with posttraumatic stress disorder. Appl Psychophysiol Biofeedback. 2023;48(1):51-65. doi: 10.1007/s10484-022-09565-z. PMID: 36331685.",1604999,2023
seo2010,2010,Pharmacotherapy,PTSD,40,,1,,CAPS-2,105.48,6.05,,Additional definitions of PTSD severity at baseline reported in the study,1.3,1.2,,,,,,1,Community,,37.4,8.4,,0.7,,0.3,,,,,,,,,,,,,0,,,,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing accident)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (127.8392 36.38525),Some Concerns,"Seo H-J, Jung Y-E, Bahk W-M, et al. A comparison of mirtazapine and paroxetine for the treatment of patients with posttraumatic stress disorder: a randomized open-label trial. Clin Psychopharmacol Neurosci. 2010;8(2):84-9.",35572,2019
shapiro2015,2015,Psychotherapy,PTSD,17,,,"NR (participants described as having ""moderate to high"" IES-R scores)",IES-R,43.03,14.98,,Additional definitions of PTSD severity at baseline reported in the study,,,study conducted 6 weeks after traumatic event,,,,,1,Community,,39.8,12.9,,0.941,,0.059,,,,,,,,,,,,,,,,,Terrorism/political violence/forced displacement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (35.00445 31.4611),Some Concerns,"Shapiro E, Laub B. Early EMDR intervention following a community critical incident: a randomized clinical trial. Journal of EMDR Practice and Research. 2015 Feb;9(1):17-27. doi: 10.1891/1933-3196.9.1.17.",47811,2019
shemesh2011,2011,Psychotherapy,PTSD,60,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,57.13,10.99,,0.3333,,0.6667,,,,,,,,,,,,,,,,,Illness/medical procedure,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Shemesh E, Annunziato RA, Weatherley BD, et al. A randomized controlled trial for the safety and promise of cognitive-behavioral therapy using imaginal exposure in patients with posttraumatic stress disorder resulting from cardiovascular illness. J Clin Psychiatry. 2011 Feb;72(2):168-74. doi: 10.4088/JCP.09m05116blu. PMID: 20441725",34244,2019
shestatsky1988,1988,Pharmacotherapy,PTSD,13,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,5.6,,,,,,0.4,0.6,Mixed,,38.5,,,,,,,,,,,,,,,,,,0.2,,0%,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (accident with death of son)",,,,,,,,,,,,,,,,,,,,,,,GAD,0.2,,0,,POINT (35.00445 31.4611),High,"Shestatsky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res. 1988 May;24(2):149-55. doi: 10.1016/0165-1781(88)90057-1. PMID: 3406235.",758,2019
simon2008,2008,Psychotherapy & pharmacotherapy,PTSD,25,,1,,SPRINT,16.65,8.2,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,45.61,14.11,,0.5652,,0.4348,Race and Ethnicity data reported,0.7391,0.1304,,0.0435,,0.087,,0.0435,,0%,,0.5217,,,,Mixed,"rape/sexual assault, intimate partner violence, accidents, illness/medical procedure, other (exposure to war)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Simon NM, Connor KM, Lang AJ, et al. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. J Clin Psychiatry. 2008 Mar;69(3):400-5. PMID: 18348595.",30521,2019
simpson2022,2022,Psychotherapy,PTSD,101,,1,,CAPS-5,33.43,8.05,,Additional definitions of PTSD severity at baseline reported in the study,,,mean age at trauma: 21.51 (SD 12.57),,,,0.29,0.71,Mixed,"Veteran status only assessed for n=66 (left off questionnaire at university site, n=35); values entered reflect reported percentages for those with data",42.1,13.07,,0.56,,0.44,Race and Ethnicity data reported,0.53,0.18,0.05,0.05,,0.19,Other includes study-reported other (6%) and multiracial (13%),0.21,,,49.5% taking psychiatric medication(s) at baseline,,,,,Mixed,"Combat-related; Rape/sexual assault; Community/school violence; Other (""traumatic loss"", ""another trauma type"")",8.47,2.83,,,,,Alcohol,Alcohol,Included,"Current AUD, DSM-5: 100% (inclusion criterion)
Non-tobacco drug use disorder, MINI for DSM-5: 39%
Current cannabis use: 57%
Current tobacco use: 45%
Current other drug use: 22%",,,,,,,Psychotic disorder,0,Exclusion criterion,,,,,,,,,POINT (-95.71289 37.09024),Low,"Simpson TL, Kaysen DL, Fleming CB, et al. Cognitive processing therapy or relapse prevention for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. PLoS One. 2022;17(11):e0276111. doi: 10.1371/journal.pone.0276111. PMID: 36445895.",1613818,2023
sloan2004,2004,Psychotherapy,PTSD,51,,1,,PDS,17.1,6.1,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,18.9,1.6,,1,,0,Race data reported,0.4898,0.2857,,,,0.2245,,,,,,,,,,Mixed,"rape/sexual assault, accidents, child sexual abuse, community/school violence, other (witness to murder)",,,,,,63.27% reported ≥2 tramatic events,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Sloan DM, Marx BP. A closer examination of the structured written disclosure procedure. J Consult Clin Psychol. 2004 Apr;72(2):165-75. doi: 10.1037/0022-006X.72.2.165. PMID: 15065952.",28170,2019
sloan2007,2007,Psychotherapy,PTSD,85,,1,,PDS,18.5,8.1,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,18.7,1.1,,0.8049,,0.1951,Race data reported,0.5732,0.2805,,,,0.1463,,,,,,,,,,Mixed,"rape/sexual assault, community/school violence, accidents, other (witness to murder)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Sloan DM, Marx BP, Epstein EM, et al. Does altering the writing instructions influence outcome associated with written disclosure? Behav Ther. 2007 Jun;38(2):155-68. doi: 10.1016/j.beth.2006.06.005. PMID: 17499082.",32045,2019
sloan2011,2011,Psychotherapy,PTSD,47,,1,,PSS-I,25,5.4,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,18.9,1.1,,,,,Race and Ethnicity data reported,0.5714,0.2143,,0.0714,,0.1429,,0.0952,,,,,,,,Mixed,"rape/sexual assault, community/school violence, accidents, combat-related, other (witness to a murder)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Sloan DM, Marx BP, Greenberg EM. A test of written emotional disclosure as an intervention for posttraumatic stress disorder. Behav Res Ther. 2011 Apr;49(4):299-304. doi: 10.1016/j.brat.2011.02.001. PMID: 21367400.",36171,2019
sloan2012,2012,Psychotherapy,PTSD,46,,1,,CAPS,73.57,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,40.65,13.1,,0.65,,0.35,Race and Ethnicity data reported,0.37,0.37,,0.04,,0.22,,0.08,,70%,,0.25,,,,Accidents,,,,"85% had history of physical assault, 60% history of sexual assault",,,Median 10.0,,,Included,"AUD: 10%


SUD ""in full remission"": 38%",,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Low,"Sloan DM, Marx BP, Bovin MJ, et al. Written exposure as an intervention for PTSD: a randomized clinical trial with motor vehicle accident survivors. Behav Res Ther. 2012 Oct;50(10):627-35. doi: 10.1016/j.brat.2012.07.001. PMID: 22863540.",39268,2019
sloan2018a,2018,Psychotherapy,PTSD,126,,1,,CAPS-5,36.6,9.51,,Additional definitions of PTSD severity at baseline reported in the study,16.198,15.058,Symptom duration,,,,0.2619,0.7381,Mixed,,43.9,14.6,,0.4762,,0.5278,Race and Ethnicity data reported,0.5476,0.3413,0.0317,0.0159,0.0079,0.0556,,0.0952,,,,0.2936,MDD,,,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,0.348,,POINT (-95.71289 37.09024),Some Concerns,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018b,2018,Psychotherapy,PTSD,198,,1,,CAPS-5,39.6,9.68,,Additional definitions of PTSD severity at baseline reported in the study,27.8,,,0,,,1,0,Veteran,,55.82,12.05,,0,,1,Race data reported,0.742,0.167,0.015,,,0.076,,,,24.75%,,0.5606,,,,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),,,,,,,,,Included,"SUD: 0%


Alcohol abuse: 2.02%


Cannabis abuse: 2.53%",,,,,,,Current psychotic symptoms,0,,,,,GAD,0.197,,,,POINT (-95.71289 37.09024),Low,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2022,2022,Psychotherapy,PTSD,169,,1,,CAPS-5,35.48,,SE 1.12,Additional definitions of PTSD severity at baseline reported in the study,,,,1,,,0,0,Active Duty Military,,33.65,8.43,,0.195,,0.805,Race and Ethnicity data reported,0.349,0.337,,,,0.065,"Other includes ""individuals who identified as American Indian or Alaska Native, Asian, Pacific Islander, or biracial""",0.249,,,,,,0%,"Moderate/severe: 0% (excluded)
Mild: NR",,,,,,,,,,,,,,,,,Excluded current suicide risk,,,,Excluded active psychosis,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Sloan DM, Marx BP, Resick PA, et al. Effect of written exposure therapy vs cognitive processing therapy on increasing treatment efficiency among military service members with posttraumatic stress disorder: a randomized noninferiority trial. JAMA Netw Open. 2022 Jan 4;5(1):e2140911. doi: 10.1001/jamanetworkopen.2021.40911. PMID: 35015065.",1586434,2023
smajkic2001,2001,Pharmacotherapy,PTSD,40,,1,,PSS,39.56,6.87,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,51.34,10.11,,0.5625,,0.4375,,,,,,,,,,,,,,,,,Terrorism/political violence/forced displacement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Smajkic A, Weine SM, Djuric-Bijedic Z, et al. Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms. J Trauma. Stress. 2001 Jul;14(3):445-52. doi: 10.1023/A:1011177420069. PMID: 11534876.",16085,2019
smyth2008,2008,Psychotherapy,PTSD,25,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,,,,,,,0.56,,0.44,Race data reported,0.84,,0.16,,,,,,,,,,,,,Mixed,"combat-related, rape/sexual assault",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Smyth JM, Hockemeyer JR, Tulloch H. Expressive writing and post-traumatic stress disorder: effects on trauma symptoms, mood states, and cortisol reactivity. Br J Health Psychol. 2008 Feb;13(1):85-93. doi: 10.1348/135910707X250866. PMID: 18230238.",30627,2019
somohano2022,2022,Psychotherapy,PTSD+SUD,83,,1,,PCL-5,48.55,,SE 2.37,Additional definitions of PTSD severity at baseline reported in the study,,,Age at first trauma: mean 9.26 (SD 8.70),,,,,1,Community,,34.67,9.27,,1,"Gender
Cisgender female: 98.8%
Gender neutral: 1.2%
Sexual orientation
Heterosexual: 76.5%
Lesbian: 3.7%
Bisexual: 19.8%",0,Race and Ethnicity data reported,0.728,0.086,0.037,,,0.148,"Other
Multiracial: 7.4%
Identity not listed: 7.4%",0.099,,,Previous times in treatment: mean 3.04 (SD 1.91),,,,,,,,,,,,,Mixed Alcohol/Drug,Mixed Alcohol/Drug,Included,"Primary drug of choice
Methamphetamines: 46.2%
Alcohol: 30.8%
Heroin: 9.0%
Prescription opiate: 3.8%
Cocaine: 3.8%
Cannabis: 3.8%
Crack: 1.2%
Other: 1.2%",,,,,Excluded: active suicidality,,,,Excluded: hallucinations,,,,,,,,53.6% currently in residential treatment center (clinical setting for trial),POINT (-95.71289 37.09024),High,"Somohano VC, Bowen S. Trauma-Integrated Mindfulness-Based Relapse Prevention for Women with Comorbid Post-Traumatic Stress Disorder and Substance Use Disorder: A Cluster Randomized Controlled Feasibility and Acceptability Trial. J Integr Complement Med. 2022 May 31;31:31. doi: 10.1089/jicm.2021.0306. PMID: 35648046.",1602354,2023
sonne2016,2016,Psychotherapy & pharmacotherapy,PTSD,207,,1,,HTQ,3.21,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,43.7,9.7,,0.401,,0.599,,,,,,,,,,,,,0.9855,,,,Terrorism/political violence/forced displacement,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (10.02799 55.98126),Some Concerns,"Sonne C, Carlsson JM, Bech P, et al. Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study. BMC Psychiatry. 2016 Nov 8;16(1):383. doi: 10.1186/s12888-016-1081-5. PMID: 27825327.",45853,2019
spangler2020,2020,Pharmacotherapy,PTSD,75,,0.675,,CAPS,66.4,18.4,,Additional definitions of PTSD severity at baseline reported in the study,,,,0.514,1,,0.486,0,Mixed,,37.8,8.5,,0.149,,0.851,Race data reported,0.635,,,,,0.365,,,,0%,,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Low,"Spangler PT, West JC, Dempsey CL, et al. Randomized controlled trial of riluzole augmentation for posttraumatic stress disorder: efficacy of a glutamatergic modulator for antidepressant-resistant symptoms. J Clin Psychiatry. 2020 Oct 27;81(6):27. doi: 10.4088/JCP.20m13233. PMID: 33113596.",1560381,2022
spence2011,2011,Other study class,PTSD,44,,1,,PCL-C,59.07,9.88,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,42.6,13.1,,0.8095,,0.1905,,,,,,,,,,,,,0.619,,,,Mixed,"rape/sexual assault, accidents, community/school violence, other (not specified)",,,,6.3,3.03,,,,,,,,,,,,,,,,,,,,,,,POINT (134.491 -25.73289),High,"Spence J, Titov N, Dear BF, et al. Randomized controlled trial of internet-delivered cognitive behavioral therapy for posttraumatic stress disorder. Depress Anxiety. 2011 Jul;28(7):541-50. doi: 10.1002/da.20835. PMID: 21721073.",37944,2019
spence2014,2014,Other study class,PTSD,125,,0.856,,PSS-I,31.83,9.39,,Additional definitions of PTSD severity at baseline reported in the study,18,15.6,,,,,,1,Community,,41,11.4,,0.864,,0.136,,,,,,,,,,,24.40%,,,,,,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",8.52,3.7,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (134.491 -25.73289),Some Concerns,"Spence J, Titov N, Johnston L, et al. Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73-80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009.",42408,2019
spivak2006,2006,Pharmacotherapy,PTSD,40,,1,,CAPS-2,78.5,15,completers,Additional definitions of PTSD severity at baseline reported in the study,7.6,11.2,,,,,,1,Community,,40.08,9.2,,0.475,,0.525,,,,,,,,,,,,,,,,,Accidents,,,,,1.2,0.5,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (35.00445 31.4611),High,"Spivak B, Strous RD, Shaked G, et al. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial. J Clin Psychopharmacol. 2006 Apr;26(2):152-6. doi: 10.1097/01.jcp.0000203195.65710.f0. PMID: 16633143.",1548487,2019
stappenbeck2015a,2015,Psychotherapy,PTSD+SUD,80,"characteristics for analyzed sample, N=78",1,,PSS-I,29.8,8.9,,Additional definitions of PTSD severity at baseline reported in the study,,,mean 15.1 (SD 10.3) age in years at earliest trauma,0,,,0.269,0.731,Mixed,,44.3,11.5,,0.487,,0.513,Race and Ethnicity data reported,0.423,0.436,0.026,0.013,,0.102,,0.038,,,,,,,,,,,,,6,2.7,,Alcohol,Alcohol,Included,Current alcohol dependence: 100%,,,,,,,,,,,,,,,,0.256,,POINT (-95.71289 37.09024),Some Concerns,"Stappenbeck CA, Luterek JA, Kaysen DL, et al. A controlled examination of two coping skills for daily alcohol use and PTSD symptom severity among dually diagnosed individuals. Behav Res Ther. 2015a Mar;66:8-17. doi: 10.1016/j.brat.2014.12.013. PMID: 25617814.",43808,2020
stecker2014,2014,Psychotherapy,PTSD,300,,1,,PCL-M,59.5,11.7,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,0,Mixed,"""returning service members""",29.4,6.2,,0.1277,,0.8723,Race data reported,0.6934,0.1387,,,,0.1679,,,,100%,,,,,,,,,,,,,,,,Included,,,,"Suicidal thoughts, PHQ-9 item 9, score >0",0.3394,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Stecker T, McHugo GJ, Xie HY, et al. RCT of a brief phone-based CBT intervention to improve PTSD treatment utilization by returning service members. Psychiatr Serv. 2014 Oct;65(10):1232-7. doi: 10.1176/appi.ps.201300433. PMID: 24933496.",44566,2020
stein2002,2002,Pharmacotherapy,PTSD,19,,1,,CAPS,85.1,19.5,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,52.4,7.4,,0,,1,,,,,,,,,,,0%,,,,,,Combat-related,,,,,,,,,,,,,,,,,,Psychotic symptoms,0,,,,,,,,,,POINT (-95.71289 37.09024),High,"Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry. 2002 Oct;159(10):1777-9. doi: 10.1176/appi.ajp.159.10.1777. PMID: 12359687.",24689,2019
stein2021,2021,Pharmacotherapy,PTSD,149,,1,,CAPS-5,33.8,10.2,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,,Mixed,Some sites active-duty military hospitals; eligibility includes veteran or civilian,36,12.4,,0.651,,0.349,Race data reported,0.6438,0.1507,0.0274,0.0616,,0.1164,"Multiracial abstracted as ""other""",,,,,,,,TBI not excluded unless there was serious cognitive impairment,Mixed,Combat-related; Other (not specified),,,,,,,,,Excluded,Current (past 3 months) moderate or severe DSM-5 AUD or SUD: 0% (excluded),,,,,"Excluded: current, imminent risk of suicide assessed by the Columbia-Suicide Severity Rating Scale (threshold NR)",,,,Excluded: active psychosis,,,,,,,,,POINT (-95.71289 37.09024),Low,"Stein MB, Jain S, Simon NM, et al. Randomized, placebo-controlled trial of the angiotensin receptor antagonist losartan for posttraumatic stress disorder. Biol Psychiatry. 2021 Oct 1;90(7):473-81. doi: 10.1016/j.biopsych.2021.05.012. PMID: 34275593.",1574095,2023
steinert2016,2016,Psychotherapy,PTSD,86,,1,,PCL-C,66.6,11,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,27.5,8.4,,0.6071,,0.3929,,,,,,,,,,,,,,,,,Mixed,"intimate partner violence, accidents, rape/sexual assault, combat-related, community/school violence, other (trafficking)",,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (104.9069 12.72005),High,"Steinert C, Bumke PJ, Hollekamp RL, et al. Treating post-traumatic stress disorder by resource activation in Cambodia. World Psychiatry. 2016 Jun;15(2):183-5. doi: 10.1002/wps.20303. PMID: 27265714.",45144,2019
stenmark2013,2013,Psychotherapy,PTSD,81,,1,,CAPS,83.69,15.88,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,35.28,11.06,,0.3086,,0.6914,,,,,,,,,,,,,0.3951,,,,Terrorism/political violence/forced displacement,,,,,8.15,2.48,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (15.34833 68.75014),Low,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",46540,2019
steuwe2021,2021,Psychotherapy,PTSD,58,"60 randomized, 2 excluded due to protocol violations (ITT sample = 58)",1,,CAPS for DSM-IV,77.67,14.68,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,31.05,8.29,,1,,0,Not reported,,,,,,,,,,,"All participants had ""at least one non-successful previous outpatient treatment"" for borderline personality disorder
At baseline, 87.5% of participants were taking a psychotropic medication",0.6,major depression assessed by SCID,,,Mixed,Child physical abuse; Child sexual abuse; Child other abuse; Community/school violence,,,,,,"CTQ mean and SD are provided for each trauma type, but not overall",,,Excluded,Current SUD: 0% (excluded),,,Attempted suicide at least once,1,"Attempted suicide at least once: 100%
At least one non-suicidal self injury (NSSI) event during 4 weeks prior to admission: 59.5%
Experienced suicidal thoughts during 4 weeks prior to admission: 82.9%",,Schizophrenia,0,Excluded lifetime diagnosis of schizophrenia,Borderline personality disorder,1,Inclusion criterion; mean 6.97 (SD 1.30) BPD criteria met,,,,,Trial conducted in residential inpatient setting.,POINT (10.38578 51.10698),High,"Steuwe C, Berg M, Beblo T, et al. Narrative exposure therapy in patients with posttraumatic stress disorder and borderline personality disorder in a naturalistic residential setting: a randomized controlled trial. Front Psychiatry 2021 Nov 26;12:765348. doi: 10.3389/fpsyt.2021.765348. PMID: 34899426.",1584985,2023
sullivan2021,2021,Pharmacotherapy,PTSD,245,Sample characteristics reported for N=231 in modified ITT population,1,,CAPS-5,39.5,7.9,,Additional definitions of PTSD severity at baseline reported in the study,7,3.4,Mean time since trauma,0.1645,,,0.8095,0.026,Mixed,"Active duty military includes current reservists (16 participants) and active duty military (22 participants); 225 participants were in active duty military at time of index trauma, with 38 in active duty during the study period, leaving 187 veterans. The remaining 6 participants were law enforcement officers, categorized as Community.",33.6,7.8,,0.069,,0.931,Race and Ethnicity data reported,0.661,0.245,0.016,0.02,,0.057,"""Other"" includes 2% multiple races and 3.7% other races",0.188,,,,,,Moderate/severe: 0%,Exclusion criterion,Mixed,"Combat-related, Other (unspecified)",,,,,,,,,Excluded,"Alcohol use disorder in past 6 months: 0% (excluded)


Substance use disorder in past 6 months, other than tobacco: 0% (excluded)",,,,,"Lifetime suicidal ideation with plan: 8.2%


Lifetime actual suicide attempt: 5.6%",,"Schizophrenia, assessed on MINI 7.0",0,Exclusion criterion,"Antisocial personality disorder, assessed on MINI 7.0",0,Exclusion criterion,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Sullivan GM, Gendreau RM, Gendreau J, et al. Randomized clinical trial of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related PTSD and the role of sleep quality in treatment response. Psychiatry Res. 2021 Jul;301:113974. doi: 10.1016/j.psychres.2021.113974. PMID: 33979763.",1569175,2022
suris2013a,2013,Psychotherapy,PTSD,129,"sample characteristics reported for n=86 analyzed; 129 randomized, 86 analyzed due to removing patients treated by a low-fidelity therapist",1,,CAPS,84.57,2.94,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,"VA disability status ""approved"", PTSD: 21%",1,0,Veteran,,46.1,9.66,,0.8488,,0.1512,Race data reported,0.4419,0.407,,,,0.1512,,,,,,,,,,MST,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Surís A, Link-Malcolm J, Chard K, Ahn C, North C. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. Epub 2013 Jan 16. PMID: 23325750.",41233,2019
suris2013b,2013,Other mixed,PTSD,54,"sample characteristics reported for n=51 analyzed; 54 randomized, 51 analyzed (1 participant with missing data and 2 participants with invalid CAPS scores were excluded from analysis)",1,,CAPS,71.33,15.73,,Additional definitions of PTSD severity at baseline reported in the study,18.38,16.83,,0,,,1,0,Veteran,,43.02,14.91,,0,,1,Race and Ethnicity data reported,0.5294,0.3922,0.0196,,,0.0588,,0.1373,,,,,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Surís AM, Smith JC, Powell CM, et al. Interfering with the reconsolidation of traumatic memory: sirolimus as a novel agent for treating veterans with posttraumatic stress disorder. Ann Clin Psychiatry. 2013 Feb;25(1):33-40. PMID: 23376868.",87369,2019
suris2017,2017,Other mixed,PTSD,54,,1,,PCL,55.85,10.97,,Additional definitions of PTSD severity at baseline reported in the study,12.09,14.73,Years since qualifying trauma,0,,,1,0,Veteran,,37.5,13.69,,0,,1,Race and Ethnicity data reported,0.6667,0.2593,,,,0.0556,,0.0556,,,,0,Current major depressive disorder with melancholia was an exclusion criterion,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Surís A, Holliday R, Adinoff B, Holder N, North CS. Facilitating Fear-Based Memory Extinction With Dexamethasone: A Randomized Controlled Trial in Male Veterans With Combat-Related PTSD. Psychiatry. 2017 Winter;80(4):399-410. doi: 10.1080/00332747.2017.1286892. PMID: 29466111.",49780,2019
susanty2022,2022,Psychotherapy,PTSD,91,,1,,PCL-5,58.41,9.36,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,25.43,6.22,,0.912,,0.088,Not reported,,,,,,,,,,64.80%,No previous mental health treatment,,,,"Excluded: ""brain damage""",Mixed,Rape/sexual assault; Intimate partner violence; Other (not specified),,,,,,,,,Excluded,Current substance use disorder: 0% (excluded),,,,,Excluded: acute suicidality,,Current or previous psychotic disorder,0,Exclusion criterion,Paranoid personality disorder,0,Excluded,,,,,"Report ""previous disease hospitalization"" of 38.5% under ""medical history""",POINT (117.2401 -2.21505),High,"Susanty E, Sijbrandij M, Srisayekti W, et al. The Effectiveness of Eye Movement Desensitization for Post-traumatic Stress Disorder in Indonesia: A Randomized Controlled Trial. Front Psychol. 2022;13:845520. doi: https://dx.doi.org/10.3389/fpsyg.2022.845520. PMID: 35548495.",1593739,2023
talbot2014,2014,Psychotherapy,PTSD,45,,0.8889,,"PCL, excluding sleep symptoms",44.58,9.29,,Additional definitions of PTSD severity at baseline reported in the study,18.48,2.05,,,,,0.2,0.8,Mixed,,37.2,10.5,,0.6889,,0.3111,Race data reported,0.7111,0.1333,,0.1111,,0.0444,,,,0%,,0.2,,,,,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Talbot LS, Maguen S, Metzler TJ, et al. Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial. Sleep. 2014 Feb 1;37(3):327-41. doi: 10.5665/sleep.3408. PMID: 24497661.",42060,2020
tang2021,2021,Other mixed,PTSD,28,,1,,,,,mean scores provided in graph format only,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0,,0,1,Community,,39.12,10.68,,1,,0,,,,,,,,,,,,,0.96,"Major depressive disorder, current",0%,"Excluded ""traumatic brain injury with loss of consciousness >15 min.""",,,8.6,2.8,Life Events Checklist,,,,,,Included,"Alcohol dependence: 24.0%


Substance dependence: 20.0%",,,Suicide risk: high,0.76,Measure not described,,Psychotic disorder,0.04,Participant diagnosis of unspecificied schizophrenia spectrum and other psychotic disoder,,,,Generalized anxiety disorder,0.76,,,,POINT (-106.3468 56.13037),Low,"Tang VM, Trought K, Gicas KM, Kozak M, Josselyn SA, Daskalakis ZJ, Blumberger DM, Voineskos D, Knyahnytska Y, Pasricha S, Chung Y, Zhou Y, Isserles M, Wong AHC. Electroconvulsive therapy with a memory reactivation intervention for post-traumatic stress disorder: A randomized controlled trial. Brain Stimul. 2021 May-Jun;14(3):635-642. doi: 10.1016/j.brs.2021.03.015. Epub 2021 Mar 27. PMID: 33785406.",1572125,2022
tarrier1999a,1999,Psychotherapy,PTSD,72,,1,,CAPS,74.66,16.95,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,38.6,11.6,,0.5806,treatment completers only,0.4194,,,,,,,,,,,,,0.54,,,,Mixed,"accidents, other (crime, not specified)",,,,,,,,,Included,"AUD: 7%


SUD: NR",,,,,,,,,,,,,,,"GAD: 43%;


Panic disorder: 25%;


Simple phobia: 10%",,,POINT (-2.865634 54.12387),Some Concerns,"Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.",9173,2019
taylor2003a,2003,Psychotherapy & CIH,PTSD,60,,0.9667,,,,,,Additional definitions of PTSD severity at baseline reported in the study,8.7,10.8,,0,0,,0,1,Community,,37,10,,0.75,,0.25,Race data reported,0.7667,,,,,0.2333,,,,,,0.4167,,,,Mixed,"rape/sexual assault, accidents, community/school violence",,,,,,65% experienced more than 1 traumatic event,,,,,,,,,,,,,,,,,,,"Panic disorder with or without agoraphobia: 31.67%


Social anxiety disorder: 11.67%


Specific phobia: 10.00%


Generalized anxiety disorder: 6.67%


Obsessive compulsive disorder: 5.00%


Anxiety disorder not otherwise specified: 1.67%",,,POINT (-106.3468 56.13037),High,"Taylor S, Thordarson DS, Maxfield L, et al. Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol. 2003a Apr;71(2):330-8. doi: 10.1037/0022-006X.71.2.330. PMID: 12699027.",25484,2020
taylor2008,2008,Pharmacotherapy,PTSD,13,,1,,PCL-C,59,13,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,49,10,,0.8462,,0.1538,,,,,,,,,,,0%,,0.7692,,,,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,"Obsessive-compulsive disorder: 7.69%;


Panic disorder: 7.69%",,,POINT (-95.71289 37.09024),High,"Taylor FB, Martin P, Thompson C, et al. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry. 2008 Mar 15;63(6):629-32. doi: 10.1016/j.biopsych.2007.07.001. PMID: 17868655.",1548486,2019
terheide2016,2016,Psychotherapy,PTSD,72,,1,,CAPS,76.5,18.15,,Additional definitions of PTSD severity at baseline reported in the study,7.95,6.86,,,,,,1,Community,,41.45,11.32,,0.2778,,0.7222,,,,,,,,,,,,,0.7778,,,,Mixed,"terrorism/political violence/forced displacement, community/school violence",13.75,5.55,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (5.281473 52.10081),High,"Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.",45021,2019
thierree2021,2021,Other mixed,PTSD,38,,1,,CAPS,82.7,15,,Additional definitions of PTSD severity at baseline reported in the study,,,Age at onset of symptoms: 22.7 years (SD 9.1),,,,,1,Community,,32.5,10.6,,0.6579,,0.3421,Not reported,,,,,,,,,,,All naïve to trauma-focused psychotherapy; 58% on SSRI at baseline,0.4211,"Current depressive episode, MINI",,"Excluded ""those with identified neurological pathologies""",Mixed,Combat-related; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Terrorism/political violence/forced displacement; Other (injury threatening survival),,,,3.7,2.5,,,,Excluded,Current psychoactive substance addiction: 0% (excluded),,,"Current suicidal thoughts, MINI",0.2632,,,,,Excluded acute or chronic delusional conditions,,,,,,,,,POINT (2.536185 46.18701),Some Concerns,"Thierree S, Raulin-Briot M, Legrand M, et al. Combining trauma script exposure with rTMS to reduce symptoms of post-traumatic stress disorder: randomized controlled trial. Neuromodulation. 2021 Jun;25(4):549-57. doi: 10.1111/ner.13505. PMID: 35667770.",1576800,2023
thorp2019,2019,Psychotherapy & CIH,PTSD,87,,1,,CAPS,69.73,14.75,,Additional definitions of PTSD severity at baseline reported in the study,,,mean 43.12 (SD 5.80) years since index trauma,0,,,1,0,Veteran,,65.41,5.44,,0,,1,,,,,,,,,,,,,0.2069,,,,Mixed,"combat-related, natural or manmade disasters",,,,,,,,,,,,,,,,,,,,,,,Any anxiety disorder using SCID for DSM-IV-TR,0.4598,,,,POINT (-95.71289 37.09024),High,"Thorp S, Glassman LH. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. J Anxiety Disord. 2019 May;64:45-54. doi: 10.1016/j.janxdis.2019.02.003. PMID: 30978622.",51843,2020
tripodi2019,2019,Psychotherapy,PTSD+SUD,40,,1,,PCL-C,57.12,15,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0,,0,1,Community,,39.94,8.8,,1,,0,Race data reported,0.697,0.1515,,,,0.1515,,,,,,,,,,,,,,,,,,Mixed Alcohol/Drug,Mixed Alcohol/Drug,Excluded,History of substance use disorder: 100%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Tripodi SJ, Mennicke AM, McCarter SA, et al. Evaluating seeking safety for women in prison: a randomized controlled trial. Res Soc Work Pract. 2019 Mar;29(3):281-90. doi: 10.1177/1049731517706550.",1587979,2020
tucker2001,2001,Pharmacotherapy,PTSD,323,,1,,CAPS-2,73.7,16.7,,Additional definitions of PTSD severity at baseline reported in the study,,,mean 14.9 [SD 13.6] years since trauma,,,,0.0684,0.9316,Mixed,,40.8,,range 18 to 78,0.658,,0.342,Race data reported,0.7231,0.0945,,0.013,,0.1694,,,,,,0.3518,,,,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, seeing someone hurt or die)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,"GAD: 15.96%;


Panic disorder: 10.75%;


Social anxiety disorder: 8.79%;


Obsessive-compulsive disorder: 2.28%",,,,High,"Tucker PM, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-8. PMID: 11775045.",24214,2019
tucker2003,2003,Pharmacotherapy,PTSD,59,,1,,CAPS,88.74,13.83,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,38.75,11.77,,0.7414,,0.2586,Race and Ethnicity data reported,0.8621,0.0517,0.0345,,,0.0517,,0.0517,,34.48%,naive to psychotropic medication,0.881,,,,Mixed,"rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,"Panic disorder: 12.07%;


""Rashes with anxiety"": 10.34%",0.1724,,POINT (-95.71289 37.09024),High,"Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.",26085,2019
tucker2007,2007,Pharmacotherapy,PTSD,40,,1,,CAPS,89.7,13.75,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,42,11,,0.7895,,0.2105,Race data reported,0.8947,0.0526,,,,0.0526,,,,,,0.9211,,,,Mixed,"child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (non-specified)",1.16,,,,,,,,Excluded,0%,,,,,,,,,,,,,Major depression + panic,0.2895,,,,POINT (-95.71289 37.09024),Low,"Tucker P, Trautman RP, Wyatt DB, et al. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2007 Feb;68(2):201-6. PMID: 17335317.",31122,2019
tuerk2018,2018,Psychotherapy & pharmacotherapy,PTSD,26,,1,,CAPS,68.5,18.5,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,32.4,6.4,,0,,1,Race data reported,0.6154,0.3846,,,,,,,,,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Low,"Tuerk PW, Wangelin BC, Powers MB, et al. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn. Behav. Ther. 2018 Sep;47(5):351-71. doi: 10.1080/16506073.2018.1432679. PMID: 29448886.",50114,2019
tylee2017,2017,Psychotherapy,PTSD,30,,1,,PSS-I,38,6.6,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,45.8,17.8,,0,,1,Race data reported,0.7333,,,,,0.2667,,,,0%,,,,,,Mixed,"combat-related, other (not specified)",,,,2.6,0.8,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Tylee DS, Gray R, Glatt SJ, et al. Evaluation of the reconsolidation of traumatic memories protocol for the treatment of PTSD: a randomized, wait-list-controlled trial. J Mil Veteran Fam Health. 2017;3(1):21-33. doi: 10.3138/jmvfh.4120.",49612,2019
ulmer2011,2011,Psychotherapy,PTSD,22,,1,,PCL-M,63.23,,SE 2.53,Additional definitions of PTSD severity at baseline reported in the study,,,mean 15.66 [SD 15.53] years since trauma,0,,,1,0,Veteran,,45.96,11.06,,0.3182,,0.6818,Race data reported,0.333,0.333,,,,0.333,,,,,,,,,,,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Ulmer CS, Edinger JD, Calhoun PS. A multi-component cognitive-behavioral intervention for sleep disturbance in veterans with PTSD: a pilot study. J Clin Sleep Med. 2011 Feb 15;7(1):57-68.  PMID: 21344046.",36068,2019
vandenberg2015,2015,Psychotherapy,PTSD,155,,1,,CAPS,69.9,16.2,,Additional definitions of PTSD severity at baseline reported in the study,21,13.5,,,,,,1,Community,,41.2,10.5,,0.5419,,0.4581,,,,,,,,,,,,,,(2% depression with psychotic features),,,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",,,,,,"text describes ""most"" as experiencing multiple childhood traumatic events",,,,,,,,,"History of suicide attempt: 60.6%;


MINI-Plus: medium or high suicide risk: 45.2%",,,,"Delusion Rating Scale: current delusions: 61.9%


Auditory Hallucination Rating Scale: current auditory verbal hallucinations: 40.0%


MINI-Plus: psychotic disorder or mood disorder with psychotic features, lifetime diagnosis -


Schizophrenia: 61.3%;


Schizoaffective disorder: 29.0%;


Brief psychotic disorder: 0.6%;


Psychotic disorder not otherwise specified: 2.6%;


Bipolar disorder with psychotic features: 4.5%;


Depression with psychotic features: 1.9%",,,,,,,,,POINT (5.281473 52.10081),High,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenderen2018,2018,Psychotherapy,PTSD,85,,0.9412,,IES (Dutch version),46.29,12.51,,Additional definitions of PTSD severity at baseline reported in the study,4.22,4.71,,,,,,1,Community,,48.5,14.92,,0.7412,,0.2588,,,,,,,,,,,,,,,,,Other,homicidally bereaved,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (5.281473 52.10081),High,"van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.",49818,2019
vanderkolk1994,1994,Pharmacotherapy,PTSD,64,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0.4844,,0.4844,0.5156,Mixed,,40.4,7.1,,0.3438,,0.6562,,,,,,,,,,,,,0.5313,,,,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Van der Kolk BA, Dreyfuss D, Michaels MJ, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry. 1994;55(12):517-22. PMID: 7814344.",5244,2019
vanderkolk2007,2007,Psychotherapy & pharmacotherapy,PTSD,88,,1,,,,,"CAPS 1 month: 74.0 (13.4)


CAPS 1 week: 71.2 (13.0)",Additional definitions of PTSD severity at baseline reported in the study,12.9,11.9,,,,,,1,Community,,36.1,13.4,,0.8295,,0.1705,Race data reported,0.6705,,,,,,,,,,,,,,,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.",29236,2019
vanderkolk2014,2014,CIH,PTSD,76,,1,,CAPS,75.3,14.45,,Additional definitions of PTSD severity at baseline reported in the study,,,>12 years since index trauma,,,,,1,Community,,42.9,12,,1,,0,Race and Ethnicity data reported,0.781,,,,,0.219,,0.1406,,0%,,,,,,,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"van der Kolk BA, Stone L, West J, et al. Yoga as an adjunctive treatment for posttraumatic stress disorder: a randomized controlled trial. J Clin Psychiatry. 2014 Jun;75(6):e559-65. doi: 10.4088/JCP.13m08561. PMID: 25004196.",42647,2019
vanderkolk2016,2016,Nonpharmacologic biological,PTSD,52,,1,,CAPS,77.97,16.93,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,44.4,13.15,,0.8571,,0.1429,Race data reported,0.6731,0.0769,0.0192,,,0.2308,,,,0%,,,,0%,,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",,,,9.29,2.9,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vangelderen2020,2020,Other mixed,PTSD,43,,1,,CAPS,44.7,7.26,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,42.18,9.36,,0.023,,0.977,,,,,,,,,,,0%,,,,,,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")",,,,,,,,,Included,"Alcohol dependence, mild-moderate: 11.6%





Alcohol abuse: 7.0%",,,,,,,,,,,,,Anxiety disorder: MINI for DSM-IV,0.512,,,,POINT (5.281473 52.10081),Low,"van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive motion-assisted exposure therapy for veterans with treatment-resistant posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2020 Mar 23;89(4):215-27. doi: 10.1159/000505977. PMID: 32203971.",1569382,2020
vanmeggelen2022,2022,Other mixed,PTSD,44,,1,,PCL-5,47.28,11.92,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,0.455,0.545,Mixed,"Veterans are participants described as ""war veterans"" in publication",39.3,11.32,,0.48,,0.52,Not reported,,,,,,,,,,,"43.2% took  prescription drugs during the study period, and 47.7% had ""previously followed therapy""",,,,,Mixed,"Child sexual abuse; Other (""war related"")",,,,,,,,,,,,,,,excluded if actively suicidal,,,,excluded current psychotic episode,,,,,,,,,POINT (5.281473 52.10081),High,"van Meggelen M, Morina N, van der Heiden C, et al. A randomized controlled trial to pilot the efficacy of a computer-based intervention with elements of virtual reality and limited therapist assistance for the treatment of post-traumatic stress disorder. Front Digit Health. 2022;4:974668. doi: 10.3389/fdgth.2022.974668. PMID: 36329832.",1605011,2023
vantwoutfrank2019,2019,Other mixed,PTSD,20,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,40.5,8.8,,0,,1,,,,,,,,,,,,,,,,,Combat-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"van 't Wout-Frank M, Shea MT, Larson VC, et al. Combined transcranial direct current stimulation with virtual reality exposure for posttraumatic stress disorder: feasibility and pilot results. Brain Stimul. 2019 Jan - Feb;12(1):41-3. doi: 10.1016/j.brs.2018.09.011. PMID: 30266416.",1512333,2020
vanvliet2021,2021,Psychotherapy,PTSD,121,"135 randomized, 14 excluded from ITT (delayed exclusion, did not meet criteria: n=3; discontinued after randomization, before start of treatment: n=11)",1,,CAPS-5,38.53,9.03,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,,,,0.686,,0.314,Not reported,,,,,,,,,,,,,,,,Mixed,Child sexual abuse; Child physical abuse,,,,,,,,,Excluded,"Alcohol or drug dependence or misuse, DSM-5: 0% (excluded)",,,Suicidality,0.752,"Suicidal thoughts, no intention: 55.4%
Preferring to cause suicide: 19.8%",,,,,,,,,,,,,POINT (5.281473 52.10081),High,"Van Vliet NI, Huntjens RJC, Van DMK, et al. Phase-based treatment versus immediate trauma-focused treatment for post-traumatic stress disorder due to childhood abuse: randomised clinical trial. BJPsych Open. 2021 Nov;7(6):e211. doi: 10.1192/bjo.2021.1057.",1585381,2023
vera2011,2011,Psychotherapy,PTSD,14,,1,,CAPS (Spanish version),64.92,15.17,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,45.8,,,0,,1,,,,,,,,,,,,,,,0%,Moderate to severe,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Vera M, Reyes-Rabanillo ML, Juarbe D, et al. Prolonged exposure for the treatment of Spanish-speaking Puerto Ricans with posttraumatic stress disorder: a feasibility study. BMC Res. Notes. 2011 Oct 17;4:415. doi: 10.1186/1756-0500-4-415. PMID: 22005187.",38256,2019
vera2021,2021,Psychotherapy & CIH,PTSD,98,,1,,CAPS-5,42.93,9.12,,Additional definitions of PTSD severity at baseline reported in the study,,,>10 years for about 40% of the sample,,,,,1,Community,,43.62,12.09,,0.816,,0.184,Ethnicity data reported,,,,,,,,1,All were Spanish-speaking Latinos,,"""over two thirds received prior treatment for the trauma""",,,,,Mixed,"Combat-related; Rape/sexual assault; Accidents; Community/school violence; Other (exposure to ""unexpected or violent death"")",,,,,,,,,Excluded,Current AUD or SUD,,,,,Excluded: suicidal ideation,,Schizophrenia or psychotic disorders,0,Exclusion criterion,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Vera M, Oben A, Juarbe D, et al. A randomized clinical trial of prolonged exposure and applied relaxation for the treatment of Latinos with posttraumatic stress disorder. J Trauma Stress. 2022 Apr;35(2):593-604. doi: 10.1002/jts.22773. PMID: 34973048.",1585591,2023
villarreal2016,2016,Pharmacotherapy,PTSD,80,,1,,CAPS,73.12,14.12,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,47.7,11.1,,0.0625,,0.9375,Race data reported,0.525,0.2625,0.2125,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Villarreal G, Hamner MB, Ca√±ive JM, et al. Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial. Am J Psychiatry. 2016 Dec;173(12):1205-12. doi: 10.1176/appi.ajp.2016.15070967. PMID: 27418378.",45102,2019
wagner2007,2007,Psychotherapy,PTSD,8,,1,,PCL-C,54.9,14.6,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,33.5,158,,0.625,,0.375,Race data reported,,0.25,,0.25,,0.5,,,,100%,,0.5,,,,Accidents,,,,,3.2,1.8,prior traumas,,,Included,"Current substance dependence: 0%


Alcohol abuse or substance abuse: 12.50%",,,,,,,,,,,,,,,,1,,POINT (-95.71289 37.09024),High,"Wagner AW, Zatzick DF, Ghesquiere A, et al. Behavioral activation as an early intervention for posttraumatic stress disorder and depression among physically injured trauma survivors. Cogn Behav Pract. 2007 Nov;14(4):341-9. doi: 10.1016/j.cbpra.2006.05.002.",32469,2019
wagner2019,2019,Psychotherapy,PTSD,80,,1,,CAPS,78.79,15.42,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,30.06,6.74,,0.0625,,0.9375,Race and Ethnicity data reported,0.775,0.05,0.0125,,,0.1625,,0.0375,,,,0.675,,,,Other,military-related,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Wagner AW, Jakupcak M, Kowalski HM, et al. Behavioral activation as a treatment for posttraumatic stress disorder among returning veterans: a randomized trial. Psychiatr Serv. 2019 Oct 1;70(10):867-73. doi: 10.1176/appi.ps.201800572. PMID: 31337325.",52288,2020
wahbeh2016,2016,CIH,PTSD,114,,1,,CAPS,68.8,15,,Additional definitions of PTSD severity at baseline reported in the study,,,"mean 28.5 [SD 16.4] ""time since event"" [units not provided]",0,,,1,0,Veteran,,52.1,12.4,,0.0588,,0.9412,Race data reported,0.8627,,,,,0.1373,,,,,,,,,,,,,,,,,,,,Excluded,Current substance dependence disorder: 0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Wahbeh H, Goodrich E, Goy E, et al. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016 Apr;72(4):365-83. doi: 10.1002/jclp.22255. PMID: 26797725.",48070,2019
wallace2022,2022,CIH,PTSD,30,"32 originally enrolled, 2 withdrew",1,"Inclusion criteria required a PTSD diagnosis in medical record, no further information",PCL-5,55.63,14.89,,Additional definitions of PTSD severity at baseline reported in the study,,,mean 10.63 (SD 6.03) years since TBI,0,,,1,0,Veteran,,37.67,6.9,,0.067,,0.933,Race and Ethnicity data reported,0.867,0.133,0,0,,,,0.1,,,"Inclusion criteria for participants to be receiving care at the SHARE Military Initiative, which included individual and group therapy including for behavioral health; no specifics provided on prior PTSD treatment",,,100%,mTBI (inclusion criterion),,,,,,,,,,,Excluded,Known substance misuse within the past 6 months: 0% (excluded),,,,,,,,,Excluded active psychosis,,,,,,,,,POINT (-95.71289 37.09024),High,"Wallace T, Morris JT, Glickstein R, et al. Implementation of a Mobile Technology-Supported Diaphragmatic Breathing Intervention in Military mTBI With PTSD. J Head Trauma Rehabil. 2022 May-Jun;37(3):152-61. doi: 10.1097/HTR.0000000000000774. PMID: 35703895.",1620172,2023
walters2020,2020,Psychotherapy,PTSD,23,,1,,CAPS-IV,57.17,19.44,,Additional definitions of PTSD severity at baseline reported in the study,5.58,5.46,,0.1778,,,0.8222,0,Mixed,,36.54,9.8,,0.1739,,0.8261,Race and Ethnicity data reported,0.5217,0.3043,,0.0435,0.1304,,,0.2174,,,,,,0%,Moderate or severe,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Walters EM, Jenkins MM, Nappi CM, et al. The impact of prolonged exposure on sleep and enhancing treatment outcomes with evidence-based sleep interventions: a pilot study. Psychol Trauma. 2020 Feb;12(2):175-85. doi: 10.1037/tra0000478. PMID: 31246050.",52102,2020
wang2012,2012,Other mixed,PTSD,138,,1,,CAPS,66.3,20.5,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,49.3,12.8,,0.5814,,0.4186,,,,,,,,,,,,,0,,,,Natural or manmade disasters,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (103.8191 36.56177),High,"Wang Y, Hu YP, Wang WC, et al. Clinical studies on treatment of earthquake-caused posttraumatic stress disorder using electroacupuncture. Evid Based Complement Alternat Med. 2012;2012:431279. doi: 10.1155/2012/431279. PMID: 23049609.",40245,2019
watson1997,1997,CIH,PTSD,90,,1,,PTSD Interview,94.7,,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,45.6,,,0,,1,Race and Ethnicity data reported,0.8556,0.0333,0.1,,,0.0111,,0.0111,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.",9969,2019
watts2012,2012,Nonpharmacologic biological,PTSD,20,,1,,CAPS,76.95,10.93,,Additional definitions of PTSD severity at baseline reported in the study,30,10.8,,,,,1,,Veteran,,55.9,12.1,,0.1,,0.9,Race data reported,1,,,,,,,,,,,0.8,,,,Mixed,"combat-related, rape/sexual assault, community/school violence, other (multiple trauma)",,,,,,,,,Included,15.00%,,,,,,,,,,,,,,,"Panic disorder: 35.00%;


Obsessive compulsive disorder: 20.00%",,,POINT (-95.71289 37.09024),High,"Watts BV, Landon B, Groft A, et al. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul. 2012 Jan;5(1):38-43. doi: 10.1016/j.brs.2011.02.002. PMID: 22264669.",38446,2019
wells2012,2012,Psychotherapy,PTSD,20,,1,,PDS,35,6.6,,Additional definitions of PTSD severity at baseline reported in the study,,,"Treatment group: median 1.08 


Waitlist group: median 1.29 (IQR 0.79 to 3.75)",,,,,1,Community,,37.4,13.6,,0.55,,0.45,,,,,,,,,,,,,0.45,,,,Mixed,"rape/sexual assault, community/school violence, accidents",,,Treatment group: median 1.5; Waitlist group: median 1 (IQR 1.0 to 3.0),,,,,,,,,,,,,,,,,,,,GAD,0.15,,,,POINT (-2.865634 54.12387),High,"Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. J Clin Psychol. 2012 Apr;68(4):373-81. doi: 10.1002/jclp.20871. PMID: 24469928.",38376,2019
wells2015,2015,Psychotherapy,PTSD,32,,1,,PDS,36.1,8.84,,Additional definitions of PTSD severity at baseline reported in the study,,,Median 1.96 (IQR 0.83 to 7.67),,,,,1,Community,,41.2,13.6,,0.375,,0.625,,,,,,,,,,,100%,psychotherapy-naive,0.3438,,,,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (fire)",,,Median 2.0 (IQR 1.0 to 3.0),,,,,,,,,,,,,,,,,,,,Panic disorder,0.2813,,,,POINT (-2.865634 54.12387),High,"Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.",50330,2019
wheeler2020a,2020,Other study class,PTSD,30,,1,,PCL-M,42,12.62,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,42.3,9.1,,0.17,,0.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-2.865634 54.12387),High,"Wheeler M, Cooper NR, Andrews L, et al. Outdoor recreational activity experiences improve psychological wellbeing of military veterans with post-traumatic stress disorder: Positive findings from a pilot study and a randomised controlled trial. PLoS One. 2020;15(11):e0241763. doi: 10.1371/journal.pone.0241763. PMID: 33237906.",1561810,2022
wheeler2020b,2020,Other study class,PTSD,25,"sample characteristics reported for N=18; 25 were randomized, 4 participants in arm A did not show up for intervention, 3 participants in Arm B did not show up for post-waiting period intervention",1,,PCL-M,47,15.98,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,40,12.7,,0.06,,0.94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-2.865634 54.12387),High,"Wheeler M, Cooper NR, Andrews L, et al. Outdoor recreational activity experiences improve psychological wellbeing of military veterans with post-traumatic stress disorder: Positive findings from a pilot study and a randomised controlled trial. PLoS One. 2020;15(11):e0241763. doi: 10.1371/journal.pone.0241763. PMID: 33237906.",1561810,2022
whitworth2019b,2019,Other study class,PTSD,22,,1,,PDS-5,41,9.5,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,,1,Community,,33,13.3,,0.818,,0.182,Race data reported,0.2273,0.3636,,0.2727,,0.1364,,,,,,,,,,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, other (unspecified type of child abuse, unspecified ""other"")",,,,3.9,1.8,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Whitworth JW, Nosrat S, SantaBarbara NJ, et al. High intensity resistance training improves sleep quality and anxiety in individuals who screen positive for posttraumatic stress disorder: a randomized controlled feasibility trial. Ment Health Phys Act. 2019b;16:43-9. doi: 10.1016/j.mhpa.2019.04.001.",52118,2020
whitworth2019c,2019,Other study class,PTSD,30,,1,,PDS-5,40.09,10.3,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0,,0,1,Community,,29.1,7.38,,0.733,,0.267,Race data reported,0.3667,,,,,0.6333,,,,,,,,,,Mixed,"rape/sexual assault, community/school violence, other (""sudden or unexpected loss of a child or spouse"")",,,,2.53,1.48,,,,Included,10.00%,,,,,,,,,,,,,History of anxiety disorder,0.1667,,,,POINT (-95.71289 37.09024),High,"Whitworth JW, Nosrat S, SantaBarbara NJ, et al. Feasibility of resistance exercise for posttraumatic stress and anxiety symptoms: a randomized controlled pilot study. J Trauma Stress. 2019 Dec;32(6):977-84. doi: 10.1002/jts.22464. PMID: 31743507.",1548217,2020
yeh2011,2011,Pharmacotherapy,PTSD,35,,1,,CAPS,73.06,17.86,,Additional definitions of PTSD severity at baseline reported in the study,3.64,4.82,,,,,,1,Community,,40.5,11.3,,0.6774,,0.3226,,,,,,,,,,,,,0.1143,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-53.09783 -10.78778),High,"Yeh MS, Mari JJ, Costa MC, et al. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD. CNS Neurosci Ther. 2011 Oct;17(5):305-10. doi: 10.1111/j.1755-5949.2010.00188.x. PMID: 21554564.",35220,2019
yehuda2014,2014,Psychotherapy,PTSD,52,,1,,CAPS,80.9,18.2,,Additional definitions of PTSD severity at baseline reported in the study,21.1,18.4,,0,,,1,0,Veteran,,48.9,13.3,,0.1081,,0.8919,Ethnicity data reported,,,,,,,,0.4324,,,,0.3514,,,,Combat-related,,,,,,,,,,Excluded,"Current: 0%


Past: 37.84%",,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Yehuda R, Pratchett LC, Elmes MW, et al. Glucocorticoid-related predictors and correlates of post-traumatic stress disorder treatment response in combat veterans. Interface Focus. 2014 Oct 6;4(5):20140048. doi: 10.1098/rsfs.2014.0048. PMID: 25285201.",42868,2019
yehuda2015,2015,Psychotherapy & pharmacotherapy,PTSD,24,,1,,,74.2,15.6,"CAPS (lifetime): 101.8 (16.5)


CAPS (current): 74.2 (15.6)",Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,49.6,13.6,,,,,Race and Ethnicity data reported,0.4583,0.5,,0.0417,,,,0.4167,,,,0.3333,,0%,moderate or severe,Mixed,"combat-related, accidents, other (interpersonal violence)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Yehuda R, Bierer LM, Pratchett LC, et al. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome. Psychoneuroendocrinology. 2015 Jan;51:589-97. doi: 10.1016/j.psyneuen.2014.08.004. PMID: 25212409.",42838,2019
yi2022,2022,CIH,PTSD,94,Characteristics reported for completer sample (n=76),1,,IES-R,40.3,18.4,,Additional definitions of PTSD severity at baseline reported in the study,,,"Reported mean 60.1 days (SD 19.3) since motor vehicle accident, but inclusion criteria required ""MVA-related PTSD that happened at least 3 months ago""",,,,,1,Community,,41.5,14.6,,1,,0,Not reported,,,,,,,,,,,,,,,"""Having…brain damage"" was exclusion criterion",Accidents,,,,,,,,,,Excluded,"""Having substance abuse"": 0% (excluded)",,,,,"Excluded: ""currently suicidal""",,Schizophrenia or psychotic disorder,0,Exclusion criterion,,,,,,,,,POINT (103.8191 36.56177),High,"Yi L, Lian Y, Ma N, et al. A randomized controlled trial of the influence of yoga for women with symptoms of post-traumatic stress disorder. J. 2022 Apr 5;20(1):162. doi: 10.1186/s12967-022-03356-0. PMID: 35382845.",1591328,2023
youngstedt2021,2021,CIH,PTSD,71,sample characteristics reported for N=69 analyzed; 2 excluded from analysis due to initiating other treatments during the study,1,,CAPS-2,62.5,23,,Additional definitions of PTSD severity at baseline reported in the study,1.45,1.93,,0,,,1,0,Veteran,,36.8,9,,0.2319,,0.7681,,,,,,,,,,,,,0.61,MDD,0%,Significant head trauma was an exclusion criterion,Combat-related,,,,,,,,,,Excluded,high probability of abuse of alcohol or drugs over the past 3 months: 0% (excluded),,,,,high suicidality was an exclusion criterion,,Schizophrenia or psychosis,0,Exclusion criterion,,,,,,,,,POINT (-95.71289 37.09024),Some Concerns,"Youngstedt SD, Kline CE, Reynolds AM, et al. Bright light treatment of combat-related PTSD: a randomized controlled trial. Mil Med. [Epub ahead of print 29 January 2021] doi: 10.1093/milmed/usab014. PMID: 33511988.",1564540,2022
youssef2022,2022,CIH,PTSD,21,sample characteristics reported for n=20 participants,1,,PCL-5,47.1,19.8,reported for n=19 at baseline,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,42.6,10.9,,0.8,,0.2,Not reported,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Youssef NA, Holland-Winkler AM, Phung P, Waller JL, Ponkshe S. A randomized, double-blind, clinical pilot trial of adjunct ketone supplement compared to placebo for treating posttraumatic stress disorder. Ann Clin Psychiatry. 2022 Nov;34(4):240-244. doi: 10.12788/acp.0088. PMID: 36282607.",1605352,2023
yuen2015,2015,Psychotherapy,PTSD,74,"(population characteristics reported for completers, n=52)",1,,CAPS,67.03,13.47,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,43.98,15.18,,0.019,,0.981,Race and Ethnicity data reported,0.538,0.365,,,,0.097,,0.096,,,,0.423,,,,Combat-related,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,"Panic disorder: 15%;


Agoraphobia: 1.92%",,,POINT (-95.71289 37.09024),High,"Yuen EK, Gros DF, Price M, et al. Randomized controlled trial of home-based telehealth versus in-person prolonged exposure for combat-related PTSD in veterans: preliminary results. J Clin Psychol. 2015 Jun;71(6):500-12. doi: 10.1002/jclp.22168. PMID: 25809565.",44639,2019
yurtsever2018,2018,Psychotherapy,PTSD,63,,1,,IES-R,62.45,11.04,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,37.45,11.08,,0.766,,0.234,,,,,,,,,,,,,,,,,Terrorism/political violence/forced displacement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (35.16896 39.0616),High,"Yurtsever A, Konuk E, Akyüz T, et al. An Eye Movement Desensitization and Reprocessing (EMDR) group intervention for Syrian refugees with post-traumatic stress symptoms: results of a randomized controlled trial. Front Psychol. 2018 Jun 12;9:493. doi: 10.3389/fpsyg.2018.00493. PMID: 29946275.",51112,2019
zaccari2022a,2022,Psychotherapy & CIH,PTSD,42,"One participant (Arm B, CPT) withdrew before baseline data collection, N=41 ITT population; sample characteristics reported for N=41",1,"all participants had current PTSD diagnosis; data for n=38 participants reported for PTSD diagnosis according to CAPS-IV criteria at baseline (longitudinal model), 2 were subthreshold and 36 met diagnostic criteria (36/38, 94.74% with CAPS-IV diagnosis)",CAPS for DSM-IV,74.3,16.9,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,,,1,0,Veteran,,45,9.9,,1,,0,Race data reported,0.122,0.805,,,,0.073,"""Other/Mixed"" reported, abstracted as ""Other""; ""White, Non-Hispanic"" reported, abstracted as ""White""; ""African American - non-Hispanic reported, abstracted as ""Black""; no other information on ethnicity reported",,,,,,,0%,moderate or severe (excluded),MST,,,,,,,,,,Excluded,Current moderate to severe substance abuse or dependence: 0% (excluded),,,Lifetime suicide attempt,0.268,"Current, active suicidal intent or plan was an exclusion criterion",,,,,,,,,,,0.244,Past psychiatric hospitalization,POINT (-95.71289 37.09024),High,"Zaccari B, Sherman ADF, Febres-Cordero S, et al. Findings from a pilot study of Trauma Center Trauma-Sensitive Yoga versus cognitive processing therapy for PTSD related to military sexual trauma among women Veterans. Complementary therapies in medicine. 2022;70:102850. doi: 10.1016/j.ctim.2022.102850. PMID: 35820575.",1596480,2023
zalta2019,2019,Nonpharmacologic biological,PTSD,15,,1,,PCL-5,39.53,13.85,,Additional definitions of PTSD severity at baseline reported in the study,,,,0,0,,0,1,Community,,44.93,11.83,,0.5333,,0.4667,Race and Ethnicity data reported,0.2667,0.5333,,,,0.2,,0.2667,,,,,,,,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Zalta AK, Bravo K, Valdespino‐Hayden Z, et al. A placebo‐controlled pilot study of a wearable morning bright light treatment for probable PTSD. Depress Anxiety. 2019 Jul;36(7):617-24. doi: 10.1002/da.22897. PMID: 30995350.",52251,2020
zang2013,2013,Psychotherapy,PTSD,22,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,1.58 to 1.92 year since index trauma,0,0,,0,1,Community,,55.73,11.91,,0.7727,,0.2273,,,,,,,,,,,,,,,,,Natural or manmade disasters,,,,,,,"40.91% participants experienced 2-3 events, 13.64% participants experienced >3 events",,,,,,,,,,,,,,,,,,,,,,POINT (103.8191 36.56177),High,"Zang Y, Hunt NC, Cox T. A randomised controlled pilot study: the effectiveness of narrative exposure therapy with adult survivors of the Sichuan earthquake. BMC Psychiatry. 2013 Jan 31;13:41. doi: 10.1186/1471-244X-13-41. PMID: 23363689.",46041,2020
zang2014,2014,Psychotherapy,PTSD,30,,1,,IES-R,53.27,10.24,,Additional definitions of PTSD severity at baseline reported in the study,,,range 2.50 to 2.83 years since event,,,,,1,Community,,53.63,12.91,,0.9,,0.1,,,,,,,,,,,,,,,,,Natural or manmade disasters,,,,,,,80% only 1; 20% had 2 to 4,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (103.8191 36.56177),High,"Zang Y, Hunt NC, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 3;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297.",46042,2019
zemestani2022,2022,Psychotherapy,PTSD,48,,1,,PCL-5,53.6,6.19,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,32.91,5.33,,1,,0,Not reported,,,,,,,,,,,,0.583,Major depressive disorder,0%,"Excluded: ""serious cognitive impairment or medical illness (e.g., brain injury)""",Mixed,Terrorism/political violence/forced displacement; Other (violent death of a relative; experienced or witnessed explosions; witnessed murder of nonfamily members; other life-threatening events),,,,,,,,,Excluded,Alcohol or substance use disorders in the past 6 months: 0% (excluded),,,,,,,,,Excluded active (past month) psychotic-spectrum symptoms,,,,,,,,,POINT (43.74353 33.03971),High,"Zemestani M, Mohammed AF, Ismail AA, et al. A Pilot Randomized Clinical Trial of a Novel, Culturally Adapted, Trauma-Focused Cognitive-Behavioral Intervention for War-Related PTSD in Iraqi Women. Behav Ther. 2022 Jul;53(4):656-72. doi: 10.1016/j.beth.2022.01.009. PMID: 35697429",1592753,2023
ziemba2014,2014,Psychotherapy,PTSD,18,,1,,,,,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,0,Mixed,,,,,0.9,,0.1,Race data reported,,0.79,,,,0.21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Ziemba SJ, Bradley NS, Landry L-AP, et al. Posttraumatic stress disorder treatment for Operation Enduring Freedom/Operation Iraqi Freedom combat veterans through a civilian community-based telemedicine network. Telemed J E Health. 2014 May;20(5):446-50. doi: 10.1089/tmj.2013.0312. PMID: 24617961.",46063,2019
zlotnick1997,1997,Psychotherapy,PTSD,46,,1,,DTS,70.9,24.05,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,39,9.59,,1,,0,Race data reported,0.9792,,0.0208,,,,,,,0%,,,,,,Child sexual abuse,,,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,0.5,,POINT (-95.71289 37.09024),High,"Zlotnick C, Shea MT, Rosen KH, et al. An affect-management group for women with posttraumatic stress disorder and histories of childhood sexual abuse. J Trauma Stress. 1997 Jul;10(3):425-36. doi: 10.1023/A:1024841321156. PMID: 9246650.",13731,2019
zlotnick2009,2009,Psychotherapy,PTSD+SUD,49,,0.835,,CAPS-I,67.2,18.9,,Additional definitions of PTSD severity at baseline reported in the study,,,mean 15.6 (SD 6.7) age in years of PTSD onset,0,,,,1,Community,,34.6,7.4,,1,,0,Race and Ethnicity data reported,0.469,0.327,,,,0.204,,0.142,,,,,,,,Mixed,"rape/sexual assault, community/school violence",,,,,,all of the women reported repeated trauma,Drug,Mixed Alcohol/Drug,Included,"Current


Substance dependence: 100%  (Based on use prior to entering prison)


Substance dependence: 100%


Alcohol dependence: 87.8%


Lifetime alcohol abuse: 4.1%",,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.",32555,2020
zoellner2017,2017,Psychotherapy & pharmacotherapy,PTSD,42,,1,,PSS-I,31.98,6.73,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,37.5,12.4,,0.7143,,0.2857,Race and Ethnicity data reported,0.7857,0.119,0.0476,0.0952,,,,0.0952,,52.38%,,,,,,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (-95.71289 37.09024),High,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zohar2002,2002,Pharmacotherapy,PTSD,42,,1,,CAPS-2,92.2,12.6,,Additional definitions of PTSD severity at baseline reported in the study,7.3,8,,0,,,1,0,Veteran,,40,8,,0.88,,0.12,,,,,,,,,,,,,,,,,Mixed,"combat-related, accidents, other (captivity)",,,,,,,,,Excluded,0%,,,,,,,,,,,,,,,,,,POINT (35.00445 31.4611),Some Concerns,"Zohar J, Amital D, Miodownik C, et al. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22(2):190-5. doi: 10.1097/00004714-200204000-00013. PMID: 11910265.",24564,2019
zucker2009,2009,CIH,PTSD,45,"(population characteristics reported for completers, n=38)",1,,PCL-C,53.22,11.05,,Additional definitions of PTSD severity at baseline reported in the study,,,,,,,,1,Community,,,,proportion in age groups: 18 to 30: 18.4%; 31 to 40: 31.6%; 41 to 50: 34.2%; 51 to 60: 15.8%,0.447,,0.553,Race and Ethnicity data reported,0.316,0.553,,0.053,,0.079,,0.026,,,,,,,,,,,,,,,,,,Included,100%,,,,,,,,,,,,,,,,1,,POINT (-95.71289 37.09024),High,"Zucker TL, Samuelson KW, Muench F, et al. The effects of respiratory sinus arrhythmia biofeedback on heart rate variability and posttraumatic stress disorder symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2009;34(2):135-43. doi: 10.1007/s10484-009-9085-2. PMID: 19396540.",33842,2019
